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SOMMARIO 
 
Vi è un crescente interesse fra la comunità scientifica internazionale, le 
compagnie farmaceutiche e la ricerca clinica nel trovare delle valide alternative 
ai modelli standard nello sviluppo di nuove strategie terapeutiche e di processi di 
scoperta di nuovi farmaci. I ricercatori si basano tuttora sull’utilizzo di linee 
cellulari immortalizzate, cellule primarie estratte da organi e su modelli animali. 
Queste metodiche sono valide e largamente utilizzate per scopi generali, ma il 
più delle volte presentano dei limiti evidenti. Le linee cellulari e cellule primarie 
spesso non riproducono fedelmente le esatte caratteristiche dei tessuti in vivo, 
poiché perdono alcune caratteristiche fisiche e funzionali quando sono coltivate 
in vitro. D’altra parte, i modelli animali sono ancora necessari per lo studio di 
patologie specifiche e nel test di nuovi composti, ma risultano essere dispendiosi 
in termini di tempo e denaro e spesso mostrano una scarsa capacità predittiva 
nei confronti degli effetti sull’uomo. Quindi, le cellule staminali pluripotenti 
umane rappresentano una valida alternativa ai modelli esistenti, grazie alle loro 
capacità di essere espanse in vitro indefinitamente e di poter differenziare in 
tutti i tipi cellulari derivanti dai tre foglietti germinali. Negli ultimi anni 
l’attenzione si è concentrata sui tessuti ingegnerizzati, differenziati a partire da 
cellule pluripotenti. Questi hanno la possibilità di trasformare radicalmente il 
modo in cui studiamo in vitro la fisiologia e la patofisiologia umana. Ciò non di 
meno, vi sono ancora problemi nei processi di differenziamento di cellule 
staminali embrionali e pluripotenti indotte umane in vitro. Questo perché si 
riscontra difficoltà nel dirigere specificamente il destino cellulare verso un 
determinato tipo cellulare in modo robusto, e per la scarsa riproducibilità delle 
condizioni fisiologiche in cui questi processi hanno normalmente luogo in vivo. In 
questo ambito, le nuove micro-tecnologie possono dare un aiuto 
nell’oltrepassare queste limitazioni, poiché permettono di lavorare in micro-scala 
in maniera difficilmente riproducibile in condizioni di coltura standard. In questo 
contesto, lo scopo di questa tesi di dottorato è quello di differenziare 
efficacemente cellule staminali pluripotenti umane per riuscire ad ottenere 
rilevanti tipi cellulari, quali cardiomiociti ed epatociti. La strategia applicata per 
l’ottenimento di questi modelli umani in vitro si basa sull’applicazione di 
tecnologie in micro-scala per permettere la riproduzione in vitro delle nicchie 
fisiologiche, che guidano il differenziamento e permettono lo sviluppo 
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funzionale. In particolare sono stati utilizzati dei micro-pozzetti tridimensionali 
per modulare l’accumulo di fattori endogeni in corpi embrioidi umani in 
differenziamento, per studiare lo sviluppo dei tre foglietti germinali guidato da 
diversi microambienti cellulari. È stata poi imposta una modulazione delle 
proprietà meccaniche dei nuclei di cellule pluripotenti tramite utilizzo di substrati 
micro-strutturati, per lo studio della capacità peculiare di deformazione nucleare 
di tali cellule e si è valutato l’effetto sulla pluripotenza e il differenziamento 
precoce. Inoltre sono state utilizzate tecnologie micro-fluidiche per modulare 
selettivamente il microambiente cellulare solubile, in modo da ottimizzare il 
mantenimento della pluripotenza in chip micro-fluidici, nonché lo sviluppo 
cellulare precoce e il differenziamento funzionale in cardiomiociti ed epatociti. È 
stata ottenuta un’alta percentuale di cardiomiociti contrattili nei chip che 
mostravano risposte funzionali corrette a stimoli di calcio. La tecnologia micro-
fluidica ha permesso poi di ottenere un’alta percentuale di epatociti in chip 
rispetto alle condizioni di coltura standard. Queste cellule mostravano 
caratteristiche fenotipiche e funzionali corrette, che sono state poi analizzate in 
condizioni più fisiologiche sotto un gradiente stabile di ossigeno, mimando le 
condizioni in vivo. Questi tipi cellulari specifici, generati in chip da cellule 
staminali pluripotenti umane tramite un approccio multi-stadio, mostrano un 
differenziamento funzionale specifico, che apre a nuove prospettive per test 
multi-parametrici su larga scala basati su tessuti funzionali umani. 
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INTRODUZIONE 
 
Lo sviluppo di nuovi modelli in vitro di tessuti umani, in cui le cellule umane si 
sviluppano in un microambiente fisiologico, offre straordinarie opportunità di 
studiare la fisiologia e la patofisiologia umana in un contesto organo-specifico 
(Huh et al. 2012). 
Tale prospettiva potrebbe fornire una soluzione effettiva ai limiti delle 
colture cellulari convenzionali, che non riescono a ricapitolare effetti e 
caratteristiche di malattie umane complesse, e potrebbe inoltre contribuire 
efficacemente all’uso di test animali dispendiosi che spesso offrono uno scarso 
potere predittivo della fisiologia umana. 
 In questa direzione, la comunità scientifica e le agenzie governative 
riconoscono l’enorme importanza dello sviluppo di nuovi modelli, che diano la 
possibilità di svolgere test multi-parametrici economici per studi ad hoc di 
sviluppo, malattie e patogenesi, o per testare nuove e specifiche strategie 
terapeutiche. 
I saggi fisiologici in vitro aiuterebbero a migliorare il grado di trasferimento 
delle scoperte pre-cliniche alla clinica, ma da questo punto di vista, un 
componente critico per tali test sarebbe l’uso di modelli cellulari affidabili che 
riescano a catturare la complessità della situazione clinica in esame (Engle and 
Puppala, 2013). Per questo motivo vengono subito in mente le cellule primarie 
umane, dati i loro vantaggi maggiori rispetto alle linee cellulari, quali 
l’espressione di importanti proteine target nel loro normale ambiente normale. 
Però anche questi tipi cellulari presentano svantaggi significativi (Eglen et al. 
2008). In primis, la scarsa disponibilità data dalla difficile reperibilità di tessuti 
estratti da pazienti. Le cellule differenziate in modo terminale poi non sono 
proliferanti e risulta impossibile una loro espansione in coltura (Goldbard, 2006).  
Le cellule primarie mostrano spesso in coltura un fenotipo instabile de-
differenziato dopo l’isolamento dal tessuto, il che rende l’interpretazione dei dati 
difficile e limita la finestra temporale disponibile per la sperimentazione  (Sahi et 
al. 2010). Per alcuni tessuti, gli attuali protocolli di coltura sono incapaci di 
ricapitolare lo stato cellulare di interesse. La generazione di cellule staminali 
embrionali umane (hESCs) e di cellule staminali pluripotenti indotte umane 
(hiPSCs) ha offerto una valida alternativa all’uso di cellule primarie nello sviluppo 
di farmaci e nella generazione di modelli di tessuti umani  (Engle and Puppala, 
2013). Queste cellule possono essere espanse in coltura indefinitamente in 
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opportune condizioni, e possono essere fatte differenziare nei tipi cellulari 
terminali derivanti dai tre foglietti germinali, ectoderma, endoderma e 
mesoderma. Il processo di differenziamento in vitro ricapitola gli aspetti del 
normale sviluppo cellulare, offrendo quindi un’opportunità di compiere studi di 
sviluppo e processi rigenerativi. 
Il tessuto cardiaco ed il tessuto epatico sono due dei maggiori tessuti di 
interesse nel processo di sviluppo di modelli patologici e sviluppo di farmaci. La 
fase di sviluppo pre-clinico dei farmaci presenta un alto grado di fallimento a 
causa di effetti cardiaci indesiderati. Inoltre, tossicità cardiache non riconosciute 
preoccupano sempre più, non solo in test clinici, ma anche per quanto riguarda 
farmaci già in commercio. Da qui risulta l’importanza dello sviluppo di modelli in 
vitro rilevanti, che rispecchino la funzionalità normale del tessuto cardiaco 
(Agarwal et al., 2013). 
Al momento anche gli epatociti primari umani costituiscono un modello 
comune per saggi in vitro. Sfortunatamente, proteine e funzioni chiave vengono 
perse quando queste cellule sono mantenute in coltura. Per queste ragioni vi è 
una impellente necessità di studiare nuovi modelli che riescano a mimare cellule 
epatiche umane e che possano predire gli effetti di molecole candidate nello 
sviluppo di nuovi composti o farmaci (Sartipy and Björquist, 2011). 
Il Capitolo 1 si focalizzerà sull’introduzione dei modelli di cellule staminali 
umane adottati in questo lavoro di dottorato, con una descrizione delle 
caratteristiche più importanti, incluso un focus sul microambiente e i maggiori 
pathway proteici coinvolti nel mantenimento della pluripotenza. Sarà discusso lo 
stato dell’arte di diverse micro-tecnologie applicate alla biologia cellulare e sarà 
introdotto lo scopo generale di questa tesi. 
Il Capitolo 2 introduce le metodologie applicate per lo sviluppo in laboratorio 
degli strumenti micro-ingegneristici utilizzati nelle colture cellulari, quali i micro-
pozzetti di idrogel di poliacrilammide, i substrati micro-strutturati e le 
piattaforme micro-fluidiche. Saranno inoltre presentate le metodiche per la 
coltura di cellule staminali e il loro differenziamento in tipi cellulari specifici. 
Il Capitolo 3 si focalizzerà sui risultati ottenuti nella modulazione del 
microambiente cellulare tramite l’uso di idrogel tridimensionali e il suo effetto 
sugli stadi precoci del differenziamento. Inoltre saranno presentati i risultati sul 
controllo meccanico della morfologia dei nuclei di cellule staminali e sarà 
presentata una analisi degli effetti della deformazione durante la pluripotenza in 
diversi tipi cellulari e durante il differenziamento precoce in cellule pluripotenti. 
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Nel Capitolo 4 saranno descritti i risultati sul controllo del microambiente 
solubile cellulare durante lo stato di pluripotenza e come il mantenimento di 
cellule staminali possa essere ottimizzato in colture in micro-fluidica, tramite 
cambi medium a intervalli definiti. 
Il Capitolo 5 si focalizzerà poi sull’utilizzo di piattaforme microfluidiche per 
dirigere lo sviluppo precoce dei foglietti germinali. In questo Capitolo saranno poi 
presentati i risultati sull’utilizzo di questa tecnologia per l’obbiettivo principale di 
dirigere selettivamente il differenziamento di cellule staminali pluripotenti 
umane in cardiomiociti ed epatociti funzionali. 
Nel Capitolo 6 saranno presentate la discussione generale e le conclusioni del 
lavoro, insieme ad un caso particolare di studio, esposto come prospettiva futura 
del lavoro, del gradiente di ossigeno generato nel chip micro-fluidico per riuscire 
a mimare le condizioni di un microambiente fisiologico in cui gli epatociti si 
trovano in vivo all’interno del lobulo epatico. 
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SUMMARY 
 
There is a growing interest by scientific community, together with 
pharmaceutical companies and clinical researcher on finding valid alternatives to 
standard models in the development of new therapeutic strategies and robust 
drug screening processes. Research still relies on the use of immortalized cell 
lines, primary cell extracted from living organs and animal models. These 
methodologies are valid and still mainstream for general purposes, but most of 
the times present evident limits. Cell lines and primary cells often fail to 
reproduce the exact characteristics of the tissue found in vivo, because they lose 
some of the features and functionalities when grown in culture. On the other 
hand, animal models, even if necessary for the study of specific diseases and new 
compound testing, are expensive and time-consuming, and often show poor 
predictive capacity and scarce reproducibility of the human condition. Hence, 
human pluripotent stem cells could represent a valid alternative to the existing 
models, thank to their capacity to be expanded indefinitely and differentiate into 
almost all cell types found in vivo. In the recent years, there has been a growing 
attention on engineered tissues differentiate from pluripotent cells. They have 
the capacity to transform the way to study human pathophysiology and 
physiology in vitro. Nevertheless, there are still major problems in the process of 
differentiating human embryonic and induced pluripotent stem cell in vitro. This 
is because of the difficulty to specifically direct cell fate to a particular cell type in 
a robust way, and for the poor reproduction of the physiological conditions 
under which these processes take place. In this direction, new microtechnologies 
could help overcome these major limitations, because they allow working on 
microscales, in a way that cannot be reproduced by standard culture conditions. 
In this context, the aim of this PhD thesis is to efficiently differentiate human 
pluripotent stem cells in order to obtain functional relevant cell types, such as 
cardiomyocytes and hepatocytes. The strategy applied for the obtainment of 
these human in vitro models rely on the application of microscale technologies 
for reproducing in vitro the main physiological cues, which guide differentiation 
and allow functional development. In particular, three-dimensional microwell 
were used for modulating endogenous factor accumulation on differentiating 
human embryoid bodies, to screen for selective germ layer commitment guided 
by a differential microenvironment around the differentiating cells. Furthermore, 
a mechanical modulation of the pluripotent nuclei mechanical properties was 
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imposed with the use of microstructured substrate, for the study of the peculiar 
capacity of nuclear cell deformation, and its effect in pluripotency and early 
differentiation. Moreover, microfluidic technologies were used to selectively 
modulate cell soluble microenvironment, in order to optimize pluripotency 
maintenance, early germ layer commitment, and functional differentiation into 
cardiomyocytes and hepatocytes. A high percentage of spontaneously beating 
cardiomyocytes on chip was obtained, showing proper functional response to 
calcium stimuli. On the other hand, microfluidic technology allowed to obtain a 
higher percentage of hepatocytes compared to standard culture conditions. 
These cells showed proper phenotypic and functional characteristics, which were 
also analyzed in a more physiological condition under a defined oxygen gradient, 
mimicking in vivo physiological conditions. These specific cell types generated on 
chip from human pluripotent stem cells through a multi-stage approach show 
specific functional differentiation, which opens a new perspective for multi-
parametric and large scale human tissue-based screening assays. 
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INTRODUCTION 
 
The development of new in vitro human tissue models, in which cultured 
human cells recapitulate the whole living organ microenvironment, offers an 
extraordinary opportunity to study human physiology and pathophysiology in an 
organ-specific context (Huh et al. 2012). 
This perspective could provide an effective solution to the limitations of 
conventional cell cultures, which fail to recapitulate complex, organ-level disease 
processes in humans, and it could efficiently contribute to the use of expensive 
and time-consuming animal testing, which often shows poor predictive power of 
human physiology. 
In this direction, also the scientific community, the major pharmaceutical 
companies and the government agencies are recognizing the paramount 
importance of developing new models, which would allow to perform cost 
effective and multi-parametric assays for ad hoc studies in development, disease 
and pathogenesis, or for screening specific therapeutic strategies. 
If physiologically relevant in vitro assays are to improve the success in 
translating preclinical discoveries to the clinic, a critical component will be the 
use of more relevant cellular systems, which capture the complexity of the 
clinical situation (Engle and Puppala, 2013). For this reason one would 
immediately think of primary human cells, because of their major advantages 
over cell lines, such as the expression of target proteins functioning in their 
normal environment. However, primary cells present some significant 
disadvantages (Eglen et al. 2008). First of all there is a limited availability caused 
by the shortage of tissues extracted from patients. Further differentiated cells do 
not proliferate, so their expansion in culture is impossible (Goldbard, 2006). 
Primary cells often exhibit an unstable, dedifferentiated phenotype in culture 
after isolation, which makes data interpretation difficult and limits the available 
time window for experimentation (Sahi et al. 2010). 
For some tissues, the current culture protocols are incapable of 
recapitulating the cellular state of interest. The generation of human embryonic 
stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) has offered 
a valid alternative to human primary cells for use in drug development and 
human tissue model generation (Engle and Puppala, 2013). Under proper 
conditions, these cells can be expanded in culture indefinitely and eventually 
directed to differentiate into a variety of terminal cell types within the three 
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germ layers, ectoderm, endoderm and mesoderm. The in vitro differentiation 
process recapitulates aspects of normal development, opening up the 
opportunity to study developmental and regenerative processes. 
Two of the major tissues of interest in the process of disease modeling and 
drug development are cardiac and hepatic tissues. Preclinical drug development 
is severely hampered by high failure rates due to cardiac side effects. In addition, 
unforeseen cardiac toxicities are also a growing concern not only for clinical trials 
but also for already marketed drugs. Hence, the importance of developing 
relevant in vitro models which recapitulate cardiac tissue level functionality 
(Agarwal et al., 2013). Accordingly, at present, primary human hepatocytes 
constitute a common model for in vitro safety assessment. Unfortunately, key 
proteins and functions are missing in these cells when kept in culture. For these 
reasons there is a urgent need for new model systems that better mimic human 
liver cells and that are able to predict effect of candidate molecules in the 
development of new drugs or chemicals (Sartipy and Björquist, 2011). 
Chapter 1 will focus on the introduction of the human stem cell models 
adopted during the PhD project, with a description of their most important 
characteristics, including a focus on their microenvironment and main pathways 
involved in maintenance of pluripotency. The state of the art of different 
microtechnologies applied to cell biology will be discussed, together with the 
general aim of the thesis. 
Chapter 2 introduces the methodologies applied in order to set up the 
microengineering tools used for cell culture, such as polyacrylamide hydrogel 
microwells, microstructures substrates and microfluidic platforms. It will be also 
presented the methodology for stem cell culture and differentiation into specific 
cell lines. 
Chapter 3 will focus on the results obtained in the modulation of the cell 
microenvironment through the use of the three-dimensional hydrogels, and its 
effect on early differentiation stages. Further results on a mechanical control of 
stem cell nuclei morphology will be presented, and there will be an analysis on 
the effect of the deformation during pluripotency in different cell types and 
during early germ layer commitment in pluripotent cell types. 
Chapter 4 will describe the results on the control of the cell soluble 
microenvironment during pluripotency state and how stem cell maintenance can 
be optimized in microfluidic cell culture through intermittent medium perfusion. 
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Chapter 5 will focus next on the use of microfluidic platforms to drive stem 
cell early germ layer commitment. This chapter presents then the results on this 
technology used for its main goal of selectively directing human pluripotent stem 
cell differentiation into functional cardiomyocyte and hepatocyte-like cells. 
Chapter 6 will present the general discussion and conclusions, together with 
a case study as a future perspective of an oxygen gradient generated in the 
microfluidic chip in order to better mimic physiological microenvironment 
condition in which hepatocytes are found in vivo in the liver lobules. 
 
 
 
References 
 
Dongeun Huh, Daniel C. Leslie, Benjamin D. Matthews, Jacob P. Fraser, Samuel Jurek, Geraldine A. 
Hamilton, Kevin S. Thorneloe, Michael Allen McAlexander, Donald E. Ingber. A Human Disease 
Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice. SciTransl 
Med 7 November 2012: Vol. 4, Issue 159, p. 159ra147 
Engle SJ, Puppala D. Integrating human pluripotent stem cells into drug development. Cell Stem 
Cell. 2013 Jun 6;12(6):669-77. doi: 10.1016/j.stem.2013.05.011. 
Eglen RM, Gilchrist A, Reisine T. The use of immortalized cell lines in GPCR screening: the good, 
bad and ugly. Comb Chem High Throughput Screen. 2008 Aug;11(7):560-5. 
Goldbard S. Bringing primary cells to mainstream drug development and drug testing. Curr Opin 
Drug Discov Devel. 2006 Jan;9(1):110-6. 
Sahi J, Grepper S, Smith C. Hepatocytes as a tool in drug metabolism, transport and safety 
evaluations in drug discovery. Curr Drug Discov Technol. 2010 Sep;7(3):188-98. 
Agarwal A, Goss JA, Cho A, McCain ML, Parker KK. Microfluidic heart on a chip for higher 
throughput pharmacological studies. 2013 Sep 21;13(18):3599-608. 
Sartipy P, Björquist P. Concise review: Human pluripotent stem cell-based models for cardiac and 
hepatic toxicity assessment. Stem Cells. 2011 May;29(5):744-8. doi: 10.1002/stem.631. 
 
  
 XI 
 
FOREWORD 
 
During these three years of PhD work, I have been able to learn how to work 
in an interdisciplinary environment, merging my industrial biotechnology 
background with clinical expertise, and chemical engineering knowhow. The 
opportunity to work in a multidisciplinary laboratory gave me the possibility to 
explore new frontiers in scientific research and open my mind to challenging 
situations. I would like to thank my PhD supervisor, Prof. Annarosa Floreani, for 
her dedication to this project, for the trust she put in me and for introducing me 
to new academic experiences. I would also like to thank my PhD co-tutor Dr. 
Nicola Elvassore for giving me this chance and always believing in me, and for all 
the things I learned thank to him. 
The author is grateful to the Università degli Studi di Padova, Fondo Sociale 
Europeo, Progetti di Eccellenza Cariparo, Progetti di Eccellenza Giovani 
Ricercatori of Ministero della Salute, for financial support to the research 
activity. 
During the period of the PhD program, the following publication have been 
produced: 
 
• Giobbe GG, Zagallo M, Riello M, Serena E, Masi G, Barzon L, Di Camillo B, Elvassore N. 
Confined 3D microenvironment regulates early differentiation in human pluripotent stem 
cells. Biotechnol Bioeng. 2012 Dec;109(12):3119-32. 
• Giobbe GG, Michielin F, Martewicz S, Giulitti S, Luni C, Floreani A, Elvassore N. Integrated 
multi-stage tissue on a chip generation from human pluripotent stem cells. Nat Methods. 
(under revision). 
• Zatti S, Martewicz S, Serena E, Uno N, Giobbe GG, Kazuki Y, Oshimura M & Elvassore N. 
Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne 
muscular dystrophy patient–derived cardiomyocytes. Molecular Therapy - Methods & 
Clinical Development. doi:10.1038/mtm.2013.1. Published online 08 January 2014. 
• Grespan E, Giobbe GG, Badique F, Anselme K, Rühe J, Elvassore N. Human pluripotent 
stem cell nuclear self-deformation in pluripotency and differentiation. (to be submitted). 
 
Numerous abstracts were submitted to several international conferences 
during the PhD program, for oral presentations and poster presentations, 
including: Italian Association For The Study of the Liver (AISF); European 
Association for the Study of the Liver (EASL); American Assiociation for the Study 
of Liver Diseases (AASLD); International Society for Stem Cell Research (ISSCR). 

 1 
 

 1 
 
CHAPTER 1 
 
MICROTECHNOLOGIES FOR THE DEVELOPMENT OF STEM 
CELL DERIVED IN VITRO MODELS 
 
 
1.1 Human pluripotent stem cells 
 
Stem cells are undifferentiated cells, which do not show any specific 
characteristic in terms of morphology, antigenicity and function, and they have 
the capacity to self-renew and differentiate into specialized cells. Self-renewal 
allows stem cells to replicate indefinitely while maintaining an undifferentiated 
state. Plasticity, instead, allows them to differentiate into a wide range of cells, 
which maintain the original hereditary information but reduce the potential of 
their genome to specialize and acquire defined functions. The self-maintenance 
capacity is given by the peculiar characteristics of division regulated by two main 
mechanisms. Symmetric proliferative division gives rise to two identical cells 
from the mother cells, while symmetric differentiative division generates two 
identical cells but more differentiated. These two mechanisms maintain a 
constant percentage of stem cell in an organism. Stem cells allow the tissues to 
maintain an proper architectural, cytological and biochemical structure in order 
to guarantee the correct functionality of the different organs (Potten and 
Loeffler, 1990). 
Particular types of stem cells are the pluripotent cells. The first report of 
human embryonic stem cells was on 1998 (Thomson et al. 1998). This was a 
breakthrough among the international scientific community and the whole 
society still recognize huge potentiality to the applications of stem cells for 
models development, screening and disease therapies. On the other side, a large 
debate took place on whether hESCs use was ethical or not. In fact, they derive 
from the inner cell mass (ICM) of a 5-days fertilized blastocyst (Fig. 1.1), which is 
extracted and grown in culture with, or without, feeder layer cells. When the 
clonal expansion begins, only the cell colonies showing undifferentiated state, 
high clonal capacity, pluripotency and normal karyotype are kept and expanded. 
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Figure 1.1.Generation of human embryonic stem cell lines. Donor embryos are first obtained after 
in vitro fertilization or by egg activation (parthenogenetic embryos), and allowed to develop in 
vitro. Pluripotent cells are then isolated either from the inner cell mass of pre-implantation 
blastocysts or from 4, 8, or 16 -cell stage morulae. Finally, isolated cells are plated in defined hESC 
medium with or without feeder cell layers to propagate and select for pluripotent cell populations. 
These processes have resulted in hESC lines able to generate tissues from all three embryonic 
germ layers and the germline (adapted from Yabut and Bernstein, 2011). 
 
Pluripotency state is verified by the capacity to form spontaneous cell 
aggregates under appropriate culture conditions, the embryoid bodies (EB), in 
which cells start to differentiate spontaneously into various cell types. Moreover, 
when hESCs are injected in an immunocompromised mouse they generate a 
teratoma, in which cells differentiate spontaneously into several cells types. 
Therefore, hESCs can originate all the derivates of the three germ layers and are 
a precious tool for the development of in vitro models and therapeutic 
screening. 
The proof of pluripotency properties opened new and promising perspectives 
in fields such as developmental biology, genomics, pathophysiological studies, 
drug screening and development. It is worth underlying how many of the most 
common diseases (heart failure, liver diseases, neurodegenerative disorders, 
diabetes, etc.) result from cellular deficiencies or dysfunctions. In this sight, 
having the possibility of generating relevant numbers of defined cell populations, 
may allow the development of novel cell therapies or, in parallel, to perform 
studies on specialized human cells that would permit the obtainment of more 
significant data aimed at the development of the necessary therapeutic 
strategies. 
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The ethical issues centered on the use of embryos for the obtainment of 
human embryonic cells, have been a driving force towards the development of 
alternative strategies for obtaining similar and such powerful cells. In 2007 
(Takahashi et al. 2007) another breakthrough in science, first on mouse and then 
on human cells, was reported. Dr. Yamanaka found a way to overcome the 
ethical issues raised by hESCs, by reprogramming adult somatic cells to a 
pluripotent state, with selective induction of specific pluripotency factors Oct4, 
Sox2, cMyc, and Klf4 (Fig. 1.2). 
 
Figure 1.2.Generation of human induced pluripotent stem cell lines. Adult somatic cells, i.e. skin 
fibroblasts, are taken from patient, cultured in vitro and reprogrammed with specific factors i.e. 
Oct4, Sox2, Klf4, Myc, Nanog, Lin28. Reprogramming can be done by viral vectors, modified 
mRNAs etc. Pluripotent cells colonies are selected and and expanded in culture and can be 
differentiated to specific cell types (modified from Carr et al. 2013). 
 
HiPSCs share equal or similar characteristics with hESCs, but this 
groundbreaking methodology opened new perspectives especially toward a 
patient-specific medicine. Many human diseases (metabolic, genetic, 
multifactorial diseases) are difficult to study in animal models. Thus, the 
reprogrammed cells would give scientists a new tool for studying genetic and 
molecular basis on a much relevant model. It is important to underline that all 
the technologies and studies that will be presented in this thesis, have been 
performed both on hES and hiPS cells, in order to develop more relevant in vitro 
models. 
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1.2.1 Major pathways involved in pluripotency maintenance and 
differentiation 
 
Mechanisms controlling pluripotency and differentiation of pluripotent cells 
have been extensively studied, but many aspects remain still unknown. It has 
been clearly demonstrated that activin/nodal signaling maintains the pluripotent 
status of hPSCs (Vallier et al. 2009). Pluripotency is regulated by a combination of 
extrinsic and intrinsic factors. FGF (Fibroblast Growth Factor) signaling and a 
balance between TGF-Beta (Transforming Growth Factor-Beta)/Activin and BMP 
(Bone Morphogenic Protein) signaling are central to hPSCs self-renewal. Intrinsic 
factors regulating pluripotency include transcription factors such as Nanog and 
Oct4 (Octamer Binding Transcription Factor-4) (Biswas and Hutchins, 2007). 
TGF-Beta ligand superfamily, plays a major role in maintaining the self-
renewal capacity. TGF-Beta signals through two main branches: the SMAD1/5 
branch, which transduces on behalf of BMP and GDF (Growth Differentiation 
Factor), and the TGF-Beta/Activin/Nodal branch, which involves the activation of 
SMAD2/3. There are also two inhibitory SMADs: SMAD6, which selectively 
inhibits SMAD1/5, and SMAD7, which inhibits both branches of TGF-Beta 
signaling, that provide a repressive input on the pathway. Upon activation by 
phosphorylation and association with a common SMAD4, the receptor-activated 
SMADs translocates to the nucleus and, with other transcription factors, 
regulates gene expression. Activation of the TGF-Beta/Activin/Nodal branch 
through SMAD2/3 is associated with pluripotency and is required for the 
maintenance of the undifferentiated state in hPSCs (Xiao et al. 2006, James et al. 
2005). 
In contrast, BMP signaling is unable to support self-renewal and it is 
associated with differentiation to trophoblast or extraembryonic endoderm cells. 
In hPSCs, BMP4 induces differentiation into mesoderm and ectoderm, whereas 
BMP2 promotes extraembryonic endoderm differentiation. Repression of BMP 
signaling in by Noggin and FGF supports long term self-renewal. FGF2 is known as 
the best known factor promoting self-renewal in hPSCs and is capable of 
maintaining pluripotent cells in the absence of serum and feeder cells. FGF2 
promote self-renewal of Human ESCs by activating the PI3K pathway (Xu et al. 
2005). 
Nanog is another member of the group of transcription factors whose 
functions are deemed essential for the process of self-renewal in hPSCs. The 
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binding of Oct3/4 and SOX2 to its promoter regulates transcription of Nanog. 
Oct3/4, SOX2, and Nanog co-occupy the promoters of a large range of genes, 
many of which encode developmentally important transcription factors. HPSCs 
exhibit a number of signaling pathways involved in self-renewal and pluripotency 
that are interdependent and display a range of cross-talk mechanisms (Boyer et 
al. 2005, Pan and Thomson, 2007). The understanding of the exogenous and 
endogenous factors determining cell fate will facilitate the use of these cells in 
cell-based therapies and will allow further understanding of early developmental 
processes. 
 
1.2.2 Human pluripotent stem cell microenvironment 
 
The cell microenvironment is a dynamic structure, defined as the “niche” 
where the cell grows and develops. During embryonic development, various 
microenvironment factors act on embryonic stem cells to alter gene expression, 
and induce their proliferation or differentiation for the development of the fetus. 
Within the human body, stem cell niches maintain adult stem cells in a quiescent 
state, but after tissue injury, the surrounding micro-environment actively signals 
to stem cells to either promote self-renewal or differentiation to form new 
tissues. Several factors are important to regulate stem cell characteristics within 
the niche: growth factors, cytokines, stem cell-cell interactions, interactions with 
nearby differentiated cells, adhesion molecules, extracellular matrix 
components, oxygen tension, physiochemical nature of the environment (i.e. pH, 
ionic strength and metabolites) (Fig. 1.3). The stem cells and microenvironment 
may induce each other during development, and reciprocally communicate to 
maintain each other during adulthood (Scadden, 2006). 
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Figure 1.3.Components of the local microenvironment, which participate in regulating the system 
of a stem cell in its tissue site (adapted from Scadden, 2006). 
 
A pluripotent stem cell can be considered “naked” without its own 
microenvironment, and may not behave as expected during pluripotency and 
differentiation. For this reason, scientific community has been trying to recreate 
in vitro the various components of the niche found in vivo. For regenerative 
therapies, models and drug screening purposes, cell proliferation and 
differentiation must be accurately controlled. 
 
1.2.3 Human pluripotent stem cell limitations 
 
Both human embryonic and induced pluripotent stem cells have high 
potential in basic science and clinical application, but this is hindered by the 
impossibility to perfectly control them in vitro through their microenvironment. 
Some limitations during differentiation protocols to a particular cell type come as 
a consequence of this problematic: 
Non robust differentiation protocols, especially between different stem cell 
lines; 
Differentiated cells do not have an homogenous phenotype; 
Inability to reach adult cell phenotype; 
Relative low expression, or partial expression, of functional proteins defining 
a particular cell type; 
Only partial expression of functional properties; 
Partial expression of structural properties like polarization, interaction, 
architecture, vascularization, tissue structure. 
Coupling stem cells with microengineering technologies could help overcome 
these current limitations, in order to possibly reproduce some features of adult 
tissue types.  
 
1.2 Micro-technologies in pluripotent cell culture and tissue 
development 
 
Human pluripotent stem cells secrete numerous endogenous factors, which 
constitute the soluble microenvironment around cells, together with exogenous 
molecules and metabolites. In order to manipulate the microenvironment it is 
necessary to work on dimensions of micrometers. It is almost impossible to do 
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this in standard Petri dish culture plates. For this reason, in this PhD project, 
microengineering technologies have been applied to manipulate such small 
dimensions. 
Efficient control of the differentiation of hES and hiPS cells is a prerequisite 
for obtaining phenotypically homogenous populations. However, thus far, 
accurate expansion and differentiation processes of hPSC remained an open 
challenge. Multiple methods have been used to induce human pluripotent stem 
cells differentiation, including use of specific growth factors, co-culture with 
specific cell lines, culture on extracellular matrix proteins, and embryoid body 
formation (Dvash and Benvenisty, 2004; Itskovitz-Eldor et al., 2000; Keller, 2005; 
Odorico et al., 2001). EB differentiation method recapitulates the early stages of 
human embryonic development and provides a three-dimensional structure, 
most similar to in vivo conditions, where gradients of secreted factors are 
present. Recent developments in EB formation techniques have enabled more 
controlled systems capable of modulating EB shape and size, as these 
parameters have been recognized to contribute to the control of the resulting 
cell population. Non-adhesive polyethylene glycol (PEG) microwell arrays have 
been used to control the homogeneity of EB size and shape (Karp et al., 2007; 
Moeller et al., 2008). Recent studies on PEG microwell-mediated control of EB 
size have also investigated the effects on hES cell fate determination, specifically 
addressing cardiogenesis and vasculogenesis via WNT signaling pathways (Hwang 
et al., 2009). Micro-contact printing techniques have also been developed to 
regulate EB size-dependent hES cell differentiation and to investigate the stem 
cell biology (Lee et al., 2009; Park et al., 2007; Peerani et al., 2007, 2009). Concave 
(Choi et al., 2010; Park et al., 2009), convex-based (Park et al., 2009) thin PDMS 
membrane arrays and stimuli-responsive microwells (Tekin et al., 2010) for 
culturing the cells and better mimic the contour of EBs have also been 
developed. All these studies analyze the effect of factors or EB size and shape in 
regulating hPSC differentiation. The importance of growth factors in media 
during differentiation is clear, but little information about the role of secreted 
molecules during early differentiation stages has been reported, and this process 
will be further discussed in Chapter 3. 
During differentiation processes, stem cells are subjected to numerous 
stimuli, chemical, physical or mechanical. A growing number of studies try to 
analyze nuclear mechanics behavior, and there is an emergent topic in scientific 
research, which investigates the possible relationship between nuclear 
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properties and cancer, pluripotency and mechanotransduction responses (Zink et 
al. 2004,Davidson et al. 2009 and 2010, Chalut et al. 2012). Nuclear stiffness has 
been evaluated and compared in healthy and pathological cells, and a 
connection between disease and nuclear stiffness was reported (Lombardi et al. 
2010, De Vos et al. 2010). Nuclear stiffness seems to increase from human 
embryonic stem cells to differentiated cells and chromatin is shown to be less 
condensed in the pluripotent stage (Pajerowski et al. 2007). Few studies consider 
nuclear mechanics as a property of the nucleus in the cell in connection with the 
cytoskeleton. Studies on cancer cells show a strong deformation of the cell, and 
in particular of the nucleus, which adapts to the surrounding micro-topography. 
Despite such large nuclear deformation, cancer cells are still capable to divide, 
proliferate and differentiate. It has been demonstrated that this capability to 
self-deform depends on substrate topography, cell phenotype and cytoskeleton 
organization (Badique et al. 2013). Nuclear self-deformation due to geometric 
constraints on human pluripotent stem cells during differentiation will be 
analyzed in Chapter 3. 
 
1.2.1 Microfluidic technology and cell culture 
 
Microfluidics is a microengineering tool with application crossing from 
biology to chemistry, physics and medicine, which deal with fluids within 
micrometer scale devices (Whitesides 2006). This microtechnology gives major 
advantages in term of high throughput analyses, automatization of the systems, 
and the possibility to manipulate at micron scale the cell culture 
microenvironment, in terms of controlling the balance between endogenous and 
exogenous soluble factors. 
Microscale technologies were designed for applications ranging from studies 
at a single cell level to the recreation of more complex three-dimensional 
structures (Gottwald et al. 2007, Kim et al. 2007). Successful examples of tissue-
on-chip development have been provided (Huh et al. 2010, Lee et al. 2013), 
however, they were obtained from primary animal cells and, in few cases, from 
primary human cells. The possibility of developing tissue-on-chips from hPSCs 
could overcome the limited availability of human primary cells, such as human 
hepatocytes or cardiomyocytes. Cell differentiation and tissue generation are 
complex developmental processes starting from germ layer specification and 
phenotypic differentiation to tissue morphogenesis. Biomimetic scale down of 
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this multi-stage developmental process could take advantage of the intrinsic 
properties of micro-technologies and microfluidics that allow accurate control of 
cell culture microenvironment, of temporal evolution of chemical gradients and 
of mechanical features, which support specific tissue differentiation (Discher et 
al. 2009). Few studies reported on mouse embryonic stem cell cultures using 
microfluidic systems and highlight the importance of accurate soluble 
microenvironment regulation to maintain pluripotency and self-renewal 
(Przybyla and Voldman, 2012). 
The microtechnology-aided culture of pluripotent cells will be further 
discussed in Chapter 4, while functional differentiation into cells of interest will 
be discussed in Chapter 5. Cardiomyocytes and hepatocytes have been chosen as 
differentiation tissue models in the microfluidic chip, for their importance on in 
vitro model development and translational research. 
In particular, liver tissue shows a high degree of structural complexity, with 
perfectly interconnected different cell types. The smallest functional working 
unit of the human liver is the hepatic lobule. It is a small hexagonal division 
defined at histological scale, divided into concentric centrilobular, midzonal, 
periportal parts. Between two liver lobules there is a metabolic unit defined as 
the acinus. This elliptical region is divided into zone I (periportal), zone II 
(transition zone), and zone III (pericentral). Hepatocytes develop under a 
constant oxygen gradient, from the oxygenated blood of hepatic artery (pO2 60-
70 mmHg) to the less oxygenated blood of the central vein (pO2 25-35 mmHg) 
(Fig. 1.4). Functionally, a metabolic zonation is present: zone I hepatocytes are 
specialized for oxidative liver functions such as gluconeogenesis, β-oxidation of 
fatty acids and cholesterol synthesis, while zone III cells are more important for 
glycolysis, lipogenesis and cytochrome P-450-based drug detoxification (Schiff et 
al., 2007; Usynin and Panin, 2008). 
10 
 
 
Figure 1.4. Schematic representation of two adjacent hexagonal liver lobules, with the central 
acinus region within the elliptic line. Note the subdivision into the three metabolic regions, and 
the scheme of the oxygen gradients direction from the branch of the hepatic artery to the central 
veins. 
 
When differentiating in vitro hepatocytes, the liver structure complexity is 
lost, and this is one of the reasons why is difficult to obtain mature hepatocytes 
from pluripotent cells. As it will be discussed in Chapter 6, microfluidic 
techniques could help reconstruct some of the features of this complexity, such 
as the oxygen gradient, under which hepatocytes from hPSCs can differentiate 
under a more physiological condition. 
 
1.3 Aim of the thesis 
 
The aim of this PhD thesis is to efficiently differentiate human pluripotent stem cells 
through the use of microtechnologies, into functional cardiomyocytes and hepatocytes, 
which can be possibly used as in vitro models for drug and therapy development, 
disease modeling, physiological studies and improve quality of clinical trials. 
To this end, the application of microengineering techniques can help to overcome 
the major limitations of conventional cell cultures, in order to optimize pluripotency 
maintenance and functional differentiation. 
The coupling of pluripotent stem cell potential with ad hoc microtechnologies, 
would ultimately allow the development of high throughput drug and therapy 
screenings. 
 
 11 
 
 
References 
 
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of 
pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 
30;131(5):861-72. 
Carr AJ, Smart MJ, Ramsden CM, Powner MB, da Cruz L, Coffey PJ. Development of human 
embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 2013 
Jul;36(7):385-95. doi: 10.1016/j.tins.2013.03.006. 
Potten CS, Loeffler M., Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for 
and from the crypt. Development. 1990 Dec;110(4):1001-20. 
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 
Embryonic stem cell lines derived from human blastocysts. Science. 1998 Nov 6;282(5391):1145-7. 
Yabut O, Bernstein HS. The promise of human embryonic stem cells in aging-associated diseases. 
Aging. 2011 May;3(5):494-508. 
Scadden DT. The stem-cell niche as an entity of action. Nature. 2006 Jun 29;441(7097):1075-9. 
Dvash T, Benvenisty N. 2004. Human embryonic stem cells as a model for early human 
development. Best Practice & Research in Clinical Obstetrics &Gynaecology 18(6):929-940. 
Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N. 
2000. Differentiation of human embryonic stem cells into embryoid bodies comprising the three 
embryonic germ layers. Molecular Medicine 6(2):88-95. 
Keller G. 2005. Embryonic stem cell differentiation: emergence of a new era in biology and 
medicine. Genes & Development 19(10):1129-1155. 
Odorico JS, Kaufman DS, Thomson JA. 2001. Multilineage differentiation from human embryonic 
stem cell lines. Stem Cells 19(3):193-204. 
Karp JM, Yeh J, Eng G, Fukuda J, Blumling J, Suh K-Y, Cheng J, Mahdavi A, Borenstein J, Langer R 
and others. 2007. Controlling size, shape and homogeneity of embryoid bodies using 
poly(ethylene glycol) microwells. Lab on a Chip 7(6):786-794. 
Moeller H-C, Mian MK, Shrivastava S, Chung BG, Khademhosseini A. 2008. A microwell array 
system for stem cell culture. Biomaterials 29(6):752-763. 
Hwang Y-S, Chung BG, Ortmann D, Hattori N, Moeller H-C, Khademhosseini A. 2009. Microwell-
mediated control of embryoid body size regulates embryonic stem cell fate via differential 
expression of WNT5a and WNT11. Proceedings of the National Academy of Sciences of the United 
States of America 106(40):16978-16983. 
Lee LH, Peerani R, Ungrin M, Joshi C, Kumacheva E, Zandstra PW. 2009. Micropatterning of 
human embryonic stem cells dissects the mesoderm and endoderm lineages. Stem Cell Research 
2(2):155-162. 
Park J, Cho CH, Parashurama N, Li Y, Berthiaume F, Toner M, Tilles AW, Yarmush ML. 2007. 
Microfabrication-based modulation of embryonic stem cell differentiation. Lab on a Chip 
7(8):1018-1028. 
Peerani R, Onishi K, Mahdavi A, Kumacheva E, Zandstra PW. 2009. Manipulation of Signaling 
Thresholds in "Engineered Stem Cell Niches'' Identifies Design Criteria for Pluripotent Stem Cell 
Screens. Plos One 4(7). 
Peerani R, Rao BM, Bauwens C, Yin T, Wood GA, Nagy A, Kumacheva E, Zandstra PW. 2007. 
Niche-mediated control of human embryonic stem cell self-renewal and differentiation. Embo 
Journal 26(22):4744-4755. 
12 
 
Choi YY, Chung BG, Lee DH, Khademhosseini A, Kim J-H, Lee S-H. 2010. Controlled-size embryoid 
body formation in concave microwell arrays. Biomaterials 31(15):4296-4303. 
Park JY, Lee DH, Lee EJ, Lee S-H. 2009. Study of cellular behaviors on concave and convex 
microstructures fabricated from elastic PDMS membranes. Lab on a Chip 9(14):2043-2049. 
Tekin H, Anaya M, Brigham MD, Nauman C, Langer R, Khademhosseini A. 2010. Stimuli-
responsive microwells for formation and retrieval of cell aggregates. Lab on a Chip 10(18):2411-
2418. 
Zink D, Fischer A, Nickerson J. Nuclear structure in cancer cells. Nature Reviews Cancer. 2004 
SEP;4(9):677-87.  
Davidson PM, Ozcelik H, Hasirci V, Reiter G, Anselme K. Microstructured surfaces cause severe but 
non-detrimental deformation of the cell nucleus. Adv Mater. 2009 SEP 18;21(35):3586. 
Davidson PM, Fromigue O, Marie PJ, Hasirci V, Reiter G, Anselme K. Topographically induced self-
deformation of the nuclei of cells: Dependence on cell type and proposed mechanisms. Journal of 
Materials Science-Materials in Medicine. 2010 MAR;21(3):939-46.  
Chalut KJ, Hopfler M, Lautenschlager F, Boyde L, Chan CJ, Ekpenyong A, et al. Chromatin 
decondensation and nuclear softening accompany nanog downregulation in embryonic stem cells. 
Biophys J. 2012 Nov 21;103(10):2060-70.  
Pajerowski JD, Dahl KN, Zhong FL, Sammak PJ, Discher DE. Physical plasticity of the nucleus in 
stem cell differentiation. ProcNatlAcadSci U S A. 2007 OCT 2;104(40):15619-24. 
Badique F, Stamov DR, Davidson PM, Veuillet M, Reiter G, Freund J, et al. Directing nuclear 
deformation on micropillared surfaces by substrate geometry and cytoskeleton organization. 
Biomaterials. 2013 4;34(12):2991-3001. 
Whitesides GM.The origins and the future of microfluidics.Nature. 2006 Jul 27;442(7101):368-73. 
Gottwald E, Giselbrecht S, Augspurger C, Lahni B, Dambrowsky N, Truckenmüller R, Piotter V, 
Gietzelt T, Wendt O, Pfleging W, Welle A, Rolletschek A, Wobus AM, Weibezahn KF. A chip-based 
platform for the in vitro generation of tissues in three-dimensional organization.Lab Chip. 2007 
Jun;7(6):777-85. Epub 2007 Apr 16. 
Kim L, Toh YC, Voldman J, Yu H. A practical guide to microfluidic perfusion culture of adherent 
mammalian cells. Lab Chip. 2007 Jun;7(6):681-94. Epub 2007 May 11. 
Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-
level lung functions on a chip. Science. 2010 Jun 25;328(5986):1662-8. 
Lee SA, No da Y, Kang E, Ju J, Kim DS, Lee SH. Spheroid-based three-dimensional liver-on-a-chip to 
investigate hepatocyte-hepatic stellate cell interactions and flow effects. Lab Chip. 2013 Sep 
21;13(18):3529-37. 
Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control 
stem cells. Science. 2009 Jun 26;324(5935):1673-7 
Przybyla LM, Voldman J. Attenuation of extrinsic signaling reveals the importance of matrix 
remodeling on maintenance of embryonic stem cell self-renewal. Proc Natl Acad Sci U S A. 2012 
Jan 17;109(3):835-40. 
E.R. Schiff, M.F. Sorrell, W.C. Maddrey, ed. (2007). Schiff's Diseases of the Liver, Tenth Edition. 
Lippincott William & Wilkins. ISBN 0-7817-6040-2. 
I. F. Usynin and L. E. Panin. Mechanisms Determining Phenotypic Heterogeneity of Hepatocytes. 
Biochemistry, 2008, Vol. 73, No. 4, pp. 367-380. 
Vallier L, Touboul T, Brown S, Cho C, Bilican B, Alexander M, Cedervall J, Chandran S, Ahrlund-
Richter L, Weber A, Pedersen RA. Signaling pathways controlling pluripotency and early cell fate 
decisions of human induced pluripotent stem cells. Stem Cells. 2009 Nov;27(11):2655-66. doi: 
10.1002/stem.199. 
 13 
 
Biswas A, Hutchins R. Embryonic stem cells. Stem Cells Dev. 2007 Apr;16(2):213-22. 
Xiao L, Yuan X, Sharkis SJ. Activin A maintains self-renewal and regulates fibroblast growth factor, 
Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells. 2006 
Jun;24(6):1476-86. 
James D, Levine AJ, Besser D, Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary 
for the maintenance of pluripotency in human embryonic stem cells. Development. 2005 
Mar;132(6):1273-82. 
Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling 
sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005 Mar;2(3):185-90. 
Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell 
Res. 2007 Jan;17(1):42-9. 
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray 
HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. Core transcriptional regulatory 
circuitry in human embryonic stem cells. Cell. 2005 Sep 23;122(6):947-56. 
  
 
 
 CHAPTER 2 
 
MICROTECHNOLOGIES AND STEM CELL CULTURE  
 
2.1 Polyacrylamide hydrogels 
 
Polyacrylamide hydrogels can be polymerized at different concentrations, 
therefore resulting in a differential permeability to solutes. To evaluate self-
diffusivity of molecules in polyacrylamide hydrogels, FRAP experiments were 
performed. Characterization of the hydrogel permeability was obtained by the 
estimation of the local diffusion coefficient values for fluorescent probes with a 
molecular weight of 70 kDa. To perform those experiments, hydrogels obtained 
from pre-polymeric solutions with different monomer/cross linker molar ratios 
(acrylamide/bis-acrylamide ratios 29:1; 25:1; 21:1) and different pre-polymer 
concentrations (10–20%) were used and compared. The experiments were 
performed with these hydrogel compositions that show diffusional cutoff for 70 
kDa fluorescence probes, which have the same order of magnitude of EBs 
secreted factors. In Figure 2.1 there is an evident trend of the self-diffusion that 
decreases for higher concentrations of acrylamide solution. From the analysis of 
these data it is possible to define a decrease in mobility for the 70 kDa dextran in 
18–20% acrylamide hydrogels. It is interesting to suppose that soluble molecules 
with similar molecular weights and comparable hydrodynamic radii with the 
dextran used in the experiment have similar self-diffusivity in the same 
hydrogels. Therefore, hydrogels of 20% acrylamide v/w were developed, in order 
to have a cutoff for molecules with molecular weights within the range 40-70 
kDa, with a hydrodynamic radius of  19 nm (for detailed materials and methods 
see Appendix A). 
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Figure 2.1. A: Hydrogel mass equilibrium swelling ratio (Qm) decreases as the acrylamide and bis-
acrylamide concentration (weight/volume [W/V]) increases in the pre-polimer solution (ACR %). B: 
From swelling data and Flory-Rehner theory, it is possible to estimate the mesh size of the 
hydrogel network. The figure shows that the mesh size (in nm) decreases for higher 
concentrations of acrylamide or bis-acrylamide. C: Self diffusion index (TAU) versus acrylamide 
concentration, with different cross-linker content. As expected, the self-diffusion decreases as 
hydrogel network becomes more dense. D: Self diffusion index versus hydrogel network mesh size. 
Molecular mobility falls to zero for mesh size lower than the molecular radii of the molecular 
tracer (about 19 nm, MW 70 kDa). 
 
2.1.1 3D microwells production for embryoid bodies culture 
 
Three-dimensional arrays of microwells with specific dimensions have been 
produced, through the use of customized photomasks and photopolymerization 
under UV light (Fig. 2.2A). Acrylamide was polymerized and covalently bound to 
a pre-treated transparent and thin glass surface (Fig. 2.2B). In order to help cell 
seeding, concave shape wells were designed. The photomask was designed with 
a gradient of tone around the 500 µm diameter spot (Fig. 2.2C-D). As the UV light 
passes through the photomask, it gradually polymerizes the acrylamide, 
generating a concavity around the microwells (Fig. 2.2E). The diameter of 500 µm 
was chosen to develop EBs with the best average dimensions for early 
development (Choi et al. 2010, Mohr et al. 2010, Peerani et al. 2009, Tekin et al. 
2010). Microwells with ratio width/depth 1:1 and 1:2 were also chosen to create 
different culture microenvironments for EBs differentiation. 
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Figure 2.2. Microstructured PA hydrogel production. A: The microstructured PA hydrogels are 
prepared by selective photo-polymerization of the acrylamide/bisacrylamide solution under UV 
light. B: The PA hydrogel is covalently bound to a glass coverslip functionalized with 3-
aminopropyltriethoxysilane and glutaraldehyde, as shown in the schematic representation of the 
chemistry. C: Photomask for selective photopolymerization. D: Enlargement of a photomask. The 
shading is realized in order to define the concave shape of the microwells. E: Microstructured 
hydrogel, 21 mm in diameter. The color is due to the presence of cell culture medium, which keeps 
the hydrogel hydrated. 
 
2.2 Microstructured substrates fabrication 
 
Polydimethylsiloxane (PDMS, Sylgard 184) microstructured substrates were 
fabricated through a replica-molding process. In the first step, the negative 
pattern was prepared through standard soft-lithography technique, which is 
suitable to construct features with measures of micrometer to nanometer scale 
(Xia et al. 1998, Whitesides et al.2001). Silicon (Si) wafers were spin-coated with 
AZ-1518 negative photoresist (MicroChemicals) for 30 seconds at 2000 rpm and 
for 5 minutes at 80°C. The photoresist was illuminated with UV light (λ=365 nm) 
through a chrome-etched mask that consisted of a square lattice (7 μm width), 
with a lattice constant of 7 μm. Uncross-linked resist was removed rinsing the 
wafer in an AZ-1518 developer (MicroChemicals) for 20 s. The obtained 
microstructured Si-wafers were subsequently silanized by exposure to the vapor 
of (tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-trichlorosilane in vacuum for 30 
minutes, to facilitate PDMS removal during the replica-molding step. PDMS 
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elastomer was thoroughly mixed with the silicone curing agent in a 10:1 ratio, 
poured over the microstructured Si-master and kept under vacuum for 1 h to 
allow the complete filling of the pattern and air bubbles removal. The sample 
was then cured at 80°C for 3 hours and subsequently peeled off the Si-wafers. 
The final micropillar topography was characterized by confocal microscopy and 
scanning electron microscopy (SEM) (Fig. 2.3A). The height of the 
microstructures was fixed at around 6 µm. PDMS substrates can then be cleaned 
with 98% ethanol, sterilized in dry autoclave at 121°C and then used as cell 
substrates. PDMS pillars can be functionalized with matrigel for pluripotent stem 
cell adhesion and culture (Fig. 2.3B). 
 
Figure 2.3. A: PDMS micropillars obtained from a square lattice 7x7 µm. B: HESCs adhering to the 
micropillar substrate. Note the evident nuclei deformation (stained in blue with Hoechst) of the 
stem cells adapting to the microstructured geometry. 
 
2.3 Microfluidic platforms fabrication 
 
Microfluidic devices were fabricated by standard soft-lithography technique. 
As for micropillar substrates, an elastomeric stamp made PDMS is prepared by 
replica molding, by casting the liquid prepolymer and the curing agent solution 
onto a pre-made master with patterned relief structure in its surface. When 
masters features size are greater than or equal to 20 µm, patterns can be drawn 
in AutoCAD and printed onto transparent polymer sheets, through 
commercially available printers. Photomasks are used to selectively polymerize 
UV-sensible photoresists, previously spun onto a silicon wafer with defined film-
thickness. Parameters such as viscosity of the photoresist, UV-light intensity and 
baking time should be taken into account in order to achieve selective 
polymerization of the desired structure. Elastomeric stamps obtained through 
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soft-lithography technique offer several properties proper to coupling with 
biological systems. PDMS is chemically inert which makes microfluidic platform 
biocompatible, and is also highly permeable to gasses (O2, CO2, N2 diffuse 
rapidly), but not to fluids. It is transparent for detection analysis instruments like 
fluorescence microscopy. Air or oxygen-base treatments lead to the formation of 
OH- groups on its surface, which allow covalent bonding between the stamp and 
glass slides. Photomask in Figure 2.4A was used to produce microfluidic 
platforms containing 10 parallel microchannels (18 mm long, 1.5 mm wide and 
0.2 mm high). PDMS mold was cut and peeled off the Si-wafer, punched to 
obtain liquid inlets and outlets and sealed to a cleaned glass slide by plasma 
bonding (Fig. 2.4B). In Figure 2.4C is shown the completed microfluidic platform 
made of PDMS on a glass surface. Before cell culture integration, microfluidic 
were rinsed with isopropyl alcohol and sterilized in autoclave. Glass surface has 
to be opportunely functionalized, with proper adhesion protein solutions (i.e. 
matrigel), in order to promote cell adhesion. 
 
Figure 2.4: Microfluidic device for cell cultures integration. A: Photomask with microfluidic 
channels. B: Schematic of microfluidic chip. C: Completed microfluidic chip with 10 independent 
channels and medium reservoirs at the inlet of the microchannels. 
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2.4 Microfluidic oxygen gradient chip 
 
A microfluidic platform was designed to generate a stable O2 gradient inside 
the microchannels. In order to generate the gradient, it is necessary to have a 
constant gas flux, with defined gas composition, at the sides of the 
microchannels. First, a mathematical model was produce before proceeding with 
platform fabrication (Fig. 2.5A). Next, the design of the photomask was 
produced, to fabricate a platform with three independent microchannels with 
defined gradient (Fig. 2.5B). In Figure 2.5C is shown the complete oxygen 
gradient chip. This platform was produced with the same techniques used for 
micropillar substrates and 10-channels microchips. 
 
 
 
Figure 2.5: A: Mathematical model of the cross section of the microchannel (cell culture chamber 
in white) with two gas channels on the sides. One channel with a mixture of air at 21% O2 and 5% 
CO2. In the second gas channel flows a mixture of 95% N2 and 5% CO2. The gasses diffuse through 
the PDMS culture chamber walls, generating an oxygen gradient. B: Microfluidic platform 
scheme. Three culture chambers (in yellow) and two parallel and opposite gas lines, nitrogen in 
blue and oxygen in green. Into each single channel, a proper O2 gradient can be generated. C: 
Microfluidic oxygen gradient chip. The different channel were colored with standard dyes to make 
them more visible. Culture chambers (in yellow) and two gas lines (O2 green, N2 blue). 
 
In order to have the defined gas composition, flow meters (Bronkhorst) were 
used together with software Flow-Bus DDE. To validate oxygen gradient, a 
 21 
 
luminescence oxygen sensor based on a Ruthenium (Ru) complex (Sigma-Aldrich) 
was used. This is a liquid solution, which can be inserted into the culture 
chambers. Its fluorescence is quenched by oxygen in the medium, and the O2 
concentration can be extrapolated by fluorescence measure. Software 
elaboration (LasAF) was done to measure fluorescence intensity from one side to 
the other of the channels, both in control without gradient and with the mixture 
of gasses flowing in the as channels, to see if a stable O2 gradient was achievable 
(Fig. 2.6). All the measures were done at stationary state, after 5 minutes of 
fluorescence acquisition. It results that when the two gases flow at the side of 
the microchannel, they are capable of generating and maintaining on oxygen 
gradient, as long as the gas flows. This is important because the gradient has to 
be maintained for days, in order to allow cells to grow and differentiate. Gas flow 
rate was fixed to 1 mL/min, in order to generate the gradient, but not causing 
evaporation of medium from the culture chambers. 
 
Figure 2.6: A: Control channel without gas flow. No variation in Ru fluorescence is present. B: 
Channel with gas flow in the gas lines. At stationary point is present an exponential decay of Ru 
fluorescence, meaning a presence of a constant oxygen gradient in the cell culture chamber. 
 
2.5 Cell lines culture and expansion 
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HESC line HES2 (from National Stem Cell Bank, Madison, WI) was expanded in 
gelatin-coated Petri dishes (Fig. 2.7) , in co-culture with mouse embryonic 
fibroblasts (MEF, Chemicon) mitomycin C-inactivated, for various passages. 
Expansion medium is composed of DMEM F-12 (Invitrogen), 20% KO serum 
(Invitrogen), 10% MEF conditioned medium, 20 ng/mL basic fibroblast growth 
factor (b-FGF, Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), 1% non-
essential amino acid (Invitrogen) and 1% Pen/Strep (Invitrogen). HES2 were 
passaged to new feeder using trypsin 0.25% (Invitrogen) and disaggregating to 
single cell solution. For MEFs depletion and cell expansion and differentiation, 
cells were passaged on matrigel-coated (MRF 50%, BD Biosciences) 
microchannels. 
 
Figure 2.7. HES (HES2) cell colonies growing on MEF substrate, with relative enlargement of two 
adjacent colonies. Note the round shape and the compactness of the cells. 
 
HiPSC lines ADHF#1 (from Center for iPS Cell Research and Application, 
iCeMS, Kyoto University) (Fig. 2.8), Send#1 (generated with Sendai viruses), 
mRNA#1 - #2 (generated with mmRNA technology) were cultured and expanded 
during this PhD work. Human iPS reprogramming using modified mRNA 
(mmRNA) was performed according to Warren et al. 2010 (for detailed 
reprogramming protocol see Appendix B). Cells were cultured in gelatin-coated 
multiwells with mitomycin c-treated MEFs co-culture, in expansion medium 
DMEM F-12, 20% KO serum, 10 ng/mL b-FGF, 0.1 mM β-mercaptoethanol, 1% 
non-essential amino acids and 1% Pen/Strep. HiPSCs were passaged to new 
feeder using CTK solution (trypsin 0.25% - collagenase IV - Ca2+) and manually 
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detached by pick to keep technique, under stereoscopic microscope inside 
biological safety cabinet. For MEFs depletion and cell expansion and 
differentiation, cells were passaged on matrigel-coated microchannels. 
 
Figure 2.8. HiPS (ADHF#1) cell colony growing on MEF substrate. Note the homogeneity and 
compactness of the pluripotent cells. 
 
The hPSC suspension was injected into each single channel and the 
microfluidic chips were incubated overnight at 37°C and 5% CO2 atmosphere 
without perfusion, to allow cell adhesion to matrigel-treated glass substrate. We 
used proper cell seeding concentration to achieve 70% confluence cell culture at 
24 h after seeding (Fig. 2.9). 
 
Figure 2.9. HES2 cells seeded inside a microchannel (snapshot from inlet to the center of the 
channel) after 24 h of adhesion to substrate. 
 
Multiple 9-port pumps (Cavro® XR Rocket pump, TECAN) were used to 
independently deliver the medium from the reservoirs into each microfluidic 
channel. Tygon tubing 0.5 ID (Cole-Parmer) and 21 G stainless-steel needles with 
a polypropylene luer (Microtest) were used to connect the microfluidic chips to 
the pumps. Discontinuous medium delivery with defined temporal frequencies 
was achieved by automatically controlling the multi-channel syringe pump 
through LabView 8.2 (National Instruments). 
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2.5.1 Cardiac differentiation 
 
Cardiomyocyte differentiation protocol has been adapted from Lian et al. 
2012. For cardiac differentiation human pluripotent stem cells were initially 
cultured with RPMI with 1% B27 supplement without insulin (Invitrogen), and 1% 
Pen/Strep. After 24 h, the medium was changed to RPMI with 1% B27 
supplement w/o insulin, supplemented with 5 ng/mL BMP4 (R&D) and 1% 
Pen/Strep for another 4 days. After day 5 of differentiation, the medium was 
changed to RPMI with B27 supplement w/o insulin. At day 7, the cells were 
transferred to RPMI with B27 supplement complete. Cells were maintained for 
another 7-8 days in this medium, to obtain cardiomyocyte cells (Fig. 2.10). From 
day 10 to 15 of the differentiation, cell started to contract spontaneously, firstly 
isolated spots, then a consistent part of the cell monolayer. 
 
Figure 2.10.  Sequential morphological changes from human embryonic stem cells (day 0), 
through mesoderm stages (days 4 and 8) to cardiomyocyte cells (day 15). 
 
2.5.2 Hepatic differentiation 
 
Hepatic differentiation protocol has been adapted from (Hay et al. 2008). For 
endoderm differentiation cells were treated with RPMI with B27 supplement 1% 
(both Invitrogen) 100 ng/ml activin A (Peprotech), 1 mM NaB (Sigma-Aldrich) and 
Pen/Strep 1% for 1 day. After 24h medium was changed to RPMI with B27 
supplement 1% (both Invitrogen) 100 ng/ml activin A (Peprotech), 
0.5mMNaB(Sigma-Aldrich) and Pen/Strep 1% for 2-3 days. After these first two 
media, dramatic cell death was observed, and only the survived cells were 
endoderm committed. Medium was then changed to hepatic endoderm 
commitment medium to KO-DMEM, 20% KO serum, 1 mM L-glutamine, 1% 
NEAA, 0.1 mM β-mercaptoethanol (all from Invitrogen), 1% DMSO (Sigma-
Aldrich) and Pen/Strep 1% for 6-7 days. Cells were then maturated with L15 
medium (Sigma-Aldrich) supplemented with 8.3% FBS, 8.3% tryptose phosphate 
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broth (both Invitrogen), 10 μM hydrocortisone 21-hemisuccinate, 1 µM insulin 
(all from Sigma-Aldrich) and 2 mM L-glutamine containing 10 ng/ml hepatocyte 
growth factor and 20 ng/ml oncostatin M (both from R&D) and Pen/Strep 1% for 
7 days (Fig. 2.11). Hepatocyte-like cells were then kept in this medium for 
another 7 days, while doing the specific analyses and tests. 
 
Figure 2.11.  Sequential morphological changes from human embryonic stem cells (day 0), 
through endoderm stages (days 7 and 10) to hepatocyte-like cells (day 15). 
 
References 
 
Choi YY, Chung BG, Lee DH, Khademhosseini A, Kim J-H, Lee S-H. 2010. Controlled-size embryoid 
body formation in concave microwell arrays. Biomaterials 31(15):4296-4303. 
Mohr JC, Zhang J, Azarin SM, Soerens AG, de Pablo JJ, Thomson JA, Lyons GE, Palecek SP, Kamp TJ. 
2010. The microwell control of embryoid body size in order to regulate cardiac differentiation of 
human embryonic stem cells. Biomaterials 31(7):1885-1893. 
Peerani R, Onishi K, Mahdavi A, Kumacheva E, Zandstra PW. 2009. Manipulation of Signaling 
Thresholds in "Engineered Stem Cell Niches'' Identifies Design Criteria for Pluripotent Stem Cell 
Screens. Plos One 4(7). 
Tekin H, Anaya M, Brigham MD, Nauman C, Langer R, Khademhosseini A. 2010. Stimuli-
responsive microwells for formation and retrieval of cell aggregates. Lab on a Chip 10(18):2411-
2418. 
Xia, Y. & Whitesides, G. M. Soft Lithography. Angew. Chem. Int. Ed. 37, 550–575 (1998). 
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X. & Ingber, D. E. Soft Lithography in Biology 
and Biochemistry. Annu. Rev. Biomed. Eng. 3, 335–373 (2001). 
Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, 
Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly efficient reprogramming 
to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell 
Stem Cell. 2010 Nov 5;7(5):618-30. 
Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RC, Snoeys J, Black JR, Wojtacha D, Samuel K, 
Hannoun Z, Pryde A, Filippi C, Currie IS, Forbes SJ, Ross JA, Newsome PN, Iredale JP. Highly 
efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a 
signaling. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12301-6. 
Hay DC, Zhao D, Fletcher J, Hewitt ZA, McLean D, Urruticoechea-Uriguen A, Black JR, Elcombe C, 
Ross JA, Wolf R, Cui W.Lian, X. et al. Proc. Natl. Acad. Sci. 109, E1848–E1857 (2012). Efficient 
differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating 
liver development in vivo. Stem Cells. 2008 Apr;26(4):894-902. 
26 
 
Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP. 
Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation 
of canonical Wnt signaling. Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57
 CHAPTER 3 
 
MICROENVIRONMENT AND HUMAN PLURIPOTENT STEM 
CELL EARLY DIFFERENTIATION 
 
3.1 Microenvironment modulation through hydrogel microwells 
 
In order to manipulate pluripotent cell culture microenvironment, 
polyacrylamide hydrogels we used, because they are highly tunable in molecule 
permeability, and highly tunable in shape through photo-polymerization. Such 
hydrogels have been used to generate microwells to culture single differentiating 
embryoid bodies (EBs) derived from human pluripotent stem cells. The 
importance of growth factors in media during differentiation is well-known, but 
little information about the role of endogenous secreted molecules during early 
differentiation stages has been reported. When cultured in the absence of 
specific growth factors in medium, embryoid bodies can self-regulate their own 
differentiation through secretion of endogenous factors (Keller, 2005). In this 
perspective, a biomaterial that can locally accumulate soluble secreted 
molecules in a confined microenvironment has been designed. Two different 
heights of three-dimensional hydrogel microwells with defined diffusional 
properties have been produced and compared with suspension EBs as a control, 
to have three different microenvironment conditions for analyzing effects on 
early stem cell differentiation (Fig. 3.1). Embryoid bodies cultured in the three 
differentiation niches were examined through transcriptomic and proteomic 
analyses, in order to assess differential expressions of genes involved in early 
embryonic development, in the different culture conditions. 
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Figure 3.1. Schematic of embryoid bodies in standard cell culture dishes and compartmentalized 
into the two types of microwells. A: EBs in suspension; B: EBs in microwells 500 µm × 450 µm, 1:1 
ratio; C: 500 µm × 1 mm, 1:2 ratio. Black arrow represent endogenous factors diffusion, pink 
arrows indicate medium diffusion. In standard cell culture dishes, molecules secreted by 
differentiating embryoid bodies are rapidly distributed in the bulk medium. In microwells, 
molecules with different diffusivities will distribute in the EB microenvironment and into the 
surrounding medium by diffusion. 
 
A seeding of 4 × 105 cells per well was defined. Figure 3.2A shows an array of 
approximately 180 independent microwells, which are used for cell aggregation 
and culture. The concave microwell array allows a consistent cell seeding, which 
results in homogenous distribution of cells in all the microwells. Figure 3.2B and 
C shows that modulation of UV light intensity through use of photomasks and 
different lamps results in efficient modulation of microwell heights, with low 
standard deviation (Fig. 3.2D). The biocompatibility of polyacrylamide hydrogels 
was tested at day 10 to see if there was any toxic effect of unpolymerized PA 
monomers. With the use of Live and Dead essay cell vitality was assessed. It was 
not affected by embryoid body confinement, and viability was comparable with 
suspension embryoid bodies. These results indicate that all the PA monomers are 
washed during the washing procedures, thus the hydrogel is a hydrated and 
compatible biomaterial for cell culture. 
In Figure 3.2E–G are shown the histograms representing the distribution of 
EBs diameters in suspension, 1:1 and 1:2 µwells, during three time points at 4, 8, 
and 12 days of culture. In suspension culture the distributions are dispersed in a 
wider range, showing less uniformity in dimensions during all time points. On the 
other hand, both microstructured cultures show more symmetric distributions. 
Average EB diameters are similar both in suspension and hydrogels after 8 days, 
even if EB cultures in the microwells are more homogenous. It has been 
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previously demonstrated how important the size homogeneity of embryoid 
bodies is during cell differentiation (Bauwens et al. 2008, Hwang et al. 2009, Karp 
et al. 2007, Moeller et al. 2008). Experimental data in Figure 3.2 show that is 
possible to compare the three different culture conditions, assuming that the 
effect of EB diameter do not override the influence of local EB 
microenvironment. 
 
Figure 3.2. A: Array of EBs in the microwells of 1 mm depth (scale bar is 0.5 cm). Single EBs can 
easily be collected with a micropipette without disrupting the culture. B,C: Show enlargements of 
the vertical sections of the PA microwells of 450 µm and 1 mm depth, respectively. Scale bars in B 
and C are 250 µm. D: Measurements of the microwell depths. Panels (E–G) show quantitative 
distribution of suspension and microwell EBs diameter. E: Measurements of EBs diameters in 
suspension culture. F: Measurements of EBs diameters cultured in 500 µm width microwells and 
450 µm depth (1:1). G: Measurements of EBs diameters cultured in 500 µm width microwells and 
1 mm depth (1:2). The average embryoid body diameters (±standard deviation) after 4 days were 
312 ± 148 µm (suspension), 210 ± 80 µm (500 µm Ø microwells 1:1) and 225 ± 98 µm (500 µm Ø 
microwells 1:2); after 8 days were 375 ± 155 µm (suspension), 385 ± 77 µm (500 µm Ø microwells 
1:1) and 400 ± 68 µm (500 µm Ø microwells 1:2); after 12 days were 463 ± 191 µm (suspension), 
504 ± 102 µm (500 µm Ø microwells 1:1), and 495 ± 84 µm (500 µm Ø microwells 1:2). Note the 
dispersion of diameter in the suspension culture condition during all time points, while data 
collected from the two types of microwell cultures have more symmetric distributions. 
 
3.1.1 EB differentiation in microwells and analysis 
 
The expression patterns of embryoid bodies were assessed through 
transcriptomic analyses. Whole genome microarrays were used in order to have 
a complete overview of the gene expression in the different culture conditions. 
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The differential gene expression was tested at day 8 in HES2-derived EBs, in 
order to show early differentiation and commitment into the three germ layers 
(Keller, 2005). The same batches of cells were expanded and used to form EBs for 
the three different culture conditions, in order to have reliable results. 
Furthermore, three replicates for each microarray for consistent statistical 
analyses were done. 
In the multiclass analysis 418 probes were selected, corresponding to 380 
unique gene IDs and 8 ESTs. Among the 388 genes significantly differentially 
expressed, 189 resulted upregulated in suspension EBs compared to the cultures 
of microwell EBs. Other 203 genes were upregulated in the microstructured EB 
cultures and downregulated in suspension culture. A cluster analysis of the 
results was done with genes involved in early embryogenesis, which were 
grouped as reported in the microarray heat map in Figure 3.3. From data analysis 
it can be seen how the repetition of independent experiments and replicates 
show comparable results. There is a marked difference between gene 
expressions in suspension EBs compared to microwell EBs. It is also clear that the 
different ratio in 1:1 and 1:2 µwells do not influence gene expression, and 
therefore they have been grouped into a single category and confronted with 
suspension. 
The expression of selective genes in endoderm, mesoderm and ectoderm 
was analyzed. There is a clear effect of the confinement in the differentiation 
patterns shown by the color graduation in the heat map. Results show that 
mesoderm specification and heart development is significantly upregulated in 
suspension EB, with expression of genes such as WIF1, BOC, MYH6, and TNNT2. 
On the other hand, genes such as NKX6-2, WNT3, GLI2, GDF3, and NRG1 involved 
in pattern specification process and regionalization, brain development, 
endoderm and ectoderm are consistently upregulated in microwell confined 
embryoid bodies. The microarray analysis thus highlights a significant difference 
in the differentiation patterns of standard and confined embryoid bodies. 
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Figure 3.3. Microarray analysis. The panel shows the heat map of the gene expression values of a 
subset of genes associated to the Gene Ontology enriched terms “mesoderm,” “heart 
development,” “ectoderm,” “brain development,” “endoderm,” “pattern specification process and 
regionalization,” in the different growing conditions and replicates. Mesoderm and heart 
development genes are significantly upregulated in EBs cultured in suspension. Ectoderm, brain 
development, endoderm, pattern specification process, and regionalization genes are significantly 
upregulated in EBs cultured in hydrogel microwells. The genes are grouped using a hierarchical 
agglomerative clustering (average linkage—Euclidean distance). Heat map showing the same 
gene expressions scaled with respect to genes average value, and heat map showing the 
expressions of the all the 388 genes, are shown in the supplementary material. 
 
After microarray experiments, immunofluorescence analyses were 
conducted to evaluate the expression of specific embryonic differentiation 
markers, and to investigate any possible influence of the different culture 
conditions onto early commitment to the three germ layers. Alpha-fetoprotein 
was used to mark early endoderm specification. Brachyury T marks the early 
embryonic mesoderm, while Beta-III Tubulin is used to mark the primary 
ectoderm. The immunofluorescence of the HES2-derived EBs sections is 
represented in Figure 6. AFP marking the endoderm is noticeably more 
expressed in EBs cultured in 1:1 and 1:2 µwells and less expressed in suspension 
EBs (Fig. 3.4A–C). The same result is observable for β-III Tub marking the 
ectoderm (Fig. 3.4F–H). On the other hand, brachyury T marking the mesoderm 
results more expressed in standard suspension EBs and less expressed in 
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microwell condition (Fig. 3.4K–M). Similar results are observed for hiPS-derived 
EBs at day 8. 
 
Figure 3.4. Immunofluorescence analysis of the three germ layers on cryosections (20 µM thick) of 
8 days hES-derived EBs cultured in the three conditions. Panels (A–D) show immunolabeling with 
alpha-fetoprotein (green), which marks the endoderm, and nuclei are stained with DAPI (blue). A 
major expression of this marker is shown by the microwell culture conditions. Panel (E) shows 
HepG2 cell line expressing high levels of AFP. Panels (F–I) show the expression of the ectoderm 
marker beta-III tubulin (green), which results more expressed in the 450 µM and 1 mm µwell 
conditions. C2C12 expressing b-III Tub are shown in panel (J). Panels (K–N) show labeling for 
Brachyury T (red), which recognizes the mesoderm. This marker is more expressed in EBs cultured 
in suspension. Panel (O) show the expression of Brachyury T in cardiomyocytes derived with a 
high-efficient mesoderm differentiation protocol of EBs. Scale bar is 100 µM. 
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Quantification of immunofluorescence analyses was performed through 
cytospinned cells, and it clearly shows a difference in expression of the three 
germ layer markers among the different EB cultures. AFP and β-III Tub are 
significantly more expressed in both microwell cultures compared to suspension. 
On the other hand, brachyury T is significantly overexpressed in suspension EBs 
rather than microwells (Fig. 3.5). In order to confirm the results obtained with 8 
days old EBs, the same immunofluorescence experiments were performed on 
adherent EBs at two different time points, days 4 and 12, both for hES and hiPS 
cells. The expression of differentiation markers agrees with the results observed 
in day 8 EBs. 
 
Figure 3.5. The graph shows the immunofluorescence quantification by cytospin counts of 8 days 
hES-disaggregated EBs. Alpha-fetoprotein and beta-III tubulin are more expressed in the two 
microwell conditions, and show high significant difference compared to suspension culture. 
Brachyury T is higher expressed in suspension culture with high significant difference from 450 µm 
and 1 mm microwell cultures. Error bars are ±SD. Significativity is calculated with unpaired t-test. 
***P < 0.001, **P < 0.01. 
 
From the analysis of the immunofluorescences, it is noticeable that there is 
no evident difference between the two types of microwell culture conditions. 
Microwell depth could still influence differentiation patterns, even though this 
was not noticed in these microwell geometries. However, it could be interesting 
to verify if exogenous molecules could restore mesodermal germ layer 
differentiation, which was downregulated in microstructured cultures. To this 
purpose, an experiment was performed in which 5 ng/mL of activin A, a 
mesoderm inducing factor at low concentrations, was added in the 1 mm 
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microwell culture medium. Surprisingly, at all the time points measured, the 
expression of mesoderm marker (brachyury T) in HES2-derived EBs was 
enhanced if compared with non-treated microwell EBs as shown in Figure 3.6. 
 
Figure 3.6. Immunofluorescence analysis on adhered hES-derived EBs. Panels (A–C) show 
immunofluorescence of Brachyury T in 1 mm microwell EBs non-treated with exogenous factors. 
Panels (D–F) show immunolabeling with Brachyury T in 1 mm microwells EBs treated with Activin 
A (5 ng mL
−1
), at three different time points, 4, 8, and 12 days. Treatment with exogenous ActA 
show induction of mesoderm germ layer in microwells culture of embryoid bodies. Scale bar is 
300 µM. 
 
These outcomes on differentiation marker expression and gene expression 
can be correlated with an analysis of the relative dimensions (according to 
UniProt Database http://www.uniprot.org/) of the main secreted factors by the 
EBs, which are involved in the regulation of the differentiation patterns (Aberger 
et al., 1998; Clark et al., 2003; Germain and Littlefield, 1986; Stennard et al., 
1997). The data of the molecular weights of the endogenous factors are shown in 
Figure 3.7. From these data, it can be seen that mesoderm is more expressed in 
suspension culture, therefore it can be hypothesized that mesoderm-inducing 
factors are relatively small compared to the cutoff of the polyacrylamide, so that 
they diffuse away from the cell niche in the microwells. At the same time, 
mesoderm-inhibiting factors should be relatively larger molecules that overstay 
in the microwells and diffuse slowly from the EBs. These hypotheses have a 
confirmation in the dimensions of secreted factors that influence or inhibit 
mesoderm formation (see Fig. 3.7). In the same table the data of the 
endogenous factors referring to ectoderm and endoderm are shown. Endoderm 
factors are not clearly defined in number and molecular weight, and not much 
can be discussed for this germ layer, even though immunofluorescence and 
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microarray experiments confirm that these factors are more expressed in the 
microwell EBs. Ectoderm-inducing factors have higher molecular weight 
compared to mesoderm-inducing factors, and therefore have lower diffusional 
times through the PA mesh and remain longer in the EBs microenvironment. In 
fact, ectoderm result more expressed in embryoid bodies cultured in the 
microwells. Interestingly, these results show that a mesoderm-inducing factor 
could override the effect of endogenous factors in 1 mm microwell culture, 
restoring mesodermal commitment. 
These findings could indicate that the locally controlled availability of 
endogenous factors elicits significant differences in hPSC differentiation and may 
provide new insights into the mechanisms involved in cell differentiation. 
 
Figure 3.7. The chart shows some of the main germ layers secreted factors involved in 
embryogenic processes. The red parenthesis at the left side of the chart indicates the molecular 
weight cutoff of the PA hydrogel (around 40–70 kDa). The factors are ordered by growing 
molecular weight to show the correlation between dimensions and effect on the germ layers, to 
correlate with the data shown in the microarray and immunofluorescence analyses. Data referred 
to UniProt Database http://www.uniprot.org/. 
 
HPSC cultured in the three-dimensional system synthesize their own 
endogenous repertoire of factors and contribute to create a microenvironment 
suitable for cell growth and differentiation. Results show that the accumulation 
of endogenous factors has a deep effect on hPSC differentiation. This study could 
provide insights to the relationship between the confined cell niche and stem cell 
behavior during differentiation. In addition it sheds light on the potential effects 
of the diffusion of soluble factors and related effects on differentiation patterns 
in microenvironments, relevant to the emerging use of microstructured culture 
systems. Further experiments are required in order to study the regionalization 
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process in the EBs. It is also necessary to further study the possibility to 
modulate the microenvironment in a more accurate way, both in 3D and 2D cell 
cultures, in order to address specific differentiation. 
 
3.2 Nuclear self-deformation in pluripotency and differentiation 
 
To further evaluate effects of microenvironment variation during 
differentiation, an intrinsic property of hPSCs was considered, which has still to 
be deeply investigated and understood. This property is nuclei self-deformation 
capacity under defined geometrical constraints. 
Nuclear shape and structure in eukaryotic cells are recognized to be deeply 
related with cell function during developmental, physiological and pathological 
modifications (Lombardi et al. 2010, De Vos et al. 2010, Dahl et al. 2010, ). The 
nucleus, while regulating cell division and transcription processes, is exposed to 
mechanical stimuli from inside and outside the cell. Mechanical stimuli are 
transmitted by the cytoskeleton to the highly specialized nuclear membrane. The 
nuclear envelope connects to and interacts with the inner nucleus through the 
nuclear lamina, a dense protein network also connected to chromatin structure 
and gene regulatory complexes, which is crucial for structural support of the 
nucleus. Mechanics of the interphase cell nucleus is of paramount importance 
for the biological function of healthy cells and it is related to several pathologies 
(Lee et al. 2007, Hale et al. 2008, Lammerding et al. 2004,). 
Nuclear plasticity and self-nuclear arrangement due to geometric constraints 
on human pluripotent stem cells during differentiation has never been reported 
and the comparison between pluripotent cells and cancer cells has not yet been 
performed. 
In this part of the project, the aim was to study human pluripotent stem cell 
nuclear capacity to self-deform under defined geometrical constraints, meant as 
the spontaneous nuclear response to the morpho-topological environment. Here 
is reported how nuclei of human pluripotent stem cells have a high capability to 
deform and adapt their shape to the geometry of the substrate. Give this, the 
interest focused on understanding if this strong nuclear deformability could 
affect pluripotency and it was shown that pluripotency is not affected by a highly 
deformed nucleus. Furthermore, an investigation was done on how highly 
deformed nucleus can have an influence in the process of early germ layer 
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differentiation. Results show that the strong nuclear deformation of the nuclei 
when seeded in microstructured substrates affects the process of differentiation. 
Studies on stem cells can represent an effective model to evaluate transitions 
in nuclear plasticity from the pluripotent to the differentiated stage and to 
elucidate the underlying mechanisms. 
 
3.2.1 Pluripotency maintenance in micropillar cell culture 
 
To evaluate how nuclear deformability changes in different cell lines, 
osteosarcoma cells (SaOs-2), hESCs, hiPSCs, cord blood mesenchymal stem cells 
(CBMSCs) and human epithelial renal cells (hERC) were seeded on matrigel-
coated microstructured polymeric substrates characterized by square 
micropillars with a width of 7 micrometers, an inter-axial distance of 14 
micrometers and a height of 7 micrometers. The substrates were fabricated both 
in polydimethylsiloxane (PDMS) and poly-l-lactic acid (PLLA).  PDMS substrates 
were fabricated through replica molding technique and PLLA substrates through 
hot embossing technique. Substrate morphology was then characterized by SEM 
measurements (Fig. 3.8B). The geometrical structure of the substrates has been 
designed in order to impose a geometrical constrain to cell body and nucleus: 
the available space among micropillars is smaller than the average diameter both 
of cells and cell nuclei (for detailed materials and methods used in the work of 
nuclear deformation see Appendix D). 
HOECHST stained cell nuclei of all cell lines were observed through 
fluorescent  microscopy after two days of culture (Fig. 3.8A). A qualitative 
analysis of nuclear morphology show how SaOs-2, hESC and hiPSC nuclei strongly 
deform and assume very unusual shapes, to adapt to the morphology of the 
environment. HERCs keep a rounder shape, while CBMSCs are characterized by 
an intermediate behavior, with some nuclei showing concave shape. For each 
cell line the distribution of the number of concavities (Nc) was also evaluated 
(Figure 3.8D): cells that have a lot of concave nuclei that present only one 
concavity have to be considered less deformable than cells where high number 
of nuclei show three or four concavities. Lightly deformable cells as CBMSC and 
hERCs are characterized by nuclei that never present three or four concavities. 
To quantify this deformability two parameters were calculated, which are related 
respectively to nuclear penetration below pillar height and to nuclear shape: 
nuclear deformability (ND) and nuclear concavity (NC).  ND has been calculated 
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as the percentage of the nuclear volume that lies below pillar height (Fig. 3.8C). 
NC is the percentage of nuclei that present at least one concavity. A concavity is 
defined as a concave curvature in cell nucleus: concave shapes appear only in 
deformable nuclei to adapt to pillar interspaces. The calculation of ND show a 
higher degree of deformability of SaOs-2, hESCs and hiPSCs compared to 
CBMSCs. HERCs show low deformability (Fig. 3.8E). These data are consistent 
with results obtained through the calculation of NC (Fig. 3.8F). Again, SaOs-2, 
hESCs and hiPSCs are the cells whose nuclei adapt the most to the morphological 
environment. 
All together these results show that hPSCs have highly deformable nuclei, 
and this behavior can be compared to results found for cancer cell line SaOs-2. 
Nuclear deformability is much lower in mesenchymal cells and very strongly 
reduced in adult somatic cells. 
 
Figure 3.8. Evaluation of nuclear deformability for different cell lines. A: HOECHST stained nuclei 
of SaOs-2, hiPSCs, hESCs, and CBMSCs acquired through fluorescent microscopy at day 2. Images 
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show very deformed nuclei that assume unusual concave and sometimes branched shapes in 
hESCs, hiPSCs and SaOs-2. hERCs keep a round shape and CBMSCs show an intermediate 
behavior. B: SEM image of the PDMS microstructured substrates were cells are seeded. C: 
Confocal image of a fluorescent labeled deformed nucleus: Vb (volume below) is the part of the 
nucleus which penetrates among pillar interspaces; Va (volume above) is the part of the nucleus 
which stays above pillar height. Nuclear deformability (ND) is defined as ND=(Vb/(Va+Vb))*100. D: 
Examples of nuclei with 0 concavities (Number of concavities=Nc=0), 1 concavity (Nc=1), 2 
concavities (Nc=2), 3 concavities (Nc=3) and 4 concavities (Nc=4). The presence of such concavities 
in the nucleus is related to nuclear capability to deform. E: Plot of the nuclear deformability values 
calculated respectively for SaOs-2, hESCs, hiPSCs, CBMSCs and hERCs after fixing the cells at day 
2. hESCs , hiPSCs and SaOs-2 present a nuclear deformability above 50%. F: Plot of nuclear 
concavity, meant as the percentage of cells having Nc>= 1. The histograms show the distribution 
of the number of nuclear concavities (1 concavity Nc=1, 2 concavities Nc=2, 3 or more concavities 
Nc=3, Nc=4) calculated among all the concave nuclei for each cell line. This graph show that hESCs, 
hiPSCs and SaOs-2  present the more deformable nuclei, in particular hESCs and SaOs-2 cell lines. 
 
After assessing how hESCs have a highly deformable nucleus, an investigation 
was done to see if morphologically deformed nuclei can affect pluripotent cell 
behavior. First, an evaluation of the possible effects on pluripotency 
maintenance was done. HESCs were seeded both in flat (Ctrl) and 
microstructured (µP) matrigel-coated PDMS substrates, and cultured in 
expansion medium. After 6 days cells were fixed and immunofluorescence 
analysis of pluripotency markers Oct-4, Nanog and SSEA4 was performed (Fig. 
3.9A). The analysis shows a comparable expression of the markers between cells 
expanded in Ctrl and µP substrates. To confirm these data, quantitative real time 
PCR of pluripotency markers Nanog and Oct-4 was also performed (Fig. 3.9B). 
The results from qRT-PCR demonstrate that there is not a significant difference 
of marker expression between cells expanded on Ctrl and on µP. Pluripotency is 
maintained by hPSCs also when the expansion is performed in µP substrates, 
where cell nuclei present very deformed shapes. Consequently, self-deformation 
does not affect maintenance of pluripotency. The same experiments were 
performed on PLLA flat (Ctrl-PLLA) and microstructured (µP-PLLA) substrates and 
the same results were obtained (data not shown). 
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Figure 3.9. HESC pluripotency maintenance on microstructured substrates. A: 
Immunofluorescence panel of cells cultured on flat PDMS substrates (Ctrl), showing pluripotency 
marker expression  of Oct-4, Nanog and SSEA4. Cells cultured on PDMS microstructured 
substrates (µP). Marker expression between Ctrl and µP is similar. These panels show how nuclear 
deformation have no effect on pluripotency maintenance. B: qRT-PCR of Oct-4 and Nanog 
expression in hESCs cultured on flat PDMS (Ctrl) and pillar PDMS substrates (µP), which show 
comparable expression of pluripotency transcripts between the two conditions. Relative fold 
expression normalized on GAPDH (n=3). 
 
3.2.2 Effects of self-deformation during early differentiation 
 
Next, an analysis was done to prove if the reorganization of the nuclei 
morphology can influence the process of differentiation into the three germ 
layers. Again, hESCs were seeded both in flat (Ctrl) and microstructured (µP) 
matrigel-coated PDMS substrates. The scheme in Figure 3.10A shows all the 
steps that lead to the commitment of the cells into early germ layers. Cells were 
first expanded for two days in expansion medium to achieve 70-80% cell 
confluence. Early germ layer specification was induced for 5 days, after which 
fluorescent labeled nuclei were observed through fluorescent microscopy. 
Interestingly, nuclei from ectoderm germ layer tend to escape from pillar 
interspaces and assume a round shape, whereas nuclei from mesoderm and 
endoderm germ layers still lies among the microstructures keeping deformed 
shapes. To understand if early germ layer specification took place, an 
immunolabeling was done on specific markers for each germ layer: β-III tubulin 
for ectoderm, brachyury T for mesoderm and α-fetoprotein for endoderm (Fig. 
 41 
 
3.10B). Immunofluorescence early differentiation markers seems normally 
expressed in µP cells, compared to flat controls, and both in deformed nuclei 
(meso, endo) and de-deformed nuclei (ecto). To quantitatively assess changes in 
gene expression due to nuclear deformation, qRT-PCR was performed to quantify 
the expression of β-III Tub, Bra-T and AFP for each germ layer, both for ctrl and 
µP substrates (Fig. 3.10C). The analysis shows that the expression of β-III Tub and 
AFP is comparable between ctrl and µP substrates, whereas there is a significant 
difference between Bra-T expression in ctrl and µP substrates. Bra-T is very lowly 
expressed both in ectoderm and endoderm early germ layers when the protocol 
of early germ layers specifications are applied on cells cultured on flat substrates 
(ctrl) whereas there is an usual and significant expression of Bra-T on endoderm 
germ layer obtained from cells cultured and differentiated on microstructured 
substrates (µP). 
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Figure 3.10. HESC differentiation on microstructured substrates. A: Schematic showing 
experimental procedure of early germ layer commitment in hESCs with self-deformed nuclei. Cell 
are passaged on microstructured PDMS substrates and expanded for 2 days. Different replicates 
are then induced with specific media into 3 germ layers for 5 days B: Immunofluorescence panel 
showing differentiated hESCs on flat PDMS substrates (Ctrl) and on PDMS substrates (µP). Cells 
are marked with beta III tubulin for ectoderm, brachyury for mesoderm and alpha-fetoprotein for 
endoderm. Notably, ectoderm cell nuclei tend to homogeneously emerge from the pillars and gain 
round shape. Mesoderm and endoderm cells tend to differentiate while maintaining highly 
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deformed nuclei. C: qRT-PCR of early germ layer markers, β-III tub, bry and AFP in the 3 
differentiation protocols in both flat (Ctrl) and microstructured substrates (µP) . β-III tub is 
significantly higher expressed in ectoderm flat and pillar differentiation. Bry is significantly higher 
expressed in mesoderm flat and pillar differentiation, and notably, in endoderm pillar 
differentiated cells. AFP is significantly high in endoderm flat and pillar differentiation. Relative 
fold expression normalized on GAPDH (n=3). Student t test p-values P ≤ 0.01 (**). 
 
The nuclear deformation induced by microstructured substrates does not 
affect mesoderm specification, despite cell nuclei keep a high level of 
deformation during the all process of differentiation. Ectoderm specification can 
also take place when cells are seeded on microstructured substrates, but is 
associated to a strong loss of nuclear deformability by the cells. Endoderm germ 
layer specification is characterized by strongly deformed nuclei that do not lost 
their deformability, but this nuclear reorganization hinders the physiological 
process of differentiation. 
Being ectoderm the only germ layer showing major nuclear morphological 
changes, it was decided to further investigate nuclear behavior during 
differentiation. In Figure 3.11A is shown a time-course of live-stained HES2 nuclei 
from pluripotent state at day 0, with highly deformed shapes, to ectodermal 
commitment ad day 4, with almost entirely round-shaped nuclei. Figure 3.11B 
shows nuclear concavity quantification following a day by day measure of 
percentage concavity. Notably, major shape changes happen between day 1 and 
day 2, with almost all cells losing self-deformation capacity. It will be necessary 
to further analyze this results, mainly studying what happens when cells start 
changing morphology during ectodermal commitment. This will be done through 
cytoskeletal analyses, with chemical and biological selective inhibitors of specific 
proteins though to be involved in nuclear and cytoskeletal organization. New 
results will help to understand how important is nuclear deformation during 
differentiation and if these properties have specific relevant applications.   
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Figure 3.11. HESC ectoderm differentiation on microstructured substrates. A: Nuclear morphology 
evolution from pluripotent state (Day 0) to ectoderm germ layer (Day 4). Nuclei progressively pass 
from deformed shapes to rounder morphology. B: Nuclear concavity time-course of pluripotent 
cells (Day 0) induced to ectoderm commitment (Day 4). Major drop of NC % in between day 1 and 
day 2 of differentiation. 
 
These first results on pluripotent nuclei self-deformation capacity are 
important to understand the mechanisms of nuclear properties and plasticity. 
Further and detailed work has to be done in order to understand how this 
intrinsic property is important for pluripotency, early germ layer commitment 
and functional maturation, and to understand if there is a strict connection 
between pluripotent cells and cancer cells properties. 
Concluding, in this chapter it has been provided a strong evidence that cell 
endogenous niche is fundamental in order to modulate cell differentiation and 
fate. The methodologies presented give the possibility to modulate different 
aspects of the stem cell niche, such as endogenous factors accumulation in the 
three-dimensional hydrogel microwells, or geometrical cues, and how 
superimposed mechanical constraints influence cell behavior during early 
commitment. These strategies give the opportunity to study particular aspects in 
stem cell culture and differentiation, but they cannot be tuned during these 
processed. There is the need to find a methodology, which allows a deeper 
control over cell culture microenvironment, in order to address cell fate in a 
more precise way. 
 
References 
 
 45 
 
Keller G. 2005. Embryonic stem cell differentiation: emergence of a new era in biology and 
medicine. Genes & Development 19(10):1129-1155. 
Bauwens CL, Peerani R, Niebruegge S, Woodhouse KA, Kumacheva E, Husain M, Zandstra PW. 
2008. Control of human embryonic stem cell colony and aggregate size heterogeneity influences 
differentiation trajectories. Stem Cells 26(9):2300-2310. 
Hwang Y-S, Chung BG, Ortmann D, Hattori N, Moeller H-C, Khademhosseini A. 2009. Microwell-
mediated control of embryoid body size regulates embryonic stem cell fate via differential 
expression of WNT5a and WNT11. Proceedings of the National Academy of Sciences of the United 
States of America 106(40):16978-16983. 
Karp JM, Yeh J, Eng G, Fukuda J, Blumling J, Suh K-Y, Cheng J, Mahdavi A, Borenstein J, Langer R 
and others. 2007. Controlling size, shape and homogeneity of embryoid bodies using 
poly(ethylene glycol) microwells. Lab on a Chip 7(6):786-794. 
Moeller H-C, Mian MK, Shrivastava S, Chung BG, Khademhosseini A. 2008. A microwell array 
system for stem cell culture. Biomaterials 29(6):752-763. 
Aberger F, Weidinger G, Grunz H, Richter K. 1998. Anterior specification of embryonic ectoderm: 
the role of the Xenopus cement gland-specific gene XAG-2. Mechanisms of Development 72(1-
2):115-130. 
Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C and 
others. 2003. The Secreted Protein Discovery Initiative (SPDI), a large-scale effort to identify novel 
human secreted and transmembrane proteins: A bioinformatics assessment. Genome Research 
13(10):2265-2270. 
Germain EL, Littlefield JW. 1986. Endoderm-Secreted Factor Stimulates Growth of Embryonal 
Carcinoma Stem-Cells. In Vitro Cellular & Developmental Biology 22(2):107-112. 
Stennard F, Ryan K, Gurdon JB. 1997. Markers of vertebrate mesoderm induction. Current Opinion 
in Genetics & Development 7(5):620-627.  
Lombardi ML, Lammerding J. Altered mechanical properties of the nucleus in disease. Nuclear 
Mechanics and Genome Regulation. 2010;98:121-41. 
Dahl KN, Booth-Gauthier EA, Ladoux B. In the middle of it all: Mutual mechanical regulation 
between the nucleus and the cytoskeleton. J Biomech. 2010 JAN 5;43(1):2-8.  
De Vos WH, Houben F, Hoebe RA, Hennekam R, van Engelen B, Manders EM, et al. Increased 
plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins. 
Biochim Biophys Acta. 2010 Apr;1800(4):448-58.  
Lee JSH, Hale CM, Panorchan P, Khatau SB, George JP, Tseng Y, et al. Nuclear lamin A/C deficiency 
induces defects in cell mechanics, polarization, and migration. Biophys J. 2007 OCT;93(7):2542-52.  
Hale CM, Shrestha AL, Khatau SB, Stewart-Hutchinson PJ, Hernandez L, Stewart CL, et al. 
Dysfunctional connections between the nucleus and the actin and microtubule networks in 
laminopathic models. Biophys J. 2008 DEC 1;95(11):5462-75.  
Lammerding J, Schulze P, Takahashi T, Kozlov S, Sullivan T, Kamm R, et al. Lamin A/C deficiency 
causes defective nuclear mechanics and mechanotransduction. J Clin Invest. 2004 FEB;113(3):370-
8. 
  
 
 CHAPTER 4 
 
MICROFLUIDIC TECHNOLOGY AND HUMAN PLURIPOTENT 
STEM CELL MICROENVIRONMENT MODULATION 
 
4.1 Stem cell culture and expansion in microfluidic chip 
 
Micro-engineering human “tissues-on-chips” remains an open challenge from 
both scientific and technological points of view. In this part of the PhD project, I 
describe an efficient microfluidic-based approach for the differentiation of 
human pluripotent stem cells into functional cells, in order to generate human 
cardiomyocytes and hepatocytes on chip. This technology opens a new 
perspective for multi-parametric and large scale human organ-based screening 
assays. 
In this chapter, cell microenvironment will be analyzed with a different 
technology, which can help controlling in a more accurate way the balance 
between endogenous and exogenous factors, rather than just utilizing diffusional 
properties as in polyacrylamide hydrogel microwells. An exploration was done to 
see whether is possible to control stem cell expansion of hESCs and hiPSCs 
through a multi-stage microfluidic-based technology. (Discher et al., 2009; 
Dupont et al., 2011; Wan et al., 2011). Pluripotency maintenance during stem 
cell expansion would require an accurate balance between extrinsic and intrinsic 
cell signaling, through optimal in vitro delivery of exogenous factors and removal 
of endogenous cell-secreted factors (Korin et al., 2006; Villa-Diaz et al., 2009). 
Continuous microfluidic flow perfusion has been recently shown to generate 
soluble factor spatial gradients along the microfluidic channel that lead to 
heterogeneous cell phenotype. Here, is shown how a discontinuous periodic 
medium delivery with stage-dependent frequency (number of cycles of medium 
change per day) is an effective strategy for modulating stem cell niche 
specification in vitro (Fig. 4.1). Cell growth in continuous perfusion appears more 
inhomogeneous after 48 h of culture, compared to homogenous distribution of 
cell colonies under discontinuous medium change, which also show homogenous 
expression of pluripotency markers. Also quantification of cell colony diameters 
from inlet, center and outlet of the microchannels shows high homogeneity in 
periodic perfusion compared to continuous perfusion. 
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Figure 4.1. Microchannels with cells cultured in continuous perfusion compared with 
discontinuous medium change with a frequency of medium change of f=2d
-1
. Diameters ± S.D. of 
cell colonies have been quantified through LAS AF software with a minimum of 6 measures for 
each single position, in three independent channels for each culture condition. 
 
The identification of the role of extrinsic autocrine-paracrine factors in 
pluripotency and self-renewal and germ layer commitment (see Chapter 3), 
suggests a synergic mechanism of specific exogenous and endogenous factors in 
promoting transcriptional activity of pluripotency genes (Fig. 4.2A). The 
computational investigations on extrinsic signaling model revealed that 
frequency of periodic medium delivery strongly affects accumulation of 
exogenous and endogenous factors, thus regulating transcriptional activity of 
target genes. A frequency increase reduces the amplitude of temporal 
fluctuations of both exogenous and endogenous factors (Fig. 4.2B), thus 
maintaining sustained transcriptional activity of the associated target genes. 
However, higher frequencies of medium change produce decreased expression 
of gene transcript, due to continuous endogenous secreted factors wash-out. 
This simple schematic modeling reveals high correlation between frequency of 
medium change and extrinsic signaling regulation (for detailed materials and 
methods used in this work of hPSCs on-a-chip see Appendix B). 
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Figure 4.2. Pluripotent stem cell culture on-a-chip. A: Pluripotency signaling model in microfluidic 
stem cell culture.  Both exogenous (Ex) and endogenous (En) factors contribute to transcriptional 
activity of pluripotency genes through activation of target transcription factors (Tr). B: Signaling 
model output. Temporal profiles of normalized Ex and En factor concentrations in the microfluidic 
channel at increasing frequencies (up). Gene transcript (Gt) concentration profile plotted versus 
corresponding Transcription factor (Tr) variation during a single medium perfusion at increasing 
frequencies. C: Experimental set-up. Periodic medium delivery in microfluidic channels (200 µm 
high, 1.5 mm width, 1.8 mm length and 6 µL volume) is controlled through a multi-port delivery 
system. Different frequencies sequences are automatically programmed through Labview 
software. D: Microfluidic hPSCs culture. Half channel views showing hESCs and hiPSCs expanded 
for 6 days in microfluidic conditions with f=2d
-1
. Insets show typical morphology of stem cells 
colonies. Scale bar 50 µm. E: Immunofluorescence analysis of pluripotency markers Oct-4, Sox2, 
Tra-1-60 and Tra-1-81 for hESCs and hiPSCs after 6 days in microfluidic channels. 
 
An investigation was done on the best condition for both hESC and hiPSC 
expansion in microfluidic channels to maintain high stemness and homogeneous 
morphology among colonies at different regions along the channels. HPSCs were 
injected into multiple microfluidic platforms, each containing 8 independent 
Tra-1-60 
Tra-1-81 
e 
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channels and connected to a multi-port syringe pump, for software-automatize 
medium change (Fig. 4.2C). Cells were then cultured with defined frequency up 
to 6 days (Fig. 4.2D). Immunofluorescence staining revealed that both hESCs 
(HES2) and hiPSCs (ADHF#1) homogeneously express pluripotency markers such 
as Oct-4, Sox2, Tra-1-60 and Tra-1-81 (Fig. 4.2E). 
 
4.2 Pluripotency maintenance optimization 
 
Next, optimization of hESC microfluidic culture was performed to maintain 
high pluripotency in the channels, comparable to standard static conditions. The 
qRT-PCR analysis of pluripotency marker Oct-4 and Nanog after 6 days of culture, 
showed optimal frequencies of f=1.5d-1 and f=2d-1 (Fig. 4.3). Significant two-fold 
higher expression compared to lower (f=1d-1) and higher frequencies (f=3d-1 
f=4d-1 f=8d-1 and continuous perfusion) was observed. These results are 
consistent with the hypothesis that an appropriate balance of exogenous 
molecules and endogenous cell-secreted factors has to be provided. 
Figure 4.3. Frequency-dependent pluripotency marker expression. QRT-PCR analysis of 
pluripotency markers Oct-4 and Nanog in hESCs at different frequencies, f, compared to standard 
static culture control (Petri dish) and continuous perfusion (C.P.). p-value **P≤0.01. Data are 
shown as mean ± s.d. (n=6). 
 
In order to ensure that the depletion of metabolites within the small 
microfluidic volume is not reaching critical values (especially for low frequencies 
1d-1), quantitative detection of glucose depletion at different conditions was 
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performed. Figure 4.4 shows, first of all, that glucose concentration in the 
medium kept inside a microfluidic channel is the same as in the fresh medium, 
meaning that no evaporation effects, which could increase metabolites 
concentration, are present. Moreover, glucose concentration was measured 
inside microfluidic channels, in the presence of cells, at the end of the cycle of 
medium perfusion for three different f, i.e. f=8-2-1d-1, showing that there are no 
statistical differences, or minimal differences (only by using f=1d-1), compared to 
glucose concentration measured in Petri dish after 24h of culture. 
 
Figure 4.4. Glucose uptake in microfluidic channel compared to Petri  dish culture. Glucose 
concentration of medium inside a microfluidic channel (with no cells seeded) is equivalent to that 
of fresh medium. Glucose concentration of medium in microfluidic channel collected at the end of 
the cycle of perfusion is reported for three different frequencies of medium change. Only with 
f=1d
-1
, glucose concentration results statistically decreased  compared to standard condition in 
Petri Dish. Student t test p-values P ≤ 0.05 (*). 
 
The presented data show a crucial effect of medium change frequency on 
hPSC pluripotency maintenance and homogeneity in microfluidics, to allow 
proper factor supply, while avoiding up/downstream effects throughout the 
channels (Fig. 4.5). 
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Figure 4.5. Pluripotency marker expression at day 6 in human pluripotent stem cells cultured in 
microchannels with f=2d
-1
. First “HES2” hES cell line showing Oct-4 and Sox2 expression. Next 
“ADHF#1” hiPS cell line showing Oct-4 and Sox2 expression. High homogeneity in expression is 
shown along the microchannels with no upstream and downstream effects. 
 
4.3 Pluripotency rescue with conditioned media 
 
Pluripotency optimization experiment in microfluidic chip (see Fig. 4.3) 
showed how is possible to modulate frequency up to the best condition for cell 
culture. With this in mind, the aim was to provide strong experimental evidence 
that frequency of medium change could be used as an additional variable to 
control pluripotent stem cell microenvironment by regulating the level of 
endogenous factors within low-volume system. It is worth to underline that the 
level of extrinsic exogenous factors, could be independently regulated by tuning 
the fresh media composition, delivered within the microfluidic volume. An 
experiment was designed to analyze the rescue of pluripotency of cells under 
non-optimal culture condition (f=8d-1), using conditioned media collected from 
microfluidic optimized hESC culture (f=2d-1) (Fig. 4.6). 
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Figure 4.6. Rescue of pluripotency. QRT-PCR on pluripotency markers Oct-4 and Nanog was 
performed on f=2d
-1 
for positive control, f=8d
-1 
for negative control and f=8d
-1 
cultured with f=2d
-1 
cells conditioned medium. Cells cultured for 6 days at high f with conditioned medium show 
pluripotency marker expression comparable with positive control. Normalization on GAPDH. Data 
are shown as mean ± s.d. (n=3). Significativity is calculated with unpaired t-test. ***P < 0.001, 
**P < 0.01. 
 
 These experiment gives a proof that frequency itself is affecting stem cell 
function through the modulation of endogenous factor concentration, and that 
an optimal frequency (i.e. f=2d-1 in this microfluidic setup) allows accumulations 
of essential factors for pluripotency maintenance in microfluidics channels. 
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 CHAPTER 5 
 
HUMAN PLURIPOTENT STEM CELL FUNCTIONAL 
DIFFERENTIATION IN MICROFLUIDIC CHIP 
 
5.1 Early germ layer differentiation in microfluidic chip 
 
In this chapter, an analysis is done on whether is possible to control selective 
germ layer commitment and derive functional tissue-specific cells on a chip from 
hESCs and hiPSCs through the multi-stage microfluidic-based technology. The 
different developmental stages require cell niche specification in terms of 
accurate balance between extrinsic and intrinsic cell signaling, through optimal in 
vitro delivery of exogenous factors and removal of endogenous cell-secreted 
factors. 
 
5.1.1 Frequency controlled spontaneous differentiation 
 
HESCs were expanded for 3 days and differentiated for 4 days at different 
frequencies in spontaneous differentiating conditions, with no specific 
differentiation factor (for detailed materials and methods used in this work of 
hPSC differentiation on-a-chip see Appendix B). Expression levels of early germ 
layers markers were analyzed through qRT-PCR analysis of β-III Tub and OTX2 
(ectoderm), Bra T, GATA4 and αSMA (mesoderm), AFP, EOMES and FOXA2 
(endoderm). Under these conditions, the static Petri dish control showed mainly 
ectoderm expression. On the other hand, frequency-dependent germ layer 
enrichment was observed in microfluidic culture (Fig. 5.1). Ectoderm resulted 
highly expressed at lower frequencies (f=1d-1 and f=2d-1) and it is completely 
down regulated at higher frequency (f=8d-1) whereas mesoderm and endoderm 
expression are enhanced at higher frequency (f=8d-1). Gene expression is 
associated with cell morphology changes. These experimental observations are 
consistent with the hypothesis that ectoderm differentiation requires high 
accumulation of extrinsic endogenous factors (Chapter 3; Przybyla and Voldman, 
2012). Whereas strong endoderm enrichment is only possible with exogenous 
factor delivery. All together, these results suggest that periodic perfusion 
frequency is an additional player in directing early germ layer commitment. 
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Figure 5.1. Early germ layer induction of hESCs on-a-chip. Schematic of frequency-dependent 
differentiation with f and its correlation to En and Ex factors balance (up). QRT-PCR analysis of β-
III tubulin and OTX2 for ectoderm; brachyury T, GATA4 and alpha smooth muscle actin for 
mesoderm; alpha-fetoprotein, EOMES and FOXA2 for endoderm, in hESC spontaneous 
differentiation on chip, under different f. Cell morphology in phase contrast for each 
differentiation condition. Scale bar 50 μm. Normalization on GAPDH. Data are shown as mean ± 
s.d. (n=6). 
 
5.1.2 Specific differentiation and mesoderm optimization 
 
To verify whether an efficient and selective induction of the three germ 
layers could be achieved, hESCs were induced to ectoderm, mesoderm and 
endoderm by specific differentiation media and with ad hoc frequency (Fig. 
5.2A). Particularly, according to previous results, f=1d-1 was used for ectoderm 
specification whereas f=2d-1 and f=3d-1 for mesoderm and endoderm, 
respectively. Selective germ layer commitment was successfully obtained as 
reported by qRT-PCR analysis, which showed high expression of specific germ 
layer genes for each differentiation protocol. All other non-specific germ layer 
genes are down regulated. 
Next, an analysis was done to see if perfusion frequency can be further 
adjusted for optimizing germ layer microfluidic induction when specific 
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differentiation protocols are used. As proof of concept, results in Figure 5.2B 
show how selective induction of mesoderm was achieved by adjusting frequency 
of periodic perfusion. In particular, it resulted a 3 fold higher brachyury T 
expression at f=2d-1 and 3d-1, compared to f=1d-1 and almost null expression at 
f=12d-1. 
 
Figure 5.2. Early germ layer induction of hESCs on-a-chip. A: Early germ layer induction with 
specific media. The qRT-PCR analysis of β-III tubulin, brachyury T and AFP, and comparison 
between standard static control and microfluidic differentiation. Data are shown as mean ± s.d. 
(n=3). B: Mesoderm optimization. The qRT-PCR analysis of Oct-4 and brachyury T expression in 
different frequencies of medium change for germ layer commitment optimization. Bra T 
expression is comparable between f=3d
-1
 and f=2d
-1
, while there is a significantly lower expression 
at high and low frequencies. Normalization on GAPDH. Student’s t-test p-values **P≤0.01. Data 
are shown as mean ± s.d. (n=3). 
 
5.1.3 Homogeneity during differentiation 
 
Next question was to see if cell culture homogeneity, already shown during 
pluripotent stem cell expansion (Fig. 4.5) was also maintained during the 
differentiation processes inside the chip. As shown in Figure 5.3, periodic 
perfusion ensures maintenance of homogenous culture and marker expression 
along microchannels also during germ layer commitment and differentiation. In 
both early and late endoderm, cell distribution appears uniform, and also marker 
expression is intense and homogenous, with no signs of upstream and 
downstream effects due to local factors accumulation or washout. 
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Figure 5.3. Cell homogeneity during differentiation. Hepatic differentiation at f=2d-1 in 
microchannels at day 4 of early endoderm, and day 10 of definitive endoderm commitment. Cells 
show homogenous expression of alpha-fetoprotein at day4, and polygonal epithelial cell shape at 
day 10 along microfluidic channel. 
 
Collectively, these findings indicate that the frequency of periodic perfusion 
is an additional parameter to enhance robustness and efficiency of early germ 
layer specification. Mesoderm differentiation seems to require a proper balance 
between exogenous and endogenous molecules that can be achieved by 
frequency optimization, although dependent on cell culture density and media 
composition. Ectoderm commitment is mainly driven by endogenous 
stimulations and microfluidic differentiation can reproduce the results obtained 
with conventional cell culture methods. From technological point of view, small-
scale microfluidic volume leads to extremely reduced medium consumption (few 
microliter per day per channel) and rapid and accurate perturbation of medium 
composition that is an important prerequisite for multi-stage differentiation 
process. 
 
5.2 Functional differentiation and tissue-on-a-chip generation 
 
Lastly, the major goal of the use of microfluidic technology together with 
stem cell culture, is to demonstrated whether functional tissue-specific cell 
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generation on chip can be achieved. The focus was on cardiac and hepatic cells, 
as already explained at the beginning of the PhD thesis, which are derived from 
mesoderm and endoderm germ layers, respectively. These cell types are 
extremely relevant for tissue-on-a-chip applications. Cell differentiation was 
achieved by combining ad hoc hPSC differentiation stages, germ layer 
specification and mature differentiation with proper frequencies of periodic 
perfusion and chemical regulation of soluble microenvironment. 
 
5.2.1 Cardiac differentiation on chip 
 
First, I report how cardiac cells on chip were derived after 15 days of 
frequency-dependent multi-stage differentiation protocol (Fig. 5.4A), consisting 
on mesoderm induction (by Wnt induction), early cardiac commitment (by Wnt 
inhibition) and functional cardiac maturation (by pro-cardiac factors supply). 
Typically 5 to 10 thousands cells per channel were obtained. Almost 65% of 
cardiac troponin-T positive cells were obtained, from both hESC- (HES2) and 
hiPSC- (ADHF#1) derived cardiomyocytes (Fig. 5.4B). HPSC-derived 
cardiomyocytes show spontaneous calcium transients and excitation contraction 
coupling. In the line scan magnification in Figure 5.4C both calcium transients 
and spark-like spontaneous activity are presented. Analyzing calcium handling of 
hPSC-CM in microchannels, a functional response is present to 0.5 µM Verapamil 
with reduced calcium release after L-type channel inhibition, and response to 10 
mM caffeine with cytosolic calcium increase after ryanodine channel activation 
(Fig. 5.4D). 
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Figure 5.4. Cardiac functional differentiation on-a-chip from both hESCs and hiPSCs. A: 
Microfluidic cardiomyocyte differentiation protocol and morphology changes from pluripotent 
state to differentiated cell type. B: Cardiac troponin T positivity cell count percentage. C:  
Microfluidic calcium dynamics. Spontaneous calcium transients in hPSC-cardiomyocytes recorded 
with Fluo-4 indicator. D: Functional cardiomyocytes response to 0.5 µM Verapamil with reduction 
in calcium release, and to 10 mM caffeine with increase in cytosolic calcium. 
 
The cardiac tissue obtained in the microchannels show cardiac troponin T 
positive cells with defined sarcomeric organization (Fig. 5.5A). In every 
microchannel replicate homogenous monolayers of cells with spontaneous 
contractile activity were obtained, as shown in the video frame shot in Figure 
5.5B. These results have been replicated both with human embryonic and human 
induced pluripotent stem cells. 
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Figure 5.5. A: Immunofluorescence of hESC-derived CM showing f-actin and cardiac troponin-t 
sarcomeric organization. Scale bars 20 μm. B: Video frame shot of the central section of a 
microchannel with spontaneous contractile monolayer of hESC-CMs. 
 
It was successfully shown that it is possible to generate functional cardiac 
cells on chip and to directly perform dynamic biochemical stimulations taking 
advantage of the microfluidic environment, which allows robust, accurate, fast, 
and cost-effective spatio temporal control of cell microenvironment (Disher et 
al., 2009). 
 
5.2.2 Hepatic differentiation on chip 
 
Next, this methodology was applied to derive hepatocytes on chip. Hepatic 
cells were obtained from both hESCs and hiPSCs by early endoderm 
commitment, definitive endoderm specification and hepatocyte-like cell 
maturation steps, driven by specific periodic medium delivery (Fig. 5.6A). In 
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order to assess the robustness of the method, in addition to hESCs (HES2) and 
retrovirus-derived hiPSCs (ADHF#1), 3 different hiPSC lines were generated by 
non-integrating methods: Sendai viruses (Send#1) and modified mRNAs (RNA#1, 
RNA#2). Characteristic polygonal-shaped hepatocyte-like cells are obtained, with 
presence of bi-nucleate cells at the late stage, characteristic resembling in vivo 
hepatocytes. Compared to static Petri dish control differentiation, a shortening 
of the time required for differentiation was obtained, from ~16 days to ~14 days. 
ELISA was performed to analyze functional human albumin secretion in the 
medium by hepatocyte-like cells. At the last day of maturation, a 40% higher 
albumin secretion rate is present in microfluidic cells compared to Petri dish 
control (Fig. 5.6B). Also quantification of immunofluorescence of late stage 
albumin and CYP-3A in hESCs shows higher expression in microfluidic 
differentiated cells compared to static control (Fig. 5.6C). Albumin quantification 
shows comparable results also for all other 4 different hiPSCs lines, confirming 
the robustness of the method (Fig. 5.6D). 
 
Figure 5.6. Hepatic functional differentiation on-a-chip from both hESCs and hiPSCs. A: 
Hepatic differentiation protocol and cell change in morphology up to hepatocyte-like cells. Red 
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arrows indicate binucleate cells in late stages. B: ELISA albumin secretion quantification. 
Microfluidic-derived hepatocyte-like cells secrete 40% more albumin compared to static control at 
the last day of differentiation. Student’s t-test p-values **P≤0.01. Data are shown as mean ± s.d. 
(n=3). C: Quantification of immunofluorescence markers. Microfluidic hepatic cells show 
significant higher expression of ALB and CYP-3A compared to static control. Data are shown as 
mean ± s.d. (n=10). D: Comparison of Albumin production at Day 14 for different hiPSCs derived 
cell lines differentiated into hepatocytes-like cells. Levels of albumin secretion comparable to 
HES2-hESC line-derived hepatocytes were obtained for hiPSCs lines ADHF#1, derived with 
retroviruses, Send#1, derived with Sendai viruses and RNA#1-2, derived with mRNA technology. 
Albumin production rate is expressed as ng/mL/day/2x10
5
 cells. 
 
The hepatic tissue on chip has been characterized with immunofluorescence 
staining for cholangiocyte marker cytokeratin-19, hepatocyte marker 
cytokeratin-19, late hepatocyte markers albumin and cytochrome P450-3A (Fig. 
5.7A). The tissue has been also tested for functional activity such as glycogenesis, 
an important metabolic function of the liver to maintain normal levels of 
circulating glucose in the blood. Periodic acid oxidizes vicinal diols in the 
glycogen, creating a pair of aldehydes, which then react with the Schiff reagent 
to give a magenta color. PAS staining in Figure 5.7B shows high glycogen storage 
capacity (75% of total cells) of hESC-hepatocytes. Cells show also breakdown 
capacity of specific compounds, such as indocyanine green. Absorbed ICG is 
metabolized in the functional liver cells and excreted after few hours (Yamada et 
al. 2002). These functions are extremely relevant for hepatic drug metabolism 
studies. 
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Figure 5.7. A: Immunofluorescence analysis for cytokeratin-19 in red, alpha-fetoprotein in 
green, cytokeratin-18 in red, albumin in red, cytochrome P450-3A in red. B: Functional 
tests. Periodic acid–Schiff (PAS) stain. Pink-magenta cells retain high levels of glycogen in 
the cytoplasm. Completely white cell retain no glycogen. Nuclei are stained in purple-
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blue with haematoxylin. Indocyanine green (ICG) test. Functional hepatocyte-like cells 
incubated with ICG internalize the cyanine dye (O h) and metabolize and excrete it (6 h). 
 
The microfluidic environment together with optimized periodic perfusion 
frequency provide an effective methodology for generating hepatic-like tissues 
on a chip with remarkable functional differentiation also compared to 
conventional cell culture methods. 
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 CHAPTER 6 
 
FUTURE PERSPECTIVES AND CONCLUSIONS 
 
6.1 Future perspectives 
 
The results obtained during this PhD project shed a little light on the deep 
effects that cell soluble microenvironment have on pluripotency homeostasis, 
and cell differentiation processes. Much has still to be done in order to deeply 
understand how all the single components of the surrounding microenvironment 
cooperate actively in pluripotency and functional maturation. One of the major 
goal of scientists working in the stem cell fields, regenerative medicine, in vitro 
therapeutics and screenings, is to reach the complex features of the most 
complicated biological machine, the human body. 
 
6.1.1 Hepatic differentiation under oxygen gradient 
 
As a proof of concept, an attempt has been made to better mimic in vivo 
conditions during cell differentiation.  
With this in mind, a microfluidic chip, which can create and maintain a stable 
oxygen gradient, has been developed (see Chapter 2). For experimental reasons, 
it was not adopted the physiological pO2 range found in the liver lobule (Fig. 
1.4), but the range was enlarged from 21% oxygen to 0% oxygen, to see in the 
first experimental trials if it was possible to obtain a biological response to a 
larger gradient range. When all the experimental procedures are set up and 
robust, then it will be possible to reduce the gradient to mimic the physiological 
one. 
First, hESCs were differentiated into hepatocytes like cells in the 
microchannels with the stable gradient. The first time point was at day 9, when 
cells are committed to hepatic endoderm. Cells have been fixed and stained for 
alpha-fetoprotein (Fig. 6.1A). As a first result, qualitative analysis of the 
immunofluorescence gives a gradient of marker expression between the two 
extremes of the gradient. It results a higher expression of AFP in the oxygenated 
side of the channel (21% O2), compared to lower expression in the deoxygenated 
side (<5% O2). 
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In order to quantify the qualitative analysis, a series of region of interest 
(ROI) was selected in each fluorescence image at the extremes of the gradient, in 
the channel extremities. Same exposure time and 20X magnification was used for 
all the acquired images. The mean fluorescence of the oxygenated and 
deoxygenated sides was compared (Fig. 6.1B). A significant difference in marker 
fluorescence was obtained at the extremes of the gradient. The same analysis 
procedure was applied on images taken in the length of the gradient, and mean 
quantities were plotted against channel width. It results an exponential decay of 
the fluorescence from oxygenated to deoxygenated side (Fig. 6.1C). This is a first 
proof that it is possible to obtain a biological response to an imposed physical 
gradient. 
 
 
Figure 6.1. A: Schematic representation of air (21% O2) and nitrogen (0% O2) lines creating the 
oxygen gradient in the cell culture microchannel. HESC-derived endoderm cells at day 9 of 
differentiation stained with AFP in green. B: Graph showing mean fluorescence in arbitrary units 
of selected ROIs in the two sides of the microchannel. Data shown ± s.d. (n=12). Student’s t-test p-
value *P≤0.05. C: Graph showing mean fluorescence in arbitrary units of selected ROIs along the 
width of the microchannel. Data shown ± s.d. (n=3). 
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As a second experiment, a differentiation protocol was completed inside the 
oxygen gradient chip. This was done to evaluate if a biological effect was also 
present at mature stage. A control experiment was done on cells put under 
oxygen gradient from day 8, to see if eventual metabolic zonation could be 
induced also starting from endoderm committed cells, as it happens in vivo in 
new hepatocytes originating from adult liver stem cells (Forbes et al., 2002). 
HESC-derived hepatocyte-like cells were fixed at day 15 and stained for glycogen, 
in order to analyze metabolic differences. As shown in Figure 6.2, the cells 
subjected to oxygen gradient, both from the beginning of the experiment and 
starting from endoderm, show a qualitative difference in glycogen storage. It 
appears more present in the oxygenated side (corresponding to in vivo zone I 
hepatocytes) compared to lower glycogen storage in deoxygenated side 
(corresponding to in vivo zone III hepatocytes). In the control cells, cultured with 
no O2 gradient, glycogen storage is more homogenous. 
 
 
Figure 6.2. Periodic acid–Schiff(PAS) stain of hESC-derived hepatocyte-like cells at day 15 
of differentiation. The first image on the left show cells subject to O2 gradient from first 
day of differentiation. Central stain show cells subject to O2 gradient from day 8 of 
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differentiation. Last stain on the left shows control differentiation w/o gradient. Stain of 
cells under gradient show a glycogen (magenta-pink) decreasing gradient from high O2 
to low O2. 
 
This result is consistent to in vivo functions of gluconeogenesis in zone I (high 
O2) and glycolysis in zone III (low O2). It means that portal hepatocytes (zone I) 
tend to store higher quantities of glycogen, while central hepatocytes (zone III) 
tend to store less and use more glucose (Kudryavtseva et al., 1996). 
Much work has still to be done in order to better imitate physiological 
conditions, such as the accurate screening of functional enzymes distribution, i.e. 
all the different isoforms of cytochromes P450 (Usynin and Panin, 2008). These 
results obtained with an imposed oxygen gradient are very promising for what 
concerns tissue development, and the need of in vitro models to gradually reach 
the complexity of living tissue and organs. 
 
6.2 Conclusions 
 
The development of in vitro human tissues is hindered by the difficulty to 
give perfect chemical and physical stimuli to cells, and perfectly control cell 
culture microenvironment. 
Understanding the mechanisms that underlie stem cell self-renewal and 
differentiation is central to realizing this potential, and efforts have increasingly 
focused on elucidating the signals that regulate cell function in the tissues where 
they reside, i.e. the endogenous stem cell niche. The governing principle of this 
niche, first proposed 30 years ago, is that stem cell fate decisions are influenced 
by cells’ interactions with components of their microenvironment, and these cell 
extrinsic factors include soluble and immobilized factors, the extracellular matrix, 
and signals presented by neighboring cells. Thus, recreating or simulating this 
microenvironment may be critical for properly expanding and controlling the 
differentiation of stem cells outside the body, for both basic biological study and 
therapeutic translation (Eshghi and Schaffer, 2008). In standard in vitro cell 
cultures is still missing biomimesis. The regular Petri dish lacks of physiological 
stimuli reproducing the correct cell microenvironment, while in vivo animal 
models are not fully representative of the human physiology. Tissue engineering 
research field has deeply inspired by biomimetic concepts, and in the last years 
several strategies and technologies were developed in this perspective, to 
generate and improve engineered tissues as alternative in vitro models. 
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To this end, this PhD thesis focused on the development of functional tissues, 
starting from human pluripotent stem cells, for a possible use as in vitro models. 
The work started with the initial understanding on how a modulation of the 
soluble microenvironment is capable of affecting differentiation patterns in 
pluripotent cells (Chapter 3). In particular, polyacrylamide hydrogels were 
characterized and used for their highly selective diffusional properties. Three-
dimensional microwell allowed the obtainment of homogenous embryoid 
bodies, critical to obtain a standardize cell culture. This potential improvement in 
homogeneity may be beneficial to the reproducibility of differentiation protocols 
into specific lineages for potential tissue engineering and organ regeneration 
applications. Furthermore, hPSC cultured in the three-dimensional system 
synthesize their own endogenous repertoire of factors and contribute to create a 
microenvironment suitable for cell growth and differentiation. The results 
showed how the accumulation of endogenous factors has a deep effect on hPSC 
differentiation. The study could provide insights to the relationship between the 
confined cell niche and stem cell behavior during differentiation. In addition it 
sheds light on the potential effects of the diffusion of soluble factors and related 
effects on differentiation patterns in microenvironments, relevant to the 
emerging use of microstructured culture systems. 
Next step of the PhD work was the production of functional hepatic and 
cardiac tissues with the use of ad hoc microtechnologies. The first critical step 
was the choice of a suitable cell source, which can replace standard immortalized 
cells lines, lacking many of the adult cell characteristics and functionalities, and 
primary cell lines, difficult to extract, if not almost impossible in large quantities 
(i.e. human cardiomyocytes and human hepatocytes), and difficult to maintain 
and expand in culture for many passages. To this end, human pluripotent stem 
cells were chosen. Human embryonic stem cell lines have the possibility to be 
expanded in culture almost indefinitely, while maintaining their characteristics of 
stemness and potency. These cells are extremely versatile as they can be 
differentiated into all derivates of the three germ layers, giving the possibility to 
generate a high number of mature cells of interest (Thomson et al., 1998). 
Secondly, human induced pluripotent stem cells were produced and used as cell 
source. This is one of the major discoveries in the last decade, confirmed also by 
the Nobel Prize in Physiology or Medicine 2012 awarded to Prof. Shinya 
Yamanaka (Nobelprize.org, 2013). The hiPSCs are adult somatic cell 
reprogrammed to an embryonic state, which can then be differentiate to any cell 
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type (such as hESC) but overcomes the ethical issues involving the use of 
embryos (Takahashi et al., 2007). They have all the characteristics of hESCs, and 
they also give the possibility to derive patient-specific cell lines, in order to 
develop ad hoc models for specific in vitro therapeutic studies. 
Despite their high sensitivity to environmental conditions and their time-
demanding cell culture, different lines of hPSCs were successfully cultured and 
expanded during this study. One of the major problems of these cell types is the 
difficulty to homogenously differentiate them and maturate them to obtain 
completely functional adult cells. These problems are difficult to address in a 
standard cell culture in Petri dish, because of the impossibility to accurately 
monitor and manipulate cell microenvironment. 
Microtechnologies can help overcome the problems resulting by the poor 
control on standard Petri dish cell cultures. For this reason, microfluidic 
technology was applied to hPSCs culture in order to better control expansion and 
differentiation processes, to achieve functional tissues on chip. With this 
technology it has been possible to control cell soluble microenvironment to 
optimize hESC culture in the microfluidic channels. It was also demonstrated how 
the frequency of medium change is essential in directing early differentiation, 
and how a change in f during spontaneous differentiation results in dramatic 
changes in the germ layer commitment. Therefore, frequency has been adopted 
as a new variable to consider during stem cell microfluidic culture. 
The differentiation of hPSCs into cardiomyocytes and hepatocytes was 
achieved by standardized protocols  (Hay et al., 2008; Lian et al., 2012) combined 
with microfluidic cell culture, through hESC and hiPSC stimulation with defined 
temporal sequences of soluble factors, finely controlled by automatized media 
changes. By this, a high percentage of cardiomyocyte cells were obtained (65% of 
the cells positive to cardiac troponin t). Cardiac tissue showed remarkable self-
contraction capacity and correctly responded to functional tests, such as proper 
calcium dynamics and correct response to Verapamil and caffeine drugs. Also 
hepatic tissue showed high functional activity, such as proper albumin secretion, 
expression of functional cytochrome P450 enzyme, high levels of glycogen 
storage and metabolic function in breakdown of chemical compound 
indocyanine. Moreover, hepatic cells obtained in microfluidic channels showed 
higher percentage of hepatic markers and albumin secretion compared to 
standard differentiated Petri dish cells. 
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The micro-technologies used in this thesis are reproducible, completely 
customizable, inexpensive and extremely versatile. They were designed and 
developed with the intent of being used in the development of an in vitro model, 
able to lower cost and time of drug and therapy development, which could be 
easily used by biological researchers. The coupling of biological science with 
engineering tools offer new possibilities, otherwise not easily accessible, as 
demonstrated by the promising results obtained in this PhD thesis. 
Microengineered cell-culture systems that mimic complex organ physiology have 
the potential to be used for the development of human-relevant disease models 
that are more predictive of drug efficacy and toxicity in patients, while also 
providing greater insight into drug mechanism of action. More predictive in vitro 
assays incorporating cultured human cells also will protect public health by 
identifying environmental toxins and providing a better understanding of their 
mechanisms of action, as well as improving our ability to predict risks for specific 
compounds. In addition, the organ-on-chip microdevices could be integrated to 
study the interplay of different organs in determining pharmacokinetic 
properties of compounds at a higher level of functionality than was possible in 
the past (Huh et al., 2011). 
Concluding, in this PhD work, functional tissue-specific cells on a chip were 
derived through a robust multi-stage microfluidic technology, which allows 
accurate spatio-temporal control of cell soluble microenvironment through 
regulation of periodic-perfusion frequencies. Moreover, functionally 
differentiated cells derived in the microfluidic channels can be directly used for 
dynamic multi-parametric and large-scale drug screening or for developing 
micro-engineered human organ models. It will be important to ensure that 
appropriate biomarkers and assays are developed for use with these 
microsystems, and to validate the extrapolation of in vitro results to the human 
situation. This technology opens a new perspective in generating organs-on-chips 
from hPSCs overcoming the issues related to the limited availability of human 
primary cell sources. This last aspect will require strong scientific and 
technological efforts for further mimicking the organogenesis in vitro. 
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Abstract 
 
The therapeutic potential of human pluripotent stem (hPS) cells is threatened, among various 
problems, by the difficulty to homogenously direct cell differentiation into specific lineages. The 
transition from hPSC into committed differentiated cells is accompanied by secretome activity, 
remodeling of extracellular matrix and self-organization into germ layers. In this work, we aimed 
to investigate how different three-dimensional microenvironments regulate the early 
differentiation of the three germ layers in human embryonic stem (hES) cells derived embryoid 
bodies. In particular, a permeable, biocompatible, hydrogel microwell array was specifically 
designed for recreating a confined niche in which EB secreted molecules accumulate in 
accordance with hydrogel diffusional cut-off. Fluorescence recovery after photobleaching 
technique was performed to accurately evaluate hydrogel permeability, mesh size and diffusional 
cutoff for soluble molecules. Three different culture conditions of EB culture were analyzed: 
suspension, confinement in microwells of width/depth ratio 1:1 and 1:2. Results show that EBs 
cultured in microwells are viable and have comparable average size after 8 days culture. Whole 
genome microarrays show that significative differential gene expression was observed between 
suspension and confined EBs culture. In particular, EBs culture in microwells promotes the 
expression of genes involved in pattern specification processes, brain development, ectoderm 
and endoderm differentiation. On the contrary, suspension EBs express instead genes involved in 
mesoderm specification and heart development. These results suggest that local accumulation of 
EBs secreted molecules drives differentiation patterns, as confirmed by immunofluorescence of 
germ layer markers, in hydrogel confined EB culture from both hES cells and human induced 
pluripotent stem (hiPS) cells. Our findings highlight an additional potential role of biomaterial in 
controlling hPSC differentiation through secreted factor niche specification. 
 
Introduction 
 
Human pluripotent stem cells, and in particular human embryonic stem cell lines derived from 
the inner cell mass of blastocyst stage human embryos and human induced pluripotent stem cells 
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derived by reprogramming of human somatic cells, are capable of unlimited proliferation and 
differentiation into the three embryonic germ layers (Odorico et al., 2001; Reubinoff et al., 2000; 
Thomson et al., 1998). Efficient control of the differentiation of hES and hiPS cells is a 
prerequisite for obtaining phenotypically homogenous populations, useful in clinically relevant 
therapeutic applications. However, thus far, accurate expansion and differentiation processes of 
hPSC remains an open challenge. 
Multiple methods have been used to induce human pluripotent stem cells differentiation, 
including use of specific growth factors, co-culture with specific cell lines, culture on extracellular 
matrix proteins, and embryoid body formation (Dvash and Benvenisty, 2004; Itskovitz-Eldor et al., 
2000; Keller, 2005; Odorico et al., 2001; Schuldiner et al., 2000). Of all the approaches, EB 
formation is a simple and straightforward methodology. Aggregation of cells is imposed with 
particular culture techniques, which prevent cell adhesion to a substrate. EBs are formed from 
hPSC colonies chemically or mechanically detached from their substrate, then cultured in 
suspension in the absence of mouse embryonic fibroblasts (MEFs) or MEF-conditioned medium 
(Keller, 2005; Schuldiner et al., 2000; Tian et al., 2004; Wang et al., 2004). After some days after 
aggregation, cells start a spontaneous and anisotropic differentiation into lineages of the three 
germ layers. This differentiation method recapitulates the early stages of human embryonic 
development (Keller, 2005; Kurosawa, 2007; Tian et al., 2004; Wang et al., 2004). It provides a 
three-dimensional structure, most similar to in vivo conditions, where gradients of secreted 
factors are present. 
In the cell aggregate, the first germ layer to develop is the endoderm, which surrounds a 
pluripotent ectoderm zone and a primitive mesoderm. Primitive endoderm seems to be induced 
by the signaling of fibroblast growth factor. This germ layer differentiates into parietal and 
visceral endoderm, and deposit a basal membrane composed mainly by laminin and collagen IV. 
Endoderm promotes the differentiation of adjacent mesoderm into cardiac lineages. On the 
other hand, ectoderm secretes factors (such as Wnt), which inhibit cardiac differentiation and 
promote formation of the neural tube (Bauwens et al., 2008). As differentiation continues, cells 
acquire typical phenotypes of committed differentiated cells of the three germ lineages (Bratt-
Leal et al., 2009). Therefore, when cultured in the absence of specific growth factors in medium, 
embryoid bodies can self-regulate their own differentiation through secretion of endogenous 
factors (Keller, 2005). 
Several protocols have been established to promote an efficient and reproducible obtainment of 
the cell types of interest. Modification of medium composition, conditioning medium with 
specific cell types, and addition of growth factors are methodologies used to induce specific cell 
lineages. The most common growth factors used for these purposes are activin-A, BMP-4, bFGF, 
TGFβ, HGF, NGF, EGF, and retinoic acid (Kurosawa, 2007). Other ways to induce desired cell types 
are EB size-dependent differentiation methods. Recent developments in EB formation techniques 
have enabled more controlled systems capable of modulating EB shape and size, as these 
parameters have been recognized to contribute to the control of the resulting cell population. 
Non-adhesive polyethylene glycol (PEG) microwell arrays have been used to control the 
homogeneity of EB size and shape (Karp et al., 2007; Moeller et al., 2008). Recent studies on PEG 
microwell-mediated control of EB size have also investigated the effects on hES cell fate 
determination, specifically addressing cardiogenesis and vasculogenesis via WNT signaling 
pathways (Hwang et al., 2009). Micro-contact printing techniques have also been developed to 
regulate EB size-dependent hES cell differentiation and to investigate the stem cell biology (Lee 
et al., 2009; Park et al., 2007; Peerani et al., 2007, 2009). Concave (Choi et al., 2010; Park et al., 
2009), convex-based (Park et al., 2009) thin PDMS membrane arrays and stimuli-responsive 
microwells (Tekin et al., 2010) for culturing the cells and better mimic the contour of EBs have 
also been developed. Three-dimensional cuboidal microwell systems have also been realized to 
culture hES colonies of defined dimension for the further study of cardiac differentiation (Mohr 
et al., 2010). In order to study the spatial and temporal organization of germ layers during the 
early stages of differentiation, eight hES cell lines have been compared through the analysis of 
expression of mesoderm, endoderm and ectoderm markers in order to evaluate whether the 
differences in EB characteristics would correlate with cardiac differentiation (Pekkanen-Mattila et 
al., 2010). 
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All these studies analyze the effect of factors or EB size and shape in regulating hPSC 
differentiation. The importance of growth factors in media during differentiation is clear, but 
little information about the role of secreted molecules during early differentiation stages has 
been reported. In this perspective, we designed a biomaterial that can locally accumulate soluble 
secreted molecules in a confined microenvironment. 
In conventional in vitro culture dishes any molecule is rapidly distributed over the total volume of 
medium. We designed three-dimensional hydrogel microwells with defined diffusional 
properties. Different heights of microwells are used in order to vary the extent of factors 
accumulation (Fig. 1). For this goal, we need a hydrated, biocompatible, long-term stable in vitro 
culture system suitable for suspension culture, characterized by a non-adhesive surface, and 
above all, selectively permeant to molecules in the cell culture medium. Polyacrylamide hydrogel 
is chosen for the research purposes because it addresses the cited requirements and, in addition, 
its geometry is tunable, thus allowing for easy microwells depth modulation. The culture within 
the physically separated hydrogel microwells is also expected to increase EB size homogeneity in 
the population, preventing the formation of random cell aggregates. Embryoid bodies cultured in 
the diverse differentiation niches are examined through transcriptomic and proteomic analyses, 
in order to assess differential expressions of genes involved in early embryonic development, in 
the different culture conditions. 
 
 
Figure 1. Schematic of embryoid bodies in standard cell culture dishes and compartmentalized 
into the two types of microwells. A: EBs in suspension; B: EBs in microwells 500 µm × 450 µm, 1:1 
ratio; C: 500 µm × 1 mm, 1:2 ratio. Black arrow represent endogenous factors diffusion, pink 
arrows indicate medium diffusion. In standard cell culture dishes, molecules secreted by 
differentiating embryoid bodies are rapidly distributed in the bulk medium. In microwells, 
molecules with different diffusivities will distribute in the EB microenvironment and into the 
surrounding medium by diffusion. 
 
Materials and Methods 
 
Microstructured Hydrogel Production 
 
Hydrogels were prepared as previously described (Cimetta et al., 2009). Briefly, clean and dry 
glass slide surfaces were chemically modified by deposition of a solution of 3-
aminopropyltriethoxysilane (Sigma–Aldrich, St. Louis, MO) and glutaraldehyde 0.5% (Sigma–
Aldrich) in phosphate buffered saline (PBS; Sigma–Aldrich); this results in the formation of a 
hydrophobic coating ensuring covalent binding of the hydrogel films. Acrylamide/bis-acrylamide 
29:1 solution 40% (Sigma–Aldrich) was diluted in PBS 1× to the final concentrations of 20%. The 
photoinitiator (Irgacure 2959; Ciba Specialty Chemicals) was dissolved in methanol at 
200 mg mL
−1
 and added to the acrylamide/bis-acrylamide solution in order to obtain a final 
concentration of 20 mg mL
−1
. 
 
Four Hundred Fifty Micrometer Depth Hydrogel Microwells 
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Five hundred microliter of the prepolymer solution were dropped over the functionalized glass 
surface, confined by a polydimethylsiloxane ring. Hydrogel polymerization occurred by exposing 
the prepolymer solution to UV light for 4 min (high-pressure mercury vapor lamp, Philips HPR 
125 W, emitting at 365 nm with an incident light intensity of 20 mW cm
−2
). Selective photo-
polymerization of acrylamide solutions on the glass surface was achieved by interposing the 
photomask with the desired geometry between the light source and the glass slide. 
 
One Millimeter Depth Hydrogel Microwells 
 
This hydrogel array was prepared with two different layers. Hydrogel polymerization occurred 
first by exposing 30 µL of prepolymer solution to UV light for 3 min (Philips HPR 125 W) to obtain 
a thin film of hydrogel. Second, it was covered by 500 µL of prepolymer solution enclosed by a 
polydimethylsiloxane ring, to be exposed UV light (UV-vis lamp, Dymax Bluewave-50, 3 W, with 
filter at 366 nm) for 50 s for selective photopolymerization. Non-polymerized acrylamide was 
removed using distilled water. Such procedures resulted in homogeneous 3D hydrogels with 
21 mm diameter and an average thickness of 1 mm (Fig. 2). Hydrogels were immersed in ultra-
pure milliQ water for 4 days to ensure complete removal of the unreacted monomeric units or 
photoinitiator, and then the bottom of the glass slides were soaked in pure ethanol. After rinsing 
with ultra-pure distilled water, final sterilization occurred with 20 min exposure to UV light under 
a sterile hood. 
 
 
Figure 2. Microstructured PA hydrogel production. A: The microstructured PA hydrogels are 
prepared by selective photo-polymerization of the acrylamide/bisacrylamide solution under UV 
light. B: The PA hydrogel is covalently bound to a glass coverslip functionalized with 3-
aminopropyltriethoxysilane and glutaraldehyde, as shown in the schematic representation of the 
chemistry. C: Photomask for selective photopolymerization. D: Enlargement of a photomask. The 
shading is realized in order to define the concave shape of the microwells. E: Microstructured 
hydrogel, 21 mm in diameter. The color is due to the presence of cell culture medium, which keeps 
the hydrogel hydrated. 
 
Fluorescence Recovery After Photobleaching Analysis 
 
The FRAP method has been adapted to estimate the mobility of a fluorescent probe, with a 
defined hydrodynamic radius (TRITC-Dextran, 70 kDa) (Invitrogen, Grand Island, NY), in hydrogels 
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of PA made with different concentrations of acrylamide and bis-acrylamide. To perform FRAP 
technique the fluorescent diffusion tracer is introduced at a suitable concentration (2 mg mL
−1
) 
into the prepolymer solution. After UV polymerization, it is possible to conduct the FRAP analysis 
on a hydrated hydrogel. A concentration gradient is created by photobleaching the fluorescence 
in a small circular region (5 µm). The molecules can move in the hydrogel by means of self-
diffusion if the hydrogel mesh size is large enough, and the recovery of fluorescence is detected 
by monitoring of the signal, using low intensity excitation. FRAP was performed using a confocal 
laser scanning microscope, equipped with a laser source at 561 nm. The intensity of the 
fluorescence signal was monitored between 570 and 600 nm with a 20× objective and 5× optical 
zoom. The laser output power was set to 10 µW for a pre-bleaching period of 30 s to record the 
initial fluorescence, then to 60 µW for 20 s to achieve sufficient photobleaching for FRAP 
measurements. Fluorescence recovery was monitored for 450 s with a scansion of the bleached 
area every 10 s, decreasing the laser output power to 10 µW. To assess the fluorescence recovery 
kinetics, the intensity of fluorescence measured in the target area before photobleaching was set 
as the reference value to express the recovery of fluorescence. Then, for each time point, the 
fluorescence intensity value measured in the photobleached target area was divided by the 
intensity value recorded in a reference region located at a suitable distance from the target area. 
For each experiment, the reference region was only slightly affected by the laser bleach and this 
ratio allowed us to correct for artificial changes in fluorescence intensity due primarily to 
photobleaching caused by the exposure of the field to the excitation obtain FRAP curves light 
source. These ratios were plotted against time and fitted using a single exponential function to 
obtain FRAP curves (Fig. 1 supplementary). 
 
HES and hiPS Cell Culture 
 
HES cells (cell line HES2; National Stem Cell Bank, Madison, WI) and hiPS cells (cell line ADHF#1; 
Center for iPS Cell Research and Application, iCeMS, Kyoto University) were grown on MEFs 
(Chemicon, Temecula, CA) inactivated with mitomycin C, in growth medium consisting of DMEM 
F-12 (Gibco, Grand Island, NY), supplemented with 20% knockout serum replacement 
(Invitrogen), 10% MEF conditioned medium (not used for hiPS), 20 ng mL
−1
 basic fibroblast 
growth factor for HES2, 10 ng mL
−1
 for hiPS (b-FGF; Invitrogen), 0.1 mM β-mercaptoethanol 
(Gibco), 1% non-essential amino acid stock (Invitrogen) and 1% Penicillin/Streptomicin 
(Invitrogen). HPSC were passaged to new feeder using 1 mL trypsin 0.25% for HES2 (Invitrogen), 
and CTK solution (trypsin 0.25%–collagenase IV–Ca
2+
) for hiPS. To induce the formation of human 
EBs, undifferentiated hPSC were treated with 1 mL trypsin 0.25% and CTK, and then transferred 
to matrigel coated dishes for MEF depletion. 24–48 h later, undifferentiated hPSC were treated 
with 1 mg mL
−1
 type I collagenase (Invitrogen) for 20 min followed by 1 mL trypsin 0.25% in PBS 
for 30 s and then transferred to ultra-low adhesion plates containing EB medium: 80% knockout 
Dulbecco's modified Eagle medium (Gibco) supplemented with 20% defined fetal bovine serum 
(Hyclone), 1 mM L-glutamine, 1% non-essential amino acid stock (Gibco) and 1% 
penicillin/streptomycin. Human EBs were cultured at 37°C and 5% CO2 in a humidified incubator, 
with changes of medium every 3 days. In order to check the influence of the modulate availability 
of endogenous factors on cell differentiation, 4–8–12 days old EBs were analyzed. 
 
Microwell Cell Seeding 
 
Prior to seeding cells in microwells, each UV sterilized microstructured hydrogel was placed in a 
well of a 6-well plate, immersed in cell culture medium and incubated at 37°C for 24 h for 
equilibration. HPSC were passaged from two wells of a 6-well matrigel coated plates to one 
microstructured hydrogel in 700 µL of cell culture medium. In order to maximize cell-seeding 
efficiency, the cell suspension was aliquoted to the top of the microstructured hydrogel, taking 
care to maintain the entire volume of cell suspension on the hydrogel. Hydrogel were kept at 
room temperature for at least 15 min to allow cells to settle into microwells and then placed into 
the incubator for 24 h. Finally, 3 mL well
−1
 of EB medium was added carefully to each well of the 
6-well plate to prevent cells from being washed out of microwells. We analyzed the effects of 
microwell confinement on EBs dimensions at time points of 4, 8, and 12 days after seeding. EB 
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size distributions were quantified using image analysis by measuring the diameter of each EB at 
the microscope. 
 
Cell Viability Analysis 
 
To conduct the analyses of cell viability, about 2 × 10
5
  HES2 cells were seeded onto both 
microstructured hydrogels (microwells of 450 µm and microwells of 1 mm depth) and into ultra-
low adhesive dishes for suspension culture. EBs were cultured for days after seeding, and cell 
viability was analyzed by Live & Dead assay. Cells were incubated for 45 min at room 
temperature with a solution containing 3 µM ethidium homodimer and 3 µM calcein AM 
dissolved, in DMEM containing 10% FBS. Living cells stained green, while dead cells stained red, 
and they were visualized by fluorescence microscopy. 
 
Microarray 
 
HES2-derived EBs collected at day 8 from the three culture conditions were lysed, RNA was 
extracted and cDNA was retro-transcribed and used for microarray experiments. DNA microarray 
analysis was carried out on the EBs cultured in the three different culture conditions. Total RNA 
was isolated using TRIZOL reagent (Invitrogen) coupled to RNeasy Kit (Qiagen) according to the 
manufacturers' instruction. Labelled cDNAs were synthesized by reverse transcription from the 
total RNA using the Quick Amp Labeling Kit, one-color (Agilent, Santa Clara, CA). Whole Human 
Genome Microarray Kit, 4× 44K (Agilent) was used according to the manufacturer's protocol. 
Each probe, corresponding to a specific gene, is repeated four times in the microarray glass slide 
for consistent data analysis. For statistical purposes, two independent experiments were 
performed. For every experiment, a triplicate of each cell culture condition was analyzed. 
 
Immunofluorescence Analysis 
 
After 8 days of culture in the three different conditions, embryoid bodies were carefully collected 
from suspension and from the microwells. Each batch was included into OCT and cryosectioned 
into 20 µm thick slices. Cryosections were cut onto poly-L-lysine coated glass microscope slides. 
EBs of 4, 8, and 12 days were cultured in adherent Petri dishes for 16 h to perform further 
analyses. Immunocytochemistry was performed as described: cryosections and adhered EBs were 
first fixed with paraformaldehyde 4% (8 min at room temperature) and then washed in PBS 
solution. Sections and EBs were then permeabilized in permeabilization buffer (PBS with 0.1% 
Triton X-100, Sigma) for 8 min at RT. Aspecific binding sites were blocked for 1 h at RT with 
blocking solution (PBS with 5% decomplemented Horse Serum). Sections and EBs were then 
washed and incubated with anti-Brachyury T for mesoderm, anti-AFP for endoderm and anti-β-III 
Tubulin for ectoderm, in blocking solution overnight at 4°C in humid environment, followed by 
two washes in wash solution and then incubated with secondary antibodies (1:200 in blocking 
solution) conjugated with Alexa548 or 594, for 1 h at 37°C in humid environment. Sections and 
EBs were counterstained in DAPI (Invitrogen, 1:1,000 in PBS) for nuclear staining. Slides were 
mounted with mounting medium and the coverslips were sealed with transparent varnish. The 
resulting immunostaining was evaluated using fluorescent microscopy imaging. 
For immuno-quantification experiments, EBs were enzymatically and mechanically disaggregated 
with collagenase IV 2 mg mL
−1
 trypsin 0.25% and syringe passage. Single cells were plated in 
SuperFrost Plus glass slides by cytospin, 800 rpm for 5 min. Cells were fixed and stained with DAPI 
for total cell count, and for each marker for positive cell count. Six fields (20× magnification) were 
counted for each marker and condition, and statistical analyses were conducted. 
 
Results 
 
FRAP Analysis of Polyacrylamide Hydrogels 
 
In order to evaluate self-diffusivity of molecules in polyacrylamide hydrogels, FRAP experiments 
were performed. Characterization of the hydrogel permeability was obtained by the estimation 
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of the local diffusion coefficient values for fluorescent probes with a molecular weight of 70 kDa. 
To perform those experiments, hydrogels obtained from pre-polymeric solutions with different 
monomer/cross linker molar ratios (acrylamide/bis-acrylamide ratios 29:1; 25:1; 21:1) and 
different pre-polymer concentrations (10–20%) were used and compared. The experiments were 
performed with these hydrogel compositions that show diffusional cutoff for 70 kDa fluorescence 
probes, which have the same order of magnitude of EBs secreted factors. Figure 3A shows 
swelling ratio Qm that decreases as the acrylamide and bis-acrylamide concentration (w/v) 
increases in the pre-polimer solution. In Figure 3B the mesh size, estimated from swelling data 
and Flory–Rehner theory, is plotted versus acrylamide percentage (w/v). Estimated mesh size 
decreases as pre-polymer concentration (w/v) increases, and also decreases as acrylamide/bis-
acrylamide molar ratio in the pre-polymer solution increases. Figure 3C shows self-diffusion 
index, which is the diffusion coefficient of species when the chemical potential gradient equals 
zero. The coefficient is shown as a function of percentage of acrylamide and mesh size of the 
hydrogels. Figure 3D shows the diffusion index as a function of mesh size previously evaluated 
from Figure 3A. There is an evident trend of the self-diffusion that decreases for higher 
concentrations of acrylamide solution. There is also a unique correlation between diffusion 
coefficient and mesh size. From the analysis of these data it is possible to define a decrease in 
mobility for the 70 kDa dextran in 18–20% acrylamide hydrogels. It is interesting to suppose that 
soluble molecules with similar molecular weights and comparable hydrodynamic radii with the 
dextran used in the experiment have similar self-diffusivity in the same hydrogels. Therefore, we 
developed hydrogels of 20% acrylamide v/w, in order to have a cutoff for molecules with 
molecular weights within the range 40–70 kDa, with a hydrodynamic radius of ∼19 nm. 
 
 
Figure 3. A: Hydrogel mass equilibrium swelling ratio (Qm) decreases as the acrylamide and bis-
acrylamide concentration (weight/volume [W/V]) increases in the pre-polimer solution (ACR %). B: 
From swelling data and Flory-Rehner theory, it is possible to estimate the mesh size of the 
hydrogel network. The figure shows that the mesh size (in nm) decreases for higher 
concentrations of acrylamide or bis-acrylamide. C: Self diffusion index (TAU) versus acrylamide 
concentration, with different cross-linker content. As expected, the self-diffusion decreases as 
hydrogel network becomes more dense. D: Self diffusion index versus hydrogel network mesh size. 
Molecular mobility falls to zero for mesh size lower than the molecular radii of the molecular 
tracer (about 19 nm, MW ∼70 kDa). 
 
Size-Distribution of EBs Cultured in Microwells 
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In this work, we successfully created a three-dimensional array of microwells, with specific 
dimensions. A diameter of 500 µm was chosen to develop EBs with the best average dimensions 
for early development (Choi et al., 2010; Mohr et al., 2010; Peerani et al., 2009; Tekin et al., 
2010). We also chose to develop microwells with ratio width/depth 1:1 and 1:2 to create 
different culture microenvironments for EBs differentiation. Figure 4A shows an array of 
approximately 180 µwells completely independent, which can be used for cell aggregation. In 
order to help cell seeding, concave shape wells were designed. The photomask was designed 
with a gradient of tone around the 500 µm diameter spot (Fig. 2D). As the UV light passes 
through the photomask, it gradually polymerizes the acrylamide, generating a concavity around 
the microwell. We theoretically defined a seeding of 4 × 10
5
 cells per well. The concave microwell 
array allows a consistent cell seeding, which results in homogenous distribution of cells in all the 
microwells. Figure 4B and C shows that modulation of UV light intensity through use of 
photomasks and different lamps results in efficient modulation of microwell heights, with low 
standard deviation. The biocompatibility of polyacrylamide hydrogels was tested at day 10 to see 
if there was any toxic effect of unpolymerized PA monomers. With the use of Live and Dead essay 
we observed that cell vitality was not affected by embryoid body confinement, and viability was 
comparable with suspension embryoid bodies (Fig. 2 supplementary). These results indicate that 
all the PA monomers are washed during the washing procedures, thus the hydrogel is a hydrated 
and compatible biomaterial for cell culture. 
In Figure 4E–G are shown the histograms representing the distribution of EBs diameters in 
suspension, 1:1 and 1:2 µwells, during three time points at 4, 8, and 12 days of culture. In 
suspension culture the distributions are dispersed in a wider range, showing less uniformity in 
dimensions during all time points. On the other hand, both microstructured cultures show more 
symmetric distributions. Average EB diameters are similar both in suspension and hydrogels after 
8 days, even if EB cultures in the microwells are more homogenous. It has been previously 
demonstrated how important the size homogeneity of embryoid bodies is during cell 
differentiation (Bauwens et al., 2008; Hwang et al., 2009; Karp et al., 2007; Moeller et al., 2008). 
With the experimental data shown in Figure 4, we can compare the three different culture 
conditions, assuming that the effect of EB diameter do not override the influence of local EB 
microenvironment. 
 
 
Figure 4. A: Array of EBs in the microwells of 1 mm depth (scale bar is 0.5 cm). Single EBs can 
easily be collected with a micropipette without disrupting the culture. B,C: Show enlargements of 
the vertical sections of the PA microwells of 450 µm and 1 mm depth, respectively. Scale bars in B 
and C are 250 µm. D: Measurements of the microwell depths. Panels (E–G) show quantitative 
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distribution of suspension and microwell EBs diameter. E: Measurements of EBs diameters in 
suspension culture. F: Measurements of EBs diameters cultured in 500 µm width microwells and 
450 µm depth (1:1). G: Measurements of EBs diameters cultured in 500 µm width microwells and 
1 mm depth (1:2). The average embryoid body diameters (±standard deviation) after 4 days were 
312 ± 148 µm (suspension), 210 ± 80 µm (500 µm Ø microwells 1:1) and 225 ± 98 µm (500 µm Ø 
microwells 1:2); after 8 days were 375 ± 155 µm (suspension), 385 ± 77 µm (500 µm Ø microwells 
1:1) and 400 ± 68 µm (500 µm Ø microwells 1:2); after 12 days were 463 ± 191 µm (suspension), 
504 ± 102 µm (500 µm Ø microwells 1:1), and 495 ± 84 µm (500 µm Ø microwells 1:2). Note the 
dispersion of diameter in the suspension culture condition during all time points, while data 
collected from the two types of microwell cultures have more symmetric distributions. 
 
Microarray Functional Analysis 
 
The expression patterns of embryoid bodies were assessed through transcriptomic analyses. 
Whole genome microarrays were used in order to have a complete overview of the gene 
expression in the different culture conditions. The differential gene expression was tested at day 
8 in HES2-derived EBs, in order to show early differentiation and commitment into the three 
germ layers (Keller, 2005). The same batches of cells were expanded and used to form EBs for the 
three different culture conditions, in order to have reliable results. Furthermore, we used three 
replicates for each microarray for consistent statistical analyses. 
During preprocessing of microarray data, Loess pair-wise normalization was applied. Quality 
reports and MvA plots showed high data quality for all the arrays. In the selection step 
(univariate analysis), significant analysis of microarrays (SAM) algorithm (Tusher et al., 2001) was 
used to identify genes with statistically significant changes in expression between different 
classes. All data were permutated over 1,000 cycles by using the multiclass response format, not 
considering equal variances. Significant genes were selected based on a false discovery rate (FDR) 
threshold of 0.05 (Benjamini and Hochberg, 1995). Significant genes were tested using the two-
classes response format (suspension vs. 1:1 µwells, suspension vs. 1:2 µwells, 1:1 µwells vs. 
1:2 µwells), not considering equal variances, and selected based on a significance level of 0.05/3 
(Bonferroni correction). In the functional analysis, the probe sets were functionally annotated 
and grouped according to their biological function using Gene Ontology (GO) Biological Process 
descriptions (Ashburner et al., 2000). The functional enrichment analysis to identify the most 
relevant biological mechanisms was performed using DAVID (Dennis et al., 2003; Huang et al., 
2009). GO Fat was used instead of standard GO to filter the broadest terms so that they do not 
overshadow the more specific terms. P-values were corrected for multiple testing using FDR 
(Ashburner et al., 2000). 
In the multiclass analysis 418 probes were selected, corresponding to 380 unique gene IDs and 8 
ESTs. Among the 388 genes significantly differentially expressed, 189 resulted upregulated in 
suspension EBs compared to the cultures of microwell EBs. Other 203 genes were upregulated in 
the microstructured EB cultures and downregulated in suspension culture (table shown in Fig. 3 
supplementary). A cluster analysis of the results was done with genes involved in early 
embryogenesis, which were grouped as reported in the microarray heat map in Figure 5. From 
data analysis it can be seen that the repetition of independent experiments and replicates show 
comparable results. There is a marked difference between gene expressions in suspension EBs 
compared to microwell EBs. It is also clear that the different ratio in 1:1 and 1:2 µwells do not 
influence gene expression, and therefore they have been grouped into a single category and 
confronted with suspension. 
We analyzed the expression of genes expressed in endoderm, mesoderm and ectoderm. There is 
a clear effect of the confinement in the differentiation patterns shown by the color graduation in 
the heat map (in red and green in Fig. 5). Results show that mesoderm specification and heart 
development is significantly upregulated in suspension EB, with expression of genes such as 
WIF1, BOC, MYH6, and TNNT2. On the other hand, genes such as NKX6-2, WNT3, GLI2, GDF3, and 
NRG1 involved in pattern specification process and regionalization, brain development, 
endoderm and ectoderm are consistently upregulated in microwell confined embryoid bodies. 
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The microarray analysis thus highlights a significant difference in the differentiation patterns of 
standard and confined embryoid bodies (see Figs. 4 and 5 supplementary). 
 
 
Figure 5. Microarray analysis. The panel shows the heat map of the gene expression values of a 
subset of genes associated to the Gene Ontology enriched terms “mesoderm,” “heart 
development,” “ectoderm,” “brain development,” “endoderm,” “pattern specification process and 
regionalization,” in the different growing conditions and replicates. Mesoderm and heart 
development genes are significantly upregulated in EBs cultured in suspension. Ectoderm, brain 
development, endoderm, pattern specification process, and regionalization genes are significantly 
upregulated in EBs cultured in hydrogel microwells. The genes are grouped using a hierarchical 
agglomerative clustering (average linkage—Euclidean distance). Heat map showing the same 
gene expressions scaled with respect to genes average value, and heat map showing the 
expressions of the all the 388 genes, are shown in the supplementary material. 
 
Immunofluorescence of EBs Cryosections 
 
After microarray experiments, we conducted immunofluorescence analyses to evaluate the 
expression of specific embryonic differentiation markers, and to investigate any possible 
influence of the different culture conditions onto early commitment to the three germ layers. 
Alpha-fetoprotein was used to mark early endoderm specification. Brachyury T marks the early 
embryonic mesoderm, while Beta-III Tubulin is used to mark the primary ectoderm. The 
immunofluorescence of the HES2-derived EBs sections is represented in Figure 6. AFP marking 
the endoderm is noticeably more expressed in EBs cultured in 1:1 and 1:2 µwells and less 
expressed in suspension EBs (Fig. 6A–C). The same result is observable for β-III Tub marking the 
ectoderm (Fig. 6F–H). On the other hand, brachyury T marking the mesoderm results more 
expressed in standard suspension EBs and less expressed in microwell condition (Fig. 6K–M). 
Similar results are observed for hiPS-derived EBs at day 8. Immunofluorescence analysis for 
induced pluripotent stem cells is shown in Figure 7, where AFP and β-III Tub result more 
expressed in the two microwell culture conditions (Fig. 7A–C,E–G), while brachyury T is higher 
expressed in suspension cultures (Fig. 7I–K). Quantification of immunofluorescence analyses was 
performed through cytospinned cells, and it clearly shows a difference in expression of the three 
germ layer markers among the different EB cultures. AFP and β-III Tub are significantly more 
expressed in both microwell cultures compared to suspension. On the other hand, brachyury T is 
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significantly overexpressed in suspension EBs rather than microwells (Fig. 8). In order to confirm 
our results obtained with 8 days old EBs, we performed the same immunofluorescence 
experiments on adherent EBs at two different time points, days 4 and 12, both for hES and hiPS 
cells. The expression of differentiation markers agrees with the results observed in day 8 EBs (see 
panels in Figs. 6 and 7 supplementary). 
From the analysis of the immunofluorescences, it is noticeable that there is no evident difference 
between the two types of microwell culture conditions. Microwell dept could still influence 
differentiation patterns, even though this was not noticed in our microwell geometries. However, 
it could be interesting to verify if exogenous molecules could restore mesodermal germ layer 
differentiation, which was downregulated in microstructured cultures. To this purpose, we 
performed an experiment in which 5 ng mL
−1
 of activin A, a mesoderm inducing factor, was added 
in the 1 mm microwell culture medium. Surprisingly, at all time points measured, the expression 
of mesoderm marker (brachyury T) in HES2-derived EBs was enhanced if compared with non-
treated microwell EBs as shown in Figure 9. 
 
 
Figure 6. Immunofluorescence analysis of the three germ layers on cryosections (20 µM thick) of 8 
days hES-derived EBs cultured in the three conditions. Panels (A–D) show immunolabeling with 
alpha-fetoprotein (green), which marks the endoderm, and nuclei are stained with DAPI (blue). A 
major expression of this marker is shown by the microwell culture conditions. Panel (E) shows 
HepG2 cell line expressing high levels of AFP. Panels (F–I) show the expression of the ectoderm 
marker beta-III tubulin (green), which results more expressed in the 450 µM and 1 mm µwell 
conditions. C2C12 expressing b-III Tub are shown in panel (J). Panels (K–N) show labeling for 
Brachyury T (red), which recognizes the mesoderm. This marker is more expressed in EBs cultured 
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in suspension. Panel (O) show the expression of Brachyury T in cardiomyocytes derived with a 
high-efficient mesoderm differentiation protocol of EBs. Scale bar is 100 µM. 
 
 
Figure 7. Immunofluorescence analysis of the three germ layers on adhered (for 16 h) hiPS-
derived EBs (8 days) cultured in the three conditions. Panels (A–D) show immunolabeling with 
alpha-fetoprotein (green), and nuclei are stained with DAPI (blue). A major expression of this 
marker is shown by the microwell culture conditions. Panels (E–H) show the expression of beta-III 
tubulin (green), which results more expressed in the microwell conditions. Panels (I–L) show 
labeling for Brachyury T (red). This marker is more expressed in EBs cultured in suspension. Scale 
bar is 250 µM. 
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Figure 8. The graph shows the immunofluorescence quantification by cytospin counts of 8 days 
hES-disaggregated EBs. Alpha-fetoprotein and beta-III tubulin are more expressed in the two 
microwell conditions, and show high significant difference compared to suspension culture. 
Brachyury T is higher expressed in suspension culture with high significant difference from 450 µm 
and 1 mm microwell cultures. Error bars are ±SD. Significativity is calculated with unpaired t-test. 
***P < 0.001, **P < 0.01, *P < 0.05. 
 
 
Figure 9. Immunofluorescence analysis on adhered hES-derived EBs. Panels (A–C) show 
immunofluorescence of Brachyury T in 1 mm microwell EBs non-treated with exogenous factors. 
Panels (D–F) show immunolabeling with Brachyury T in 1 mm microwells EBs treated with Activin 
A (5 ng mL
−1
), at three different time points, 4, 8, and 12 days. Treatment with exogenous ActA 
show induction of mesoderm germ layer in microwells culture of embryoid bodies. Scale bar is 
300 µM. 
 
Discussion 
 
The aim of the present work is to investigate the influence of a confined three-dimensional 
microenvironment on hPSC differentiation. Unlike monolayer cell cultures, in which specific 
aspects of the microenvironment can be more easily investigated, a 3D organization of cells like 
the EB is more difficult to examine. Differentiation of EBs is directed by exogenous molecules 
present in the culture media, and endogenous factors produced by differentiating embryonic 
stem cells. In order to investigate the confined microenvironment influence on differentiation, 
we used simple culture media, without addition of external growth factors, which could induce 
specific patterns. We created narrowed niches where EBs can grow and differentiate. The 
polyacrylamide hydrogel was chosen because it is highly stable and equilibrated with surrounding 
medium, and therefore permits the creation of hydrated niches suitable for cell cultures. It is a 
biocompatible polymer easily moldable with UV light and characterized by a non-adhesive 
surface, which allows the formation of EBs, and it is selectively permeant to soluble molecules of 
defined dimensions. It is evident that the larger the molecule then the lower the permeability of 
the PA hydrogel to this molecule (Williams et al., 1998). This property of the biomaterial permits 
the accumulation of molecules with molecular weights higher than the polymer cutoff. 
Therefore, it is reasonable to suppose that factors produced by embryoid bodies can accumulate 
in the microwell microenvironment, when their MW exceeds the hydrogel cutoff of 40–70 kDa. 
The culture of hPSC into microstructured polyacrylamide hydrogels allowed the obtainment of 
homogenous batches of embryoid bodies compared to the standard suspension culture 
conditions. EBs grown in suspension tend to form aggregates with one other, having therefore 
more dispersed sizes. This can eventually lead to more heterogeneous results in any repeated 
analysis carried out in different batches. With microstructured hydrogels we obtained EBs with 
the same mean size as suspension, but with more homogenous dimensions. This culture 
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condition also permits to obtain physically separated embryoid bodies, avoiding undesired 
aggregates. 
To evaluate gene expression differences, EBs were cultured until primitive stage of the three 
germ layers, when specific markers of early differentiation are expressed and therefore 
recognizable (Keller, 2005). In the microarray experiments there is no significant difference 
between the two types of hydrogel, and for this reason microwell EBs gene expressions have 
been grouped and statistically compared to suspension EBs. It is possible that 1:1 ratio of the 
microwells is sufficient for an accumulation of factors and the geometry 1:2 does not influence 
anymore the microenvironment. To have a robust analysis of genes expression, we used the 
same batch of hES cells in all the experiments, and we used three replicates for each culture 
condition. The heat map shows clearly the homogeneity among the replicates, therefore the 
experiment is highly repeatable. Functional analysis of the significantly differentially expressed 
genes shows that confinement of EBs in the microwells lead to specification into ectoderm and 
endoderm, and to formation of spatial patterns in developing EBs. The culture in conventional 
dishes, on the other hand, promotes the expression of genes involved in mesoderm germ layer 
and heart development. 
This robust data analysis agrees with data obtained in the immunofluorescence experiments. The 
proteomic analyses confirm the upregulation of endoderm and ectoderm markers in microwell 
EBs, and mesoderm marker in suspension culture. These results are consistent for two different 
stem cell lines with different origins, hES and hiPS. Both microarrays and immunostaining 
analyses suggest that EBs confinement does influence cell differentiation. The fact that there is 
no difference between the two microwell conditions could indicate that the microenvironment is 
not significantly influenced by our chosen depths of the microwells, but it significantly influences 
differentiation compared to standard suspension conditions. 
These outcomes on differentiation marker expression and gene expression can be correlated 
with an analysis of the relative dimensions (according to UniProt Database 
http://www.uniprot.org/) of the main secreted factors by the EBs, which are involved in the 
regulation of the differentiation patterns (Aberger et al., 1998; Clark et al., 2003; Germain and 
Littlefield, 1986; Stennard et al., 1997). The data of the molecular weights of the endogenous 
factors are shown in Figure 10. From our data, we can see that mesoderm is more expressed in 
suspension culture, therefore it can be hypothesized that mesoderm-inducing factors are 
relatively small compared to the cutoff of the polyacrylamide, so that they diffuse away from the 
cell niche in the microwells. At the same time, mesoderm-inhibiting factors should be relatively 
larger molecules that overstay in the microwells and diffuse slowly from the EBs. These 
hypotheses have a confirmation in the dimensions of secreted factors that influence or inhibit 
mesoderm formation (see Fig. 10). In the same table the data of the endogenous factors referring 
to ectoderm and endoderm are shown. Endoderm factors are not clearly defined in number and 
molecular weight, and not much can be discussed for this germ layer, even though 
immunofluorescence and microarray experiments confirm that these factors are more expressed 
in the microwell EBs. Ectoderm-inducing factors have higher molecular weight compared to 
mesoderm-inducing factors, and therefore have lower diffusional times through the PA mesh and 
remain longer in the EBs microenvironment. In fact, ectoderm result more expressed in embryoid 
bodies cultured in the microwells. Interestingly, our results show that a mesoderm-inducing 
factor could override the effect of endogenous factors in 1 mm microwell culture, restoring 
mesodermal commitment. 
These findings could indicate that the locally controlled availability of endogenous factors elicits 
significant differences in hPSC differentiation and may provide new insights into the mechanisms 
involved in cell differentiation. 
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Figure 10. The chart shows some of the main germ layers secreted factors involved in 
embryogenic processes. The red parenthesis at the left side of the chart indicates the molecular 
weight cutoff of the PA hydrogel (around 40–70 kDa). The factors are ordered by growing 
molecular weight to show the correlation between dimensions and effect on the germ layers, to 
correlate with the data shown in the microarray and immunofluorescence analyses. Data referred 
to UniProt Database http://www.uniprot.org/. 
 
Conclusions 
 
With FRAP experiments we have shown, in an innovative way, the properties that make 
polyacrylamide hydrogels one of the most suitable materials for chromatographic purposes. We 
have evidenced the possibility of building a polymeric and biocompatible substrate with high 
selective diffusional properties. Our present results demonstrate that homogeneous-size EBs can 
be produced within a microstructured hydrogel. This technique can be used for homogenously 
initiating the formation of EBs, which is critical for obtaining standardized and separated cell 
aggregates. It can be hypothesized that EBs with similar dimensions have comparable uptake of 
soluble factors on their surfaces, and it is more probable that they follow similar differentiation 
patterns, increasing homogeneity within the obtained cell populations. This potential 
improvement in homogeneity may be beneficial to the reproducibility of differentiation protocols 
into a specific lineage for potential tissue engineering and organ regeneration applications. 
Furthermore, hPSC cultured in the three-dimensional system synthesize their own endogenous 
repertoire of factors and contribute to create a microenvironment suitable for cell growth and 
differentiation. Our results show that the accumulation of endogenous factors has a deep effect 
on hPSC differentiation. This study could provide insights to the relationship between the 
confined cell niche and stem cell behavior during differentiation. In addition it sheds light on the 
potential effects of the diffusion of soluble factors and related effects on differentiation patterns 
in microenvironments, relevant to the emerging use of microstructured culture systems. Further 
experiments are required in order to study the regionalization process in the EBs. It would be 
challenging to analyze and compare the distribution of specific markers of hPSC differentiation. 
Coupling three-dimensional microwell technologies to obtain size-controlled EBs and modulating 
the availability of endogenous factors, can contribute to the understanding of stem cell 
differentiation processes, and make this approach a useful tool to consider when developing in 
vitro differentiation protocols. 
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Supplementary material 
 
 
Fig. 1. Supplementary. Fitting of a normalized FRAP recovery curve. 
 
 
Fig. 2. Supplementary. Live/dead assay on hES-EBs in standard cell culture conditions, in A) ultra-
low adhesive cell culture dishes, B) 450μm deep microwells, C) 1mm deep microwells, 10 days 
after cell seeding. Cells in the microstructured hydrogel are viable, thus indicating that the PA 
hydrogel and the confinement do not negatively affect cell viability. Scale bars are 250 µm. 
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Fig. 3. Supplementary. Selection shows how many of the 388 genes are significantly differentially 
expressed in the two-class comparison and the sign of the differential expression. “Group 1” 
correspond to genes expressions of EBs cultured in suspension. “Group 2” correspond to genes 
expressions of EBs cultured in 450 µm microwells. “Group 3” correspond to genes expressions of 
EBs cultured in 1 mm microwells. “p” indicates upregulation in the first group of comparison 
compared to the second. “m” indicates downregulation in the first group of comparison compared 
to the second. “-“ indicates genes non-significantly differentially expressed between the two 
compared groups. 
 
 
Fig. 4. Supplementary. Microarray analysis. The panel shows the heat map of the gene expression 
values of a subset of genes associated to "mesoderm", "heart development", "ectoderm", "brain 
development", "endoderm", "pattern specification process and regionalization", in the different 
growing conditions and replicates. Values are scaled with respect to genes average value (log 
expression value of the gene minus the average log expression value of the gene across the 
experiments). 
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Fig. 5. Supplementary. Microarray analysis. The panel shows the results of the clustering of all 
the 388 differentially expressed genes with a significant difference between the suspension 
culture condition and the microwell culture condition. 
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Fig. 6. Supplementary. Immunofluorescence analysis of the three germ layers on adhered (for 16 
h) hESC-derived EBs cultured in the three conditions at two different time points, 4 and 12 days. 
Panels A-C and J-L show immunolabeling with alpha-fetoprotein (green), and nuclei are stained 
with DAPI (blue). At both time points AFP is more expressed in the two microwell culture 
conditions. Panels D-F and M-O show the expression of the ectoderm marker beta-III tubulin 
(green), which results more expressed in the 450 µM and 1 mm microwell conditions. Panels G-I 
and P-R show labeling for Brachyury T (red), which recognizes the mesoderm. This marker is more 
expressed in EBs cultured in suspension, at both time points. Scale bar is 150 µM. 
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Fig. 7. Supplementary. Immunofluorescence analysis of the three germ layers on adhered hiPSC-
derived EBs cultured in the three conditions at two different time points, 4 and 12 days. Panels A-
C and J-L show immunolabeling with alpha-fetoprotein (green). At both time points AFP is more 
expressed in the two microwell culture conditions. Panels D-F and M-O show the expression of the 
ectoderm marker beta-III tubulin (green), which results more expressed in the two microwell 
conditions. Panels G-I and P-R show labeling for Brachyury T (red). This marker is more expressed 
in EBs cultured in suspension, at both time points. Scale bar is 100 µM. 
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Abstract 
 
Micro-engineering human tissues and “organs-on-chips” remains an open challenge from both 
scientific and technological points of view. Here, we described a robust and efficient microfluidic-
based approach for the differentiation of human pluripotent stem cells into functional cells. 
Specific frequency of periodic medium perfusion enhances the selectiveness of early germ layer 
differentiation and cell commitment through extrinsic microfluidic signal perturbations. Human 
cardiomyocytes and hepatocytes generated on chip from human pluripotent stem cells through 
multi-stage approach show functional differentiation, which opens a new perspective for multi-
parametric and large scale human organ-based screening assays. 
 
Text 
 
The development of human organs-on-chips, in which the microscale engineering technologies 
are combined with cultured human cells to recapitulate whole living organ microenvironment, 
offers a unique opportunity to study human physiology and pathophysiology in an organ-specific 
context
1,2,3
. This technological perspective could provide an effective solution to the limitations of 
conventional cell culture models that fail to recapitulate complex, organ-level disease processes 
in humans and it could overcome the use of costly and time-consuming animal testing, which 
often shows poor predictive power of human physiology. Moreover, the scientific community, 
the major pharmaceutical companies and the government agencies are recognizing the 
paramount importance of developing new technologies, which allow to perform cost effective 
and multi-parametric assay for ad hoc studies in development, disease and pathogenesis, or for 
screening specific therapeutic strategies. 
Recently, successful examples of organs-on-chips development have been provided
4,5,6,7
, 
however, they were obtained from primary animal cells and, in few cases, from primary human 
cells. The possibility of developing direct organogenesis-on-chip from human pluripotent stem 
cells (hPSCs) could overcome the limited availability of human primary cells, such as human 
hepatocytes or cardiomyocytes. Human embryonic stem cells (hESCs) and induced pluripotent 
stem cells (hiPSCs) grown in culture have the potential to give rise to any fetal and adult cell type, 
but they also show intrinsic and unexpected levels of emergent self-organization for generating 
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highly ordered structures and tissues
8,9,10
, thus opening a wide perspective for multi-organ 
generation on a chip.  
Organogenesis and tissue generation are complex developmental processes starting from germ 
layer specification and phenotypic differentiation to tissue morphogenesis. Biomimetic scale 
down of this multi-stage developmental process could take advantage of the intrinsic properties 
of micro-technologies and microfluidics that allow accurate control of cell culture 
microenvironment, of temporal evolution of chemical gradients and of mechanical features, 
which support specific tissue differentiation
11,12,13
. Few studies reported on mouse embryonic 
stem cell cultures using microfluidic systems and highlight the importance of accurate soluble 
microenvironment regulation to maintain pluripotency and self-renewal
14,15,16
. We reported for 
the first time on hESCs culture on a chip
17
 and few other works dealt with hESCs modulating flow 
perfusion, mainly for maintaining pluripotency
18,19
. Integrated functional hPSC differentiation on 
a chip, which certainly requires step-by-step control of hPSCs programming for resembling early 
stages of organogenesis, has not yet been developed. 
Here, we explored whether we can control stem cell expansion, selective germ layer commitment 
and derive functional tissue-specific cells on a chip from both hESCs and hiPSCs through a multi-
stage microfluidic-based technology. The different developmental stages required cell niche 
specification in terms of accurate balance between extrinsic and intrinsic cell signaling, through 
optimal in vitro delivery of exogenous factors and removal of endogenous cell-secreted factors. 
Continuous microfluidic flow perfusion has been recently shown to generate soluble factor 
spatial gradients along the microfluidic channel that lead to heterogeneous cell phenotype. Here, 
we showed that a discontinuous periodic medium delivery with stage-dependent frequency 
(number of cycles of medium change per day) is an effective strategy for modulating stem cell 
niche specification in vitro. 
Identification of the essential role of extrinsic autocrine-paracrine factors in pluripotency and 
self-renewal and germ layer commitment
20
, suggests a synergic mechanism of specific exogenous 
and endogenous factors in promoting transcriptional activity of pluripotency genes (Fig. 1a). The 
computational investigations on extrinsic signaling model (Supplementary Methods for model 
details) revealed that frequency of periodic medium delivery strongly affects accumulation of 
exogenous and endogenous factors, thus regulating transcriptional activity of target genes. A 
frequency increase reduces the amplitude of temporal fluctuations of both exogenous and 
endogenous factors (Fig. 1b), thus maintaining sustained transcriptional activity of the associated 
target genes. However, higher frequencies of medium change produce decreased expression of 
gene transcript, due to continuous endogenous secreted factors wash-out. This simple schematic 
modeling reveals high correlation between frequency of medium change and extrinsic signaling 
regulation. 
First, we investigated the best condition for both hESC and hiPSC expansion in microfluidic 
channels to maintain high stemness and homogeneous morphology among colonies at different 
regions along the channels. HPSCs were injected into multiple microfluidic platforms, each 
containing 8 independent channels and connected to a multi-port syringe pump (Fig. 1c), were 
cultured with different frequencies up to 6 days (Fig. 1d). Immunofluorescence staining revealed 
that both hESCs and hiPSCs (ADHF#1) homogeneously express pluripotency markers such as Oct-
4, Sox2, Tra-1-60 and Tra-1-81 (Fig. 1e). We optimized the hESC microfluidic culture to maintain 
high pluripotency in the channels, comparable to standard static conditions. The qRT-PCR 
analysis of pluripotency marker Oct-4 after 6 days of culture, showed an optimal frequency of 
f=2d
-1
 (Fig. 1f). Significant three-fold higher expression compared to lower (f=1d
-1
) and higher 
frequencies (f=4d
-1
 and f=8d
-1
) was observed. These results are consistent with the initial 
hypothesis that an appropriate balance of exogenous molecules and endogenous cell-secreted 
factors has to be provided. The presented data show a crucial effect of medium change 
frequency on hPSCs pluripotency maintenance and homogeneity in microfluidics, to allow proper 
factor supply, while avoiding up/downstream effects throughout the channels (Supplementary 
Fig. S1). 
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Figure 1 | Pluripotent stem cell culture on-a-chip. (a) Pluripotency signaling model in microfluidic 
stem cell culture.  Both exogenous (Ex) and endogenous (En) factors contribute to transcriptional 
activity of pluripotency genes through activation of target transcription factors (Tr). (b) Signaling 
model output. Temporal profiles of normalized Ex and En factor concentrations in the microfluidic 
channel at increasing frequencies (up). Gene transcript (Gt) concentration profile plotted versus 
corresponding Transcription factor (Tr) variation during a single medium perfusion at increasing 
frequencies. (c) Experimental set-up. Periodic medium delivery in microfluidic channels (200 µm 
high, 1.5 mm width, 1.8 mm length and 6 µL volume) is controlled through a multi-port delivery 
system. Different frequencies sequences are automatically programmed through Labview 
software. (d) Microfluidic hPSCs culture. Half channel views showing hESCs and hiPSCs expanded 
for 6 days in microfluidic conditions with f=2d
-1
. Insets show typical morphology of stem cells 
colonies. Scale bar 50 µm. (e) Immunofluorescence analysis of pluripotency markers Oct-4, Sox2, 
Tra-1-60 and Tra-1-81 for hESCs and hiPSCs after 6 days in microfluidic channels. (f) Frequency-
dependent Oct4 expression. QRT-PCR analysis of pluripotency marker Oct-4 expression of hESCs at 
different frequencies, f, compared to standard static culture control and continuous perfusion 
(CP). Student’s t-test p-value ***P≤0.001. Data are shown as mean ± s.d. (n=3). 
 
We next investigated whether the frequency of periodic perfusion could be used for directing 
early germ layer commitment according to extrinsic endogenous and exogenous factors 
concentration (as schematized in Fig. 2a). HESCs were expanded for 3 days and differentiated for 
4 days at different frequencies in spontaneous differentiating conditions (Supplementary 
Methods). Expression levels of early germ layers markers were analyzed through qRT-PCR 
analysis of β-III tubulin (ectoderm), brachyury T (mesoderm) and alpha-fetoprotein (endoderm). 
Under these conditions, the static culture showed ectoderm and mesoderm expression but not 
endoderm. On the other hand, frequency-dependent germ layer enrichment was observed in 
microfluidic culture (Fig. 2a). Ectoderm resulted highly expressed at lower frequencies (f=1d
-1
 and 
f=2d
-1
) and it is completely down regulated at higher frequency (f=8d
-1
) whereas mesoderm and 
endoderm expression are enhanced at higher frequency (f=8d
-1
). Interestingly, pluripotency 
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markers are down regulated as the frequency increases. Gene expression is associated with cell 
morphology changes. These experimental observations are consistent with the hypothesis that 
ectoderm differentiation requires high accumulation of extrinsic endogenous factors
14,20
, 
whereas strong endoderm enrichment is only possible with specific exogenous factor delivery. All 
together, these results suggest that periodic perfusion frequency is an additional player in 
directing early germ layer commitment. 
To verify whether an efficient and selective induction of the three germ layers could be achieved, 
hESCs were induced to ectoderm, mesoderm and endoderm by specific differentiation media and 
with ad hoc frequency (Fig. 2b). Particularly, according to previous results, f=1d
-1
 was used for 
ectoderm specification whereas f=2d
-1
 and f=3d
-1
 for mesoderm and endoderm, respectively. 
Selective germ layer commitment was successfully obtained as reported by qRT-PCR analysis, 
which showed high expression of specific germ layer genes for each differentiation protocol. All 
other non-specific germ layer genes are strongly down regulated. Interestingly, endoderm has 
significantly higher expression in microfluidic conditions compared to conventional 
differentiation in Petri dish. It seems that microfluidic environment effectively washed out the 
endogenous factors that inhibit endoderm differentiation, and efficiently delivered the 
exogenous pro-endoderm factors. Immunofluorescence analyses (Fig. 2c) confirmed that highly 
selective commitment for all germ layers, with extremely low contamination from the others, is 
achievable also at the protein level in each specific differentiation protocol. 
Next, we examined if perfusion frequency can be further adjusted for optimizing germ layer 
microfluidic induction when specific differentiation protocols are used. As proof of concept, 
results in Fig. 2d showed how selective induction of mesoderm was achieved by adjusting 
frequency of periodic perfusion. In particular, we found a 3 fold higher brachyury T expression at 
f=2d
-1
 and 3d
-1
, compared to f=1d
-1
 and almost null expression at f=12d
-1
. 
Collectively, our findings indicate that the frequency of periodic perfusion is an additional 
parameter to enhance robustness and efficiency of early germ layer specification, even when 
specific protocols are adopted. In particular, we found major advantages for endoderm 
differentiation, because it requires large quantities of exogenous molecules (e.g. activin A) and 
washing out of endogenous inhibiting factors. On the other hand, mesoderm differentiation 
seems to require a proper balance between exogenous and endogenous molecules that can be 
achieved by frequency optimization, although dependent on cell culture density and media 
composition. Ectoderm commitment is mainly driven by endogenous stimulations and 
microfluidic differentiation can reproduce the results obtained with conventional cell culture 
methods. From technological point of view, small-scale microfluidic volume leads to extremely 
reduced medium consumption (few microliter per day per channel) and rapid and accurate 
perturbation of medium composition that is an important prerequisite for multi-stage 
differentiation process. 
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Figure 2 | Early germ layer induction of hESC on-a-chip. (a) Frequency-dependent differentiation. 
Schematic of frequency, f, relation to En and Ex factors balance (up). The qRT-PCR analysis (gene 
expression normalized on glyceraldehyde 3-phosphate dehydrogenase) of Oct-4, β-III tubulin, 
brachyury T and alpha-fetoprotein in hESC spontaneous differentiation on chip, under different f. 
Cell morphology in phase contrast for each differentiation condition. Scale bar 50 μm. Data are 
shown as mean ± s.d. (n=3). (b) Early germ layer induction with specific media. The qRT-PCR 
analysis of Oct-4, β-III tubulin, brachyury T and AFP, and comparison between standard static 
control and microfluidic differentiation. Data are shown as mean ± s.d. (n=3). (c) Specific 
differentiation marker expression. Differentiation protocols applied on hESC line cultured on 
matrigel-coated channels. Immunofluorescence analysis of each differentiation protocol, with 
high expression of β-III tubulin in ectoderm, brachyury T in mesoderm and AFP in endoderm. Scale 
bar 50 μm. (d) Mesoderm optimization. The qRT-PCR analysis of Oct-4 and brachyury T expression 
in different frequencies of medium change for germ layer commitment optimization. brachyury T 
expression is comparable between f=3d
-1
 and f=2d
-1
, while there is a significantly lower expression 
at high and low frequencies. Student’s t-test p-values *P≤0.05 **P≤0.01. Data are shown as mean 
± s.d. (n=3). 
 
Therefore, we then demonstrated whether functional tissue-specific cell generation on chip can 
be achieved. We focused on cardiac and hepatic cells that are derived from mesoderm and 
endoderm germ layers, respectively, are extremely relevant for organ-on-a-chip applications. Cell 
differentiation was achieved by combining ad hoc hPSCs differentiation stages, germ layer 
specification and mature differentiation with proper frequencies of periodic perfusion and 
chemical regulation of soluble microenvironment. Cardiac and hepatic cell differentiation 
protocols are described in Supplementary Methods. 
We first showed how cardiac cells on chip were derived after 15 days of frequency-dependent 
multi-stage differentiation protocol (Fig. 3a), consisting on mesoderm induction (by Wnt 
induction), early cardiac commitment (by Wnt inhibition) and functional cardiac maturation (by 
pro-cardiac factors supply). Typically 5 to 10 thousands cells per channel were obtained. We 
robustly achieved spontaneous contractile activity from both hES (HES2) and hiPS (ADHF#1)-
derived cardiomyocytes (Supplementary Videos1 and 2, respectively), 60% of cardiac troponin-T 
positive cells showing defined cardiac sarcomeric organization (Fig. 3b). HPSC-derived 
cardiomyocytes show spontaneous calcium transients and excitation contraction coupling. In the 
line scan magnification in Fig. 3c both calcium transients and spark-like spontaneous activity are 
presented. Analyzing calcium handling of hPSC-cardiomyocytes in microchannels, we observed 
cardiomyocyte functional response to 0,5 µM Verapamil with reduced calcium release after L-
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type channel inhibition, and response to 10 mM caffeine with cytosolic calcium increase after 
ryanodine channel activation (Fig. 3d). We successfully showed that it is possible to generate 
functional cardiac cells on chip and to directly perform dynamic biochemical stimulations taking 
advantage of the microfluidic environment, which allows robust, accurate, fast, and cost-
effective spatio-temporal control of cell microenvironment
11
. 
We next applied our methodology to derive hepatocyte on chip consistently with the previously 
endoderm-optimized conditions, which showed higher efficiency in endoderm differentiation 
than conventional cell culture. Hepatic cells were obtained from both hESCs and hiPSCs by early 
endoderm commitment, definitive endoderm specification and hepatocyte-like cell maturation 
steps, driven by specific periodic medium delivery (Fig. 3e). In order to prove the robustness of 
our method, in addition to hESCS (HES2) and retrovirus-derived hiPSCs (ADHF#1), we generated 3 
different hiPSC lines by non-integrating methods: Sendai viruses (Send#8) and modified mRNAs 
(mRNA#2, mRNA#5).  
Characteristic polygonal-shaped hepatocyte-like cells are obtained, with presence of bi-nucleate 
cells at the late stage, showing high expression of the specific hepatic markers albumin and 
cytochrome P450 3A (Fig. 3e-f). Similar results were obtained for all other 4 different hiPSCs lines 
(Supplementary Fig. S4). Quantification of immunofluorescence of late stage albumin and CYP-3A 
in hESCs shows higher expression in microfluidic differentiated cells compared to differentiation 
control on Petri dish (Fig. 3g and Supplementary Fig. S3b). The hepatic cells show functional 
activity by high glycogen storage capacity (75% of total cells) and indocyanine green uptake and 
clearance (Fig. 3h), which is extremely relevant for hepatic drug metabolism studies. As expected 
from prior results, compared to static conditions, we obtained a shortening of the time required 
for differentiation (from 16d to 14d) and 40% greater albumin secretion rate on the last day of 
maturation (Fig. 3i). An albumin production rate comparable with hESCs-derived hepatocytes 
was obtained with different hiPSCs lines (ADHF#1, Send#8, mRNA#2 and mRNA#5), confirming 
the robustness of the method (Fig. 3j). The microfluidic environment together with optimized 
periodic perfusion frequency provides an effective methodology for generating hepatic-like 
tissues on a chip with remarkable functional differentiation also compared to conventional cell 
culture methods. 
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Figure 3 | Cardiac and hepatic functional differentiation on-a-chip from both hESCs and hiPSCs. 
(a) Microfluidic cardiomyocyte differentiation protocol and morphology changes from pluripotent 
state to differentiated cell type. Scale bars 200 µm. (b) Immunofluorescence of hES-derived CM 
showing f-actin and cardiac troponin-t organization. Scale bars 20 µm (c) Microfluidic calcium 
dynamics. Spontaneous calcium transients in hPSC-cardiomyocytes recorded with Fluo-4 
indicator. (d) Functional cardiomyocytes response to 0,5 µM verapamil with reduction in calcium 
release, and to 10 mM caffeine with increase in cytosolic calcium. (e) Hepatic differentiation 
protocol and cell change in morphology up to hepatocyte-like cells. Red arrows indicate 
binucleate cells in late stages.  Scale bars 200 µm. (f) Immunofluorescence stain for hepatocyte-
like markers albumin and cytochrome P450 3A from hESCs. Scale bars 30 µm. (g) Quantification of 
immunofluorescence markers. Microfluidic hepatic cells show significant higher expression of ALB 
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and CYP-3A compared to static control. Data are shown as mean ± s.d. (n=10). (h) PAS staining of 
hepatic cells derived on chip; nuclei are stained in blue, pink-violet colored cells show glycogen 
storage. Indocyanine green staining of live hepatic cells; colorant is absorbed and metabolized in 
6 h by functional hepatocyte-like cells. (i) ELISA albumin secretion quantification. Microfluidic-
derived hepatocyte-like cells secrete 40% more albumin compared to static control at the last day 
of differentiation. Student’s t-test p-values *P≤0.05 **P≤0.01. Data are shown as mean ± s.d. 
(n=3). (j) Comparison of Albumin production at Day 14 for different hiPSCs derived cell lines 
differentiated into hepatocytes-like cells. Levels of albumin secretion comparable to HES2-hESC 
line-derived hepatocytes were obtained for hiPSCs lines ADHF#1, derived with retroviruses, 
Send#8, derived with Sendai viruses and mRNA#2-5, derived with mRNA technology (albumin 
production rate is expressed as ng/mL/day/2x10
5
 cells). 
 
In conclusion, we derived functional tissue-specific cells on a chip through a robust multi-stage 
microfluidic technology, which allows accurate spatio-temporal control of cell soluble 
microenvironment through regulation of periodic-perfusion frequencies. Moreover, functionally 
differentiated cells derived in the microfluidic channels can be directly used for dynamic multi-
parametric and large-scale drug screening or for developing micro-engineered human organ 
models. This technology opens a new perspective in generating organs-on-chips from hPSCs 
overcoming the issues related to the limited availability of human primary cell sources. This last 
aspect will require strong scientific and technological efforts for further mimicking the 
organogenesis in vitro. 
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Supplementary figures 
 
 
Supplementary Figure 1 | Pluripotency marker expression in human pluripotent stem cells 
cultured in microchannels with f=2d
-1
. (a) “HES2” hES cell line showing oct-4 and sox2 expression. 
(b) “ADHF#1” hiPS cell line showing oct-4 and sox2 expression. High homogeneity in expression is 
shown along the microchannels with no upstream and downstream effects. 
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Supplementary Video 2 | Cardiac monolayer differentiation on chip of hPSCs. (a) Beating 
cardiomyocytes derived from hESCs. (b) HiPSCs-derived beating cardiomyocytes in microchannels. 
 
 
 
Supplementary Figure 3 | (a-b) HES and hiPSC-derived hepatocyte-like cells. Cells from both cell 
lines show comparable differentiation into polygonal hepatocyte-like cells with similar albumin 
secretion. (c-d) Comparison between standard static (c) and microfluidic (d) hepatic 
differentiation of hPSC. Cells show similar expression of CK-18 hepatic endoderm marker. 
Microfluidic hepatocyte-like cells show higher expression of albumin and Cyp-3A compared to 
standard static differentiated cells. 
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Supplementary Figure 4 | Multiple pluripotent cell lines differentiated into hepatocyte-like cells. 
Human embryonic stem cell line HES2. Human induced pluripotent stem cell line ADHF#1 
retrovirus-derived. HiPSC line Send#8 Sendai virus-derived. HiPSC lines mRNA#2 and mRNA#5 
mRNA-derived. Panel show cells in bright field and F-actin for cell morphology and polygonal-
epithelial shape structure. Hepatocyte-like cells derived from each line have been marked for 
Cytokeratin 18, marking late hepatic endoderm epithelium. All cell have been marked also for 
Albumin, marking hepatocyte-like cell producing human albumin. 
 
Supplementary methods 
 
Computational Model 
 
Mathematical model of signaling pathway describing gene transcriptional activity promoted by 
synergic positive effect of extrinsic exogenous and endogenous factors is shown in Fig. 1a. The 
model takes into account only relevant phenomena  to highlight the effect of dynamic changes in 
extrinsic factors modulated by medium delivery frequency, f, on a hypothetic transcriptional 
activity. Black arrows in Fig. 1a indicate chemical reactions involved in the pathway. In particular, 
reactions (1) and (2) describe the coupling of exogenous, Ex, and endogenous, En, factors to 
specific membrane receptors, which promotes the activation of transcriptional factor, Tr. In 
addition, Tr is activated at a basal level through reaction (3) and induces expression of 
pluripotency-associated genes through reaction (4). Gene transcripts, Gt, in turn, produce newly 
En, as indicated by reaction (5). The model consists of four ordinary differential equations 
describing dynamic mass balance equation for the involved species Ex, En, Tr and Gt:  
 
 
 
                                                                                                                             
(1) 
d%cEx
dt
= &NExIN - &NExOUT -V1
d%cEn
dt
=- &NEnOUT -V2+V5
d%cTf
dt
=V1V2+V3
d%cGt
dt
=V4-V5











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c are concentrations of species involved in the pathway (Ex, En, Tr and Gt); ~ symbol indicates 
adimensional concentration normalized for the initial concentration value c
0
. N is the molar flux, 
given from the product between the medium flow rate and the concentration of each species, at 
the inlet and outlet of the microfluidic channel. Exogenous inlet flux is constant, as exogenous 
factors are continuously supplied with medium, whereas outlet fluxes are time-dependent. All 
chemical reaction rates are assumed first order kinetics as follows: 
 
 
                                                                                                                                                              
(2)                                                       
 
 
, 
where ki are constant of reaction with arbitrary value and dimension [t
-1
].  
As an intermittent flow perfusion for medium delivery will be used, system of equations (1) can 
be solved throughout an interval time equivalent to the reciprocal of the frequency, 1/f, and for a 
defined number of cycles, Ntot. Consequently, null inlet and outlet fluxes and opportune initial 
periodic conditions were set. Time for medium change in the microfluidic channel was assumed 
negligible and periodic concentration values of Ex and En were set equal to 1 and 0 respectively 
after every time period (1/f). The system was solved for different values of f with periodic initial 
conditions written as follows: 
                
System of ordinary equations (3) was computationally solved with MATLAB, by using ode15s 
function. Constant rates k1, k2, k4 and k5 were arbitrarily set equal to 1, whereas k3 was taken 
equal to 0.1. Ntot was chosen in order to achieve a pseudo-stationary of all species 
concentrations. 
 
Microfluidic device micro-fabrication and protein functionalization 
 
The microfluidic chip was fabricated by standard soft-lithographic techniques
1
. The master was 
photo-lithographically patterned by using SU8-2100 negative photoresist (MicroChem, Newton, 
MA) to obtain a final thickness of 200 micron, according to manufacturer’s indications. A 
premixed 10:1 ratio of polydimethylsiloxane, PDMS, pre-polymer and curing agent solution 
(Sylgard 184 kit; Dow Corning, Midland, MI) was casted on the silicon wafer and cured at 70 C° 
for 2 h. The PDMS mold was cut, peeled off, and punched with a 21G stainless steel needle (Small 
Part Inc., Logansport, IN) to obtain inlet/outlet holes. The PDMS mold was assembled and sealed 
to a 50×75 mm cleaned glass slide by plasma bonding. Eight independent medium reservoirs 
V1 = k1%cEx
V2 = k2 %cEn
V3 = k3
V4 = k4 %cTf
V5 = k5 %cGt
d%cEx
dt
= −k1 %cEx
d%cEn
dt
= −k2 %cEn + k5 %cGt
d%cTf
dt
= k1k2 %cEx %cEn + k3
d%cGt
dt
= k4 %cTf − k5 %cGt











%cEx(t =
i
f
) =1
%cEn(t = if ) = 0
%cTf (t = 0) = 0.1
%cGt (t = 0) = 0.1
i = 0,1,..., N
(3) 
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(3mm diameter and 4mm height for about 30microL volume), one for each channel, were 
obtained by sealing an additional PDMS block to the top of the device by plasma bonding. The 
assembled device was cleaned with isopropanol (Sigma-Aldrich, St. Louis, MO) and sterilized in an 
autoclave.  
Microfluidic channels were filled with Matrigel Reduced Factor, MRF (BD) diluted in IMDM 
(Invitrogen) to a final concentration of 20% and incubated overnight at 4°C. Coating solution was 
aspirated and microfluidic device was incubated at 37°C and 5% CO2 atmosphere for 1 h. 
 
Sendai viruses-mediated hiPSCs generation 
 
Human fibroblasts derived from skin-biopsy were plated and cultured in a 24-well plate and 
cultured to 70% confluence in fibroblast medium (DMEM supplemented with 10% FBS). CytoTune 
iPS Sendai Reprogramming Kit (Invitrogen) based on replication incompetent Sendai virus was 
used to deliver the four transcription factors Oct4, Sox2, Klf4 and c-Myc and induce 
reprogramming to iPSc, according to manufacturer instructions. After 24h transduction, cells 
were fed every other day for 7 days. Transduced cells were then transferred onto inactivated 
MEF feeder cells at a density of 1 x 10
4
 cells on a 6-well plate and expanded as reported below. 
 
Human induced pluripotent stem cell generation by modified mRNA 
 
Human iPS reprogramming using modified mRNA (mmRNA) was performed following the 
protocol in Warren et al (2010)
2
. Briefly, inactivated human newborn foreskin fibroblast feeders 
(NuFF-RQ, AMS Biotechnology) were seeded in 6-well tissue culture plates, coated with gelatin 
0.2%, at a density of 260 cell/mm
2
, and cultured in Dulbecco's modified Eagle medium (DMEM, 
Life Tecnologies) supplemented with 10% fetal bovine serum (FBS, Life Tecnologies). Cells were 
always incubated at 37°C and 5% CO2. After 24 h, human foreskin BJ fibroblasts (Miltenyi Biotec) 
were seeded at 10 cell/mm
2
 and cultured in Eagle's minimal essential medium (EMEM, Life 
Tecnologies) with 10% FBS. After another 24 h, medium was switched to Pluriton reprogramming 
medium (Miltenyi Biotec) supplemented with B18R interferon inhibitor (Prodotti Gianni) at a final 
concentration of 200 ng/mL, and transfections using mmRNA (Miltenyi Biotec) were started and 
repeated for 18 days, 4 hours prior to daily medium changes. The transfection mix was prepared 
pooling two solutions: the first obtained diluting 5X 100 ng/μL mmRNA of  Oct4, Sox2, Klf4, c-
Myc, Nanog, Lin28, and nuclear GFP in OptiMEM (Life Technologies), and the second diluting 10X 
lipofectamine RNAiMAX (Life Technologies) in Opti-MEM. After mixing, the final solution was 
incubated for 15 min and then added to the culture medium. At day 6 after the first transfection, 
Pluriton reprogramming medium was replaced with B18R-supplemented NuFF-conditioned 
Pluriton medium, which was produced culturing in parallel NuFF cells in T75 flasks with Pluriton 
medium supplemented with bFGF (Peprotech) at 4 ng/mL. Two days after the last transfection, 
iPS colonies were picked and passaged to MEF-coated 12-well plates and expanded as reported 
below. 
 
Human pluripotent stem cell expansion and microfluidic culture 
 
HiPSCs (cell line ADHF#1, obtained from Center for iPS Cell Research and Application, iCeMS, 
Kyoto University; cell line Send#8, generated with Sendai viruses; cell lines mRNA#2 and 
mRNA#5, generated with mmRNA technology) and hESCs (cell line HES2, from National Stem Cell 
Bank, Madison, WI) were cultured in gelatin-coated multiwells with mitomycin C-treated mouse 
embryonic fibroblasts (MEF; Chemicon) co-culture, in expansion medium DMEM F-12 
(Invitrogen), 20% KO serum (Invitrogen), 10% MEF conditioned medium (not used for hiPSCs), 20 
ng/mL basic fibroblast growth factor for hESCs, 10 ng/mL for hiPSCs (b-FGF; Invitrogen), 0.1 mM 
β-mercaptoethanol (Invitrogen), 1% non-essential amino acid (Invitrogen) and 1% Pen/Strep 
(Invitrogen). HPSCs were passaged to new feeder using CTK solution (trypsin 0.25% - collagenase 
IV - Ca
2+
) for hiPSCs and trypsin 0.25% for hESCs (Invitrogen). For MEFs depletion and cell 
expansion and differentiation, cells were passaged on matrigel-coated microchannels. 
The hPSC suspension was injected into each channel and the microfluidic chip was incubated 
overnight at 37°C and 5% CO2 atmosphere without perfusion, to allow cell adhesion to substrate. 
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We used proper cell seeding concentration to achieve 70% confluence cell culture at 24 h after 
seeding. 
A 9-port pump (Cavro® XR Rocket pump, TECAN, San Jose, CA) was used to independently deliver 
the medium from the reservoirs into each microfluidic channels. 0.5 ID Tygon tubings (Cole-
Parmer, Vernon Hills, IL) and 21G stainless-steel needles with a polypropylene luer (Microtest, 
Taipei, Taiwan) were used to connect the microfluidic chip to the pump. Discontinuous medium 
delivery with defined temporal frequencies was achieved by automatically controlling the multi-
channel syringe pump through LabView 8.2 (National Instruments, Austin, TX). For pluripotency 
maintenance, hPSCs were cultured with a 2-cycles/day expansion medium change. 
A minimum of 3 independent microfluidic channles were used for each experimental conditions. 
 
HPSCs early germ layer microfluidic differentiation 
 
For spontaneous differentiation, no exogenous factors and cytokines were used, and the basal 
medium is composed of KnockOut DMEM, FBS 20%, NEAA 1%, L-glutamine 0,5% and P/S 1% (all 
from Invitrogen). Ectoderm differentiation was induced with DMEM F-12 and Neurobasal 
medium (both from Invitrogen), 1:1 ratio, supplemented with B27 1% (Invitrogen), N2 1% 
(Invitrogen) and β-met 0.1 mM
3,4
. Mesoderm differentiation was induced with StemPro-34 
(Invitrogen) supplemented with 2 mM L-glutamine (Invitrogen), transferrin 200 ng/mL, 0.5 mM 
ascorbic acid (Sigma), activin A 0.3 ng/mL (R&D), BMP-4 3 ng/mL (R&D)
5
. Endoderm 
differentiation was induced with RPMI1640 containing 1X B27 (both from Invitrogen), 1mM 
sodium butyrate (Sigma), 100 ng/ml activinA (Peprotech) and 50 ng/mL Wnt3a (R&D)
6
 for the 
first 2 days. The second endoderm medium was KO DMEM with KO serum 20%, L-glutamine 1 
mM, NEAA 1%, DMSO 1%, β-met 0.1 mM, P/S 1% for other 2 days. HPSCs specification was 
induced for 4 days in all three germ layers. A minimum of 3 independent microfluidic channles 
were used for each experimental conditions. 
 
Microfluidic cell maturation 
 
For cardiac differentiation cells were cultured with in RPMI/B27-insulin. After 24 h, the medium 
was changed to RPMI/B27-insulin supplemented with 5 ng/mL BMP4 (R&D) for another 4 days. 
At day 5, the medium was changed to RPMI/B27-insulin. At day 7 the cells were transferred to 
RPMI/B27
7
. 
For hepatic differentiation cells were treated with 100 ng/ml activin A and 0.5mM NaB for 3 days 
in RPMI/B27. Medium was changed to KO-DMEM, 20%SR (both from Invitrogen), 1 mML-
glutamine, 1% NEAA, 0.1 mMβ-met, 1% DMSO (Sigma) for 6 days. Hepatic-like cells were 
maturated with L15 medium (Sigma) supplemented with 8.3% FBS, 8.3% tryptose phosphate 
broth, 10 μM hydrocortisone 21-hemisuccinate, 1 µM insulin (all from Sigma) and 2 mML-
glutamine containing 10 ng/ml hepatocyte growth factor and 20 ng/ml oncostatin M (both from 
R&D) for 6 days
8
. For adult specification and maturation, cells were cultured with f=2d
-1
 
maturation medium change.  
The functional differentation of cardiac and hepatic cells were performed in 30 and 50 
independent microfluidic experiments, respectively. 
 
Functional tests 
 
For cardiac functional tests, cardiomyocytes were analyzed at confocal microscopy (Leica SP5) for 
calcium transient, and caffeine and verapamil treatments
9
. 
For hepatic functional tests, hepatocyte-like cells were stained with PAS staining (Sigma) 
according to manufacturer’s instructions, for glycogen storage revelation. Indocyanine green test 
(ICG from Sigma) was performed on living tissue on chip by incubating living tissue for 15 min 
with dye solution. Green cells retaining ICG were photographed. After 6 hours, same fields were 
photographed in order to see complete clearance of ICG by functional hepatocyte-like cells. 
Albumin production and excretion was assessed by collection spent medium (10 µL from each 
micro-channel) and performing enzyme linked immunosorbent assay ELISA (Immunology 
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Consultants Laboratory, Inc.) following manufacturer’s instructions. Secreted albumin levels were 
detected at 450 nm by using plate reader Ininite F2000 PRO (Tecan). 
 
Immunofluorescence and qRT-PCR 
 
Immunofluorescence analyses were performed on paraformaldehyde 4% fixed cells for 15 min. 
Blocking and permeabilization was performed with heat inactivated serum 5%, TritonX-100 
(Sigma) 0.1% for 1h. Cells were stained using primary antibodies in blocking buffer 1 h room T, or 
overnight 4°C, depending on the antibody. Immunostaining was done with secondary antibodies 
Alexa Fluor 488, 594 (Invitrogen) and Hoechst nuclear staining incubation for 1 h at 37°C. Videos, 
bright fields and immunofluorescence images and merges were taken on Leica DMI 6000 B. 
The qRT-PCR was performed with TaqMan gene expression assay probes (Invitrogen) according 
to manufactures instructions using GAPDH (glyceraldehyde 3-phosphate dehydrogenase), 
POU5F1 (oct4), TUBB3 (beta-III tubulin), AFP (alpha-fetoprotein), T (brachyury) probe sets (all 
from TaqMan Invitrogen). Reaction was done on ABI Prism 7000 machine and results were 
analyzed with ABI Prism 7000 SDS software. GAPDH expression was used to normalize values of 
gene expression, and data are shown as relative fold change. 
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Abstract 
 
Duchenne muscular dystrophy (DMD)–associated cardiac diseases are emerging as a major cause 
of morbidity and mortality in DMD patients, and many therapies targeted to skeletal muscle 
failed to improve cardiac function. The reprogramming of patients’ somatic cells into pluripotent 
stem cells, combined with technologies for correcting the genetic defect, possesses great 
potential for the development of new treatments for genetic diseases. In this study, we obtained 
human cardiomyocytes from DMD patient– derived, induced pluripotent stem cells genetically 
corrected with a human artificial chromosome carrying the whole dystrophin genomic sequence. 
Stimulation of cytokines was combined with cell culturing on hydrogel with physiological 
stiffness, allowing an adhesion-dependent maturation and a proper dystrophin expression. The 
obtained cardiomyocytes showed remarkable sarcomeric organization of cardiac troponin T and 
α-actinin, expressed cardiac-specific markers, and displayed electrically induced calcium 
transients lasting less than 1 second. We demonstrated that human artificial chromosome 
carrying the whole dystrophin genomic sequence is stably maintained throughout the cardiac 
differentiation process and that multiple promoters of the dystrophin gene are properly 
activated, driving expression of different isoforms. These dystrophic cardiomyocytes can be a 
valuable source for in vitro modeling of DMD-associated cardiac disease. Furthermore, the 
derivation of genetically corrected, patient-specific cardiomyocytes represents a step toward the 
development of innovative cell and gene therapy approaches for DMD. 
 
Introduction 
 
Duchenne muscular dystrophy (DMD) is one of the most common and severe inherited 
neuromuscular disorders, affecting 1 in 3,500 newborn males. DMD is caused by mutations in the 
dystrophin gene encoding a key structural protein of the dystrophin glycoprotein complex, which 
connects the contracting cytoskeletal machinery of skeletal and cardiac muscle fibers to the 
extracellular matrix scaffold.1 The absence of dystrophin in DMD patients causes a broad 
spectrum of physical consequences, eventually leading to a premature death.2 Approximately 
20% of deaths are the result of cardiomyopathies and/or cardiac conduction abnormalities. The 
increased life span of patients affected by DMD allowed by the improvements in treatments of 
respiratory muscle disease made cardiomyopathies (present in ~90% of patients) emerge as a 
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major cause of morbidity and mortality.3 In addition, many experimental therapies have mainly 
focused on skeletal muscle, aiming at the restoration of dystrophin expression in myofibers, and 
have failed to improve cardiac function.4 Derivation of DMD patient–specific cardiomyocytes 
(CMs) and the correction of their genetic defect could provide a valuable cell source for in vitro 
modeling and for studying DMD-related cardiac dysfunctions, in addition to potentially 
representing a significant advancement toward an effective therapy for DMD-associated 
cardiomyopathies. The efficient reprogramming technology pioneered by Yamanaka and 
colleagues5 opened the perspective of deriving large numbers of disease-specific human cells in 
vitro. Human induced pluripotent stem (hiPS) cells are recently emerging as an ideal cell source 
for the generation of clinically relevant cardiac disease models.6 Several recent studies 
demonstrate how hiPS cell–derived CMs can be used for modeling the pathological phenotype of 
inherited cardiac disorders, such as the LEOPARD syndrome,7 type 1 and 2 long QT syndrome, 8–
10 catecholaminergic polymorphic ventricular tachycardia, 11 arrhythmogenic right ventricular 
dysplasia/cardiomyopathy,12 and the dilated cardiomyopathy.13 However, to our knowledge, 
CMs from DMD patient–derived hiPS cells have never been obtained so far. Moreover, disease-
specific hiPS cell–derived cells could represent a platform for studying in vitro the pathological 
dystrophic phenotype and for testing and validating the therapeutic approaches and their 
efficiency in restoring the normal phenotype.14 In addition, it has been recently demonstrated 
that hiPS cell–derived CMs can efficiently integrate in injured hearts of a guinea pig,15 providing 
a proof of principle for the application of these cells in regenerative medicine aiming at the 
treatment of cardiac dysfunctions. In the perspective of a therapeutic application, the genetic 
defect of CMs derived from inherited disease–specific hiPS cells should be corrected before these 
cells are reengrafted in the patient. DMD is among the most difficult genetic diseases to treat, 
and the dystrophin gene is the largest gene described in the human genome. Promising results 
have been obtained in rodent models of Duchenne cardiomyopathy using adeno-associated 
viruses carrying minimized synthetic dystrophin genes (mini- and microdystrophin).16 These 
approaches do not allow the insertion of a complete functional version of the dystrophin gene. 
On the other hand, exon-skipping approaches,17 which redirect the gene processing bypassing 
the mutation, can be applied only to defined ranges of patients, based on their specific 
mutations. Several studies suggest that utrophin may help in the preservation of heart function in 
young adult mdx mice and heterozygous mdx mice.18,19 However, similar to dystrophin, the 
large size of the utrophin gene also presents a significant challenge to gene delivery.16 Other 
approaches for the treatment of Duchenne cardiomyopathy include the forced expression of 
sarcoendoplasmic reticulum calcium-ATPase via adeno-associated virus gene transfer, aimed at 
restoring calcium homeostasis and improving cardiac contractility,20 without correction of the 
genetic defect. A highly promising gene delivery tool for the correction of the DMD gene is 
represented by human artificial chromosomes (HACs). HAC is an artificially created exogenous 
minichromosome having the ability to replicate and segregate autonomously in target human 
cells and to be stably maintained at episomal level, without integration into the host genome. In 
addition, HACs have the capacity to carry large genomic loci with all their regulatory elements.21 
An HAC vector carrying, for the first time, the whole dystrophin genomic locus including the 
associated regulatory elements (DYSHAC) was developed by Hoshiya et al.22 Furthermore, Kazuki 
et al.23 have demonstrated the complete correction of hiPS cells derived from a DMD patient, 
using the DYS-HAC, pioneering an innovative and promising therapeutic approach for the 
treatment of DMD and DMD-associated cardiac diseases. The first preclinical proof of safety and 
efficacy of DYS-HAC– mediated therapy has been provided by Tedesco et al.24 In this study, the 
authors showed a significantly ameliorated phenotype in the mdx dystrophic mouse model after 
the transplantation of mdx 
mesoangioblasts genetically corrected with the DYS-HAC. In addition, the same group recently 
reported the differentiation in mesoangioblast- like stem/progenitor cells from DMD patient–
derived hiPS cells, carrying the genetic correction with the DYS-HAC.25 
In this article, we aim to differentiate DMD patient–derived, genetically corrected hiPS cells into 
CMs with a mature phenotype and to assess the maintenance of the DYS-HAC during the 
differentiation of hiPS cells. In particular, we aim at investigating the correct activation, at HAC 
level, of the complex mechanisms regulating dystrophin expression, such as multiple promoter 
activities, which should be finely regulated in a development- and tissue-specific way. 
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An ad hoc cardiac differentiation procedure, combining the delivery of cytokines with mechanical 
stimulation, by culturing cells on hydrogel with physiological stiffness, has been designed to allow 
full CM maturation. DYS-HAC–mediated dystrophin expression restoration has been assessed at 
different stages of the differentiation process. The dystrophic CMs established in this work could 
potentially represent a valuable cell source to be used for in vitro modeling of DMD-associated 
cardiomyopathies, and at the same time, the genetically corrected dystrophic CMs possess a 
promising therapeutic potential for the treatment of DMD. 
 
Results 
 
Differentiation of hiPS cells toward the cardiac lineage 
 
To obtain DMD-specific CMs, their genetic correction, and a positive control of dystrophin 
expression, the hiPS following cell lines that differentiated toward the cardiac lineage were used: 
(i) hiPS cells derived from a DMD patient with deletion of exons 4–43 of the muscle isoform 
Dp427m (DMD hiPS cells); (ii) DMD patient–specific hiPS cells genetically corrected by an HAC 
carrying the full-length genomic dystrophin sequence (DYS-HAC hiPS cells); and (iii) hiPS cells 
derived from a healthy individual (healthy hiPS cells), carrying a normal genotype with a wild-
type copy of the dystrophin gene. First, DMD, DYS-HAC, and healthy hiPS cell lines were cultured 
and expanded in their undifferentiated state for up to 10 passages. During expansion, hiPS cell 
colonies maintained the expression of pluripotency markers such as Oct4, Sox2, c-Myc, Tra-1-60, 
and Tra-1-81, as evaluated by immunofluorescence (see Supplementary Figure S1a). In addition, 
DYS-HAC hiPS cells were monitored for the expression of the enhanced green fluorescent 
protein, a marker contained in the DYS-HAC (see Supplementary Figure S1b). The expanded 
colonies were then used for embryoid body (EB) generation. DMD, DYS-HAC, and healthy hiPS 
cell–derived EBs were differentiated toward the cardiac lineage through an ad hoc optimized 
procedure. Overall outline of this procedure is shown in Figure 1a. Remarkably, the enhanced 
green fluorescent protein gene, driven by a CAG promoter contained in the DYS-HAC,23 was 
expressed during all the stages of the differentiation procedure, in DYS-HAC hiPS cells (Figure 1b), 
in DYS-HAC hiPS cell–derived EBs (Figure 1c), and in cultured cells after EB adhesion (Figure 1d), 
indicating the stable maintenance of the DYS-HAC. During the first 16 days of the differentiation 
procedure, EBs were cultured in suspension and subjected to a staged protocol, adapted from 
the one developed by Kattman et al.,26 based on the addition of specific cytokines known to play 
a key role in cardiogenesis during embryonic development to the culture medium. This 16-day 
differentiation procedure resulted in a relevant percentage of spontaneously contracting EBs (see 
Supplementary Videos S1 and S2), ranging from a minimum of 14% for DMD hiPS cell–derived 
EBs to a maximum of 44% for healthy hiPS cell– derived EBs (Table 1). 
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Figure 1. Differentiation of hiPS cells. (a) Schematic representation of the differentiation 
procedure. (b) Undifferentiated colonies of DYS-HAC hiPS cells cultured on murine embryonic 
fibroblast feeder cells. (c) EBs generated from DYS-HAC hiPS cell colonies on day 4 of the 
differentiation procedure. (d) Cultured cells 2 days after EB adhesion. Epifluorescence images 
show the expression of EGFP in each condition, indicating the presence of the DYSHAC. BMP4, 
bone morphogenetic protein 4; DYS-HAC, human artificial chromosome carrying the whole 
dystrophin genomic sequence; EBs, embryoid bodies; EGFP, enhanced green fluorescent protein; 
hiPS cells, human induced pluripotent stem cells; VEGF, vascular endothelial growth factor; bFGF, 
basic fibroblast growth factor. 
 
 
Our recent data demonstrated that a proper cardiac differentiation requires cell–substrate 
interactions to promote functional and structural maturation of hiPS cell–derived CMs.36 For this 
reason, contracting EBs were cultured in suspension up to day 20 and then seeded on hydrogel 
substrate with a physiological stiffness for additional 4 days. Following adhesion, a remarkable 
maturation of CMs was observed in terms of both cytoskeletal architecture and cardiac marker 
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expression (Figure 2). CMs obtained on day 24 were characterized by a remarkable sarcomeric 
organization, as revealed by immunofluorescence of α-actinin, cardiac troponin T (cTnT), and F-
actin, and GAP junction formation, as revealed by immunofluorescence of connexin 43 (Figure 
2a). The percentage of cTnT-positive CMs obtained on the overall population was ~10% (Table 1). 
The same percentage increased to 44 ± 2% when only contracting EBs were selected. Expression 
of sarcomeric cardiac-specific proteins, in particular cTnT and ventricular myosin light chain, in 
adhered CMs, was also confirmed by reverse transcription–polymerase chain reaction (RT-PCR) 
(Figure 2b). For DMD hiPS cell–derived CMs, expression of ML2v, a marker of terminally 
differentiated ventricular CMs, was not observed before CM adhesion but was observed only 
after adhesion. Mesoderm- and cardiac-specific transcription factors GATA4 and NKX2.5 were 
also expressed in all conditions tested, as revealed by RT-PCR (Figure 2b) and 
immunofluorescence (Figure 2a), respectively. CMs cultured in adhesion displayed both 
spontaneous and electrically induced calcium transients lasting less than 1 second, typical of 
calcium cycling during contraction (Figure 2c), together with a diffuse intracellular distribution of 
cardiac-specific sarcoendoplasmic reticulum calcium-ATPase (Figure 2a), a key element of the 
calcium handling machinery needed for calcium reuptake after contraction. 
Taken together, these results show that functionally differentiated CMs were derived from DMD, 
DYS-HAC, and healthy hiPS cells. The observed differences in terms of percentage of 
spontaneously contracting EBs and cTnT-positive CMs on the overall population (Table 1) can be 
due to the intrinsic variability related to the use of different hiPS cell lines and the efficiency of 
the cardiogenic protocol itself. HAC-driven expression of dystrophin sequences originally deleted 
in the DMD patient We then focused on the genetically corrected CMs, testing the restoration of 
HAC-mediated dystrophin expression. DYS-HAC is the first vector carrying the whole dystrophin 
genomic locus, including all the associated regulatory elements.22 This potentially allows proper 
activation of the complex mechanism regulating dystrophin expression, for instance, the 
activities of seven different promoters driving transcription of tissue-specific isoforms and exon-
skipping and exon-scrambling events, which are finely regulated in both development- and 
tissue-specific manner.1 The possibility to restore dystrophin expression in a tissue-specific 
manner, following native regulation mechanisms, makes DYS-HAC a promising tool for the 
treatment of DMD also at cardiac muscle level. 
 
Figure 2. Characterization of hiPS cell–derived CMs. (a) Immunofluorescence of α-actinin; cardiac 
troponin T (cTnT) and F-actin; connexin 43 (Cnx43); sarcoendoplasmic reticulum calcium-ATPase 
(SERCA2a); and GATA4 in adhered CMs on day 24 of the differentiation procedure. Nuclei are 
counterstained with DAPI. (b) RT-PCR shows the expression of NKX2.5, cTnT, and MLC2v in EBs 
obtained from DMD, healthy, and DYS-HAC hiPS cells cultured in suspension (on day 20) and on 
the EB-derived adhered cells on day 24 of the differentiation procedure. (c) Typical calcium 
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transients displayed by hiPS cell–derived CMs on day 24 of the differentiation procedure. The 
histogram reports quantitative evaluation of calcium reuptake rate by the half-life of calcium 
decay and the calcium release phase as the time to peak. Data are presented as SD. CMs, 
cardiomyocytes; DAPI, 4′,6-diamidino-2-phenylindole; DMD, Duchenne muscular dystrophy; DYS-
HAC, human artificial chromosome carrying the whole dystrophin genomic sequence; hiPS cells, 
human induced pluripotent stem cells; MLC2v, ventricular myosin light chain; RT-PCR, reverse 
transcription–polymerase chain reaction. 
 
First, dystrophin expression was analyzed on healthy, DMD, and genetically corrected DYS-HAC 
hiPS cells during the cardiac differentiation procedure, by RT-PCR using specific primers designed 
to span exon–exon junctions localized inside the deleted genomic sequence of the DMD patient 
(from exon 4 to 43 of the muscle dystrophin isoform) (Figure 3a). mRNA from human heart and 
skeletal muscle was used as positive control. As expected, healthy hiPS cell–derived EBs displayed 
dystrophin expression both when cultured in suspension and after adhesion, whereas, as 
expected, in DMD hiPS cell–derived EBs, no dystrophin expression was observed in any condition 
(Figure 3b). In DYS-HAC hiPS cell–derived EBs, dystrophin expression was restored both when 
cultured in suspension and after adhesion. A positive result was obtained for each of the five 
exon junctions checked, distributed on the whole deleted genomic region. HAC-driven expression 
of multiple dystrophin isoforms In vivo, CMs are known to express the full-length muscle 
dystrophin isoform (Dp427m), together with other isoforms, such as the Dp260 (ref. 27) and 
Dp71, the smallest but multifunctional product of the DMD gene expressed in many tissues, 
including cardiac muscle. Dp71 has been shown to contribute to the proper clustering and 
anchoring of structural and signaling proteins to the plasma membrane and of nuclear envelope 
proteins to the inner nuclear membrane.28 
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Figure 3. HAC-driven expression of dystrophin sequences originally deleted in DMD patients. (a) 
The genomic organization of the dystrophin gene: the gray vertical bars represent the exons; the 
green arrows indicate the promoters driving the expression of the different dystrophin isoforms 
within the gene1,2; primer pairs used to amplify exon–exon junctions inside the deleted region are 
indicated by red arrowheads, and those used to amplify specific isoforms are indicated by blue 
arrowheads. Exon number is referred to exons composing the muscle dystrophin isoform Dp427m. 
(b) RT-PCR of specific dystrophin sequences localized inside the patient with deletion of exons (Ex) 
4–43. Primers were constructed to spam five different exon–exon junctions (Ex. J.). cDNA from 
human heart and skeletal muscle was used as positive control. Analyses were performed at three 
different stages of the differentiation process: undifferentiated colonies, differentiated EBs 
cultured in suspension (day 20), and adhered cells (day 24), for each hiPS cell lines (DMD, healthy, 
and DYS-HAC hiPS cells). cDNA from human tissues was used as positive control. cDNA, 
complementary DNA; DMD, Duchenne muscular dystrophy; DYS-HAC, human artificial 
chromosome carrying the whole dystrophin genomic sequence; EBs, embryoid bodies; HAC, 
human artificial chromosome; hiPS cells, human induced pluripotent stem cells; RT-PCR, reverse 
transcription–polymerase chain reaction. 
 
The expression of different dystrophin isoforms such as Dp427m, Dp260, Dp140, and Dp71 was 
analyzed by RT-PCR during the cardiac differentiation procedure on healthy, DMD, and DYS-HAC 
hiPS cells (Figure 4a). mRNA from human tissues was used as positive control. As expected, 
healthy hiPS cell–derived EBs (both in suspension and after adhesion) displayed the expression of 
all the four different dystrophin isoforms. The expression of isoform Dp140 indicates the 
presence of other cell types in addition to CMs, which are expected in this type of differentiation 
procedures.29 In DMD hiPS cell–derived EBs, the expression of the Dp260 isoform, the promoter 
of which stands within the large genomic deletion (exons 4–43), was not observed, whereas 
isoforms Dp140 and Dp71 were still detectable as their promoters are downstream of the 
deleted area (intron 44 and intron 62, respectively). The amplicon relative to isoform Dp427m is 
still present, as the primers specific for this isoform are designed on the first transcribed exons 
(exons 1–3), upstream of the deletion, testifying a proper initiation of dystrophin transcription. 
On DYS-HAC hiPS cell–derived EBs (both in suspension and after adhesion), expression of all 
isoforms can be observed, notably with the restoration of Dp260 isoform transcript. To assess the 
efficiency of HAC-driven recovery of dystrophin mRNA levels, we performed RT-PCR experiments 
targeted at the isoforms expressed in the cardiac tissue (Figure 4b). A set of primers targeting 
exons 25–26 identifying all Dp427 isoforms was used in addition to the Dp427m-specific one to 
assess the relative expression of Dp427 transcripts inside the deleted genomic region. Confirming 
the previous results of the RT-PCR, DMD hiPS cell–derived EBs did not display at all the 
expression of transcripts from inside the deleted genomic region, both in regard to Dp427 
isoforms, the transcription of which is truncated after exon 4, and in regard to Dp260 isoform, 
the transcription of which cannot be initiated. The expression of the truncated Dp427m isoform 
and the short Dp71 isoform was variable among the different experiments, not reaching 
statistical significance (n = 3). Differentiated healthy and DYS-HAC hiPS cell–derived CMs 
displayed similar amounts of all transcripts tested, highlighting the proper function of the HAC in 
driving and regulating the transcription of different dystrophin isoforms. 
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Figure 4. HAC-driven expression of multiple dystrophin isoforms. (a) RT-PCR of dystrophin 
isoforms Dp427m, Dp260, Dp140, and Dp71 at three different stages of the differentiation 
process: undifferentiated colonies, differentiated EBs cultured in suspension (day 20), and 
adhered cells (day 24), for each hiPS cell lines (DMD, healthy, and DYS-HAC hiPS cells). cDNA from 
human tissues was used as positive control. (b) Realtime PCR for dystrophin isoforms present in 
cardiac tissue. Muscle-specific Dp427m is double checked with Dp427m-specific primer set 
spanning exons 1–3 and an all Dp427 isoform-specific primer set spanning exons 25–26. Data are 
presented as mean ± SD. cDNA, complementary DNA; DYS-HAC, human artificial chromosome 
carrying the whole dystrophin genomic sequence; EBs, embryoid bodies; HAC, human artificial 
chromosome; hiPS cells, human induced pluripotent stem cells; RT-PCR, reverse transcription–
polymerase chain reaction; DMD, Duchenne muscular dystrophy. 
 
Taken together, these analyses on mRNA transcripts show that, during the cardiac differentiation 
protocol, dystrophin expression is correctly restored by the DYS-HAC and multiple dystrophin 
isoforms are expressed. 
HAC-mediated restoration of dystrophin protein expression and correct subcellular localization In 
vivo, in physiological conditions, dystrophin is a key structural protein creating a bridge across the 
sarcolemma, which provides a flexible connection between the basal lamina of the extracellular 
matrix and the inner cytoskeleton. For this important role, dystrophin should be correctly folded 
and localized under the plasma 
membrane of skeletal and cardiac muscle cells. For this reason, we verified the proper 
restoration of dystrophin expression at protein level and its subcellular localization by 
immunofluorescence and confocal microscopy. Analyses were performed 4 days after EB 
adhesion on substrate with a physiological stiffness 
of 15 kPa (Figure 5a). DYS-HAC hiPS cell–derived EBs displayed a clear dystrophin expression at 
membrane localization, drawing the boundaries of cTnT-positive CMs. A similar dystrophin 
staining was observed in healthy hiPS cell–derived EBs. On the other hand, as expected, in DMD 
hiPS cell–derived EBs, any dystrophin staining was observed. These results were confirmed by 
western blot analysis, in which full-length dystrophin was not observed in DMD hiPS cell– derived 
CMs, whereas its expression was perfectly restored in CMs corrected with the DYS-HAC (Figure 
5b). Although much less abundant, other dystrophin isoforms were also detectable in the DYS-
HAC–corrected cells (see Supplementary Figure S2). These results demonstrate that the DYS-HAC 
restores the expression of dystrophin at protein level, which can correctly localize at membrane 
localization in genetically corrected, hiPS cell–derived CMs. 
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Figure 5. HAC-mediated restoration of dystrophin protein expression and correct subcellular 
localization. (a) Confocal microscopic analysis of dystrophin and cardiac troponin T expression on 
CMs obtained on day 24 of the differentiation procedure from DMD, healthy, and DYS-HAC hiPS 
cells. Nuclei are counterstained with DAPI. (b) Western blot analysis for dystrophin isoforms with 
a polyclonal antibody and for cardiac marker troponin T detected in two isoforms in the samples 
from human hiPS cell–derived cardiomyocytes. CMs, cardiomyocytes; DAPI, 4′,6-diamidino-2-
phenylindole; DMD, Duchenne muscular dystrophy; DYS-HAC, human artificial chromosome 
carrying the whole dystrophin genomic sequence; HAC, human artificial chromosome; hiPS cells, 
human induced pluripotent stem cells. 
 
Discussion 
 
The derivation of genetically corrected, patient-specific hiPS cells has been recently shown to be 
a promising strategy for modeling genetic diseases. In particular, An et al.30 reported the 
derivation of hiPS cells from Huntington’s disease patients’ fibroblasts that were genetically 
corrected by an homologous recombination approach and differentiated into DARPP-32–positive 
neurons. Tedesco et al.25 reprogrammed fibroblasts and myoblasts from limb-girdle muscular 
dystrophy patients in hiPS cells and developed a protocol for the derivation of mesoangioblast-
like cells that were genetically corrected in vitro with a lentiviral vector carrying the human α-
sarcoglycan gene. The huge potential of hiPS cell technology has also been demonstrated in 
modeling human cardiovascular diseases. Some pioneering proof-of-concept studies on patients 
with inherited arrhythmogenic diseases, most notably different subtypes of long QT syndrome, 
reported the derivation of hiPS cell–derived cardiac cells to reproduce the clinical phenotype “in 
the petri dish.”14,31 In this work we derived, for the first time to our knowledge, human CMs 
(hCMs) from DMD patient–specific hiPS cells and genetically corrected hCMs from DYS-HAC–
containing hiPS cells. Different procedures for the cardiac differentiation of pluripotent stem cells 
have been reported in literature, mainly reproducing in vitro the processes of embryonic 
development through the stimulation of soluble cytokines, driving pluripotent stem cells toward 
early mesoderm specification until the derivation of cardiac progenitor cells.26,32,33 However, 
the major drawback of their application, both in vitro and in vivo, is their immature phenotype. 
To study the restoration of dystrophin expression and its correct localization in cardiac cells, the 
derivation of hCMs characterized by a functionally and structurally mature phenotype is of 
paramount importance. We developed an ad hoc optimized differentiation procedure integrating 
a cytokine-based EB differentiation with a subsequent step of adhesion-dependent maturation. 
Increasing evidence demonstrate that adhesion and substrate sensing are key requirements for 
the process of muscle cell functional differentiation. In our previous work, we have shown that 
the development of sarcomeric structures of human striated muscles is influenced by the 
substrate on which the cells are cultured.34 Furthermore, in our group, it has been recently 
demonstrated that adhesion on substrate with a physiological stiffness promotes functional 
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maturation of hCMs, allowing a shortening of calcium transients.36 Using the procedure 
developed, we derived hCMs presenting expression of cardiac-specific markers, a defined 
sarcomeric organization, and calcium transients lasting less than 1 second. In these conditions, 
dystrophin has been observed to correctly localize at membrane level on both healthy and 
genetically corrected hCMs. Certain variability has been observed in the expression of cardiac 
muscle markers along the differentiation process, for the different hiPS cell lines. This could be 
explained since, as widely reported in literature, hiPS cell lines derived from different cells and 
different clones can have a different ability to differentiate toward the cardiac lineage. In 
addition, it has been recently demonstrated that in vitro cultured DMD skeletal muscle cells 
display a delay in the appearance of typical myogenic markers.35 Similarly, we observed a delay 
in the expression of the late cardiac differentiation marker ventricular myosin light chain in DMD-
derived cardiac cells, compared with the healthy and genetically corrected (DYS-HAC) ones. 
Further analyses could be performed to specifically address this issue in cardiac muscle. hiPS cell–
derived CMs represent a unique platform for testing in vitro the efficiency of the DYS-HAC in 
restoring a proper dystrophin expression at cardiac level, in a patient-specific manner. DYS-HAC is 
a potential tool for use in DMD gene correction, and its ability to properly restore dystrophin 
expression on differentiated human cells has been recently reported.25 However, its efficiency in 
restoring different isoforms’ expression on differentiated hCMs has not been extensively 
investigated so far. For the first time, we demonstrated that DYS-HAC (i) does not hinder and is 
stably maintained during cardiac differentiation of hiPS cells; (ii) allows a proper dystrophin 
expression restoration during the cardiac differentiation procedure of hiPS cells (in particular, the 
expression of specific sequences deleted in the patient was observed); (iii) drives the 
transcription of multiple dystrophin isoforms in CMs at similar expression levels compared with 
healthy hiPS cell–derived CMs, in particular, the full-length muscle isoform Dp427m and the 
cardiac isoform Dp260, which are not expressed in the DMD patient with deletion of exons 4–43; 
and (iv) allows the recovery of full-length dystrophin protein that localizes properly at the cell 
membrane. These results highlight DYS-HAC as a potential tool for use in gene correction of DMD 
patient cells. 
Finally, the coupling of DMD CMs with specific technologies for testing cardiac functionality, such 
as measurement of force generation or performance under stressed condition, will provide a 
unique platform for studying in vitro the pathogenesis of DMD-associated cardiac disease and its 
correction. 
 
Materials and methods 
 
hiPS cell culturing and cardiac differentiation 
 
hiPS cells, obtained as previously reported,23 were cultured on a feeder layer of mitomycin-C–
inactivated murine embryonic fibroblasts. Composition of the culture medium was as follows: 
Dulbecco's modified Eagle medium/F12 (Life Technologies) containing 20% knockout serum (Life 
Technologies), 2 mmol/l of l-glutamine (Life Technologies), 0.1 mmol/l of nonessential amino 
acids (Life Technologies), 0.1 mmol/l of 2-mercaptoethanol (Life Technologies), 50 units and 50 
mg/ml of penicillin and streptomycin (Life Technologies), and 4 ng/ml of basic fibroblast growth 
factor (Peprotech). To maintain the pluripotent state for a high number of passages and avoid 
chromosomal aberrations, the colonies were passed as described 
below—usually once a week. hiPS cells were washed with phosphate-buffered saline (PBS) and 
treated with 1 ml of CTK solution for 30 seconds. CTK solution was prepared as follows: 5 ml of 
2.5% trypsin (Life Technologies), 5 ml of 1 mg/ml collagenase IV (Sigma-Aldrich), 0.5 ml of 0.1 
mol/l CaCl2 (Sigma-Aldrich), and 10 ml of knockout serum were all added to 30 ml of distilled 
water. The mechanical separation of colonies was performed with the use of a stereomicroscope 
to dissect the undifferentiated colonies into several pieces using a cutting pipette. These selected 
pieces were then replated for expansion onto dishes containing fresh murine embryonic 
fibroblast feeders or moved to ultralow adhesion plates to be cultured in suspension for EB 
generation. The obtained EBs were differentiated in suspension using a protocol adapted from 
Kattman et al.26 Briefly, for EB formation, the detached and separated colonies were maintained 
for 24 hours in basal medium (StemPRO-34; Life Technologies), 2 mmol/l of l-glutamine (Life 
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Technologies), 150 μg/ml of transferrin (Roche), 50 μg/ml of ascorbic acid (Sigma-Aldrich), 0.4 
mmol/l of monothioglycerol (Sigma-Aldrich), 50 units and 50 mg/ml of penicillin and 
streptomycin (Life Technologies) supplemented with 10 ng/ml of human bone morphogenetic 
protein 4 (R&D). From day 1 to day 4, EBs were cultured in basal medium with 10 ng/ml of 
human bone morphogenetic protein 4, 5 ng/ml of human basic fibroblast growth factor (R&D), 
and 6 ng/ml of hActivin A (R&D). From day 4 to day 8, the EB culture medium consisted of basal 
medium and 10 ng/ml of human vascular endothelial growth factor (R&D) and 150 ng/ml of hDKK 
(R&D). Finally, from day 8 to day 14, the EB culture medium consisted of basal medium and 10 
ng/ml of human vascular endothelial growth factor and 5 ng/ml of human basic fibroblast growth 
factor. Cultures were maintained in a 5% CO2, 5% O2, and 90% N2 environment for the first 16 
days and then transferred to a 5% CO2 air environment. The obtained EBs were maintained in 
suspension using the last medium described until day 20 and then seeded on hydrogel substrates 
with a physiological stiffness of 15 kPa (prepared as previously described)34,36,37, functionalized 
with 100 μg/ml of laminin (BD), and cultured in these conditions for additional 4 days. 
 
Immunofluorescence 
 
A standard immunohistochemistry protocol was used. Briefly, cells were fixed with PBS 
containing 2% paraformaldehyde (Sigma-Aldrich) for 7 minutes, permeabilized with PBS 
containing 0.5% Triton X-100 (Sigma-Aldrich), and blocked in PBS containing 2% horse serum for 
45 minutes, at room temperature. Primary antibodies were applied for 1 hour at 37 °C. Cells were 
washed in PBS (Life Technologies) and incubated with fluorescence-conjugated secondary 
antibodies against mouse, rabbit, or goat, depending on primary antibody used, for 45 minutes at 
37 °C. Finally, nuclei were counterstained with 4′,6-diamidino-2-phenylindole (Sigma-Aldrich), 
and samples were mounted with Elvanol and viewed under Leica TCS SP5 fluorescence confocal 
microscope (Leica). Primary antibodies used were the following: mouse monoclonal 
anti-cTnT (Thermo Scientific; #MS-295-P; 1:100 dilution), mouse monoclonal anti-α-actinin 
(Sigma-Aldrich; #A7811; 1:100 dilution), rabbit polyclonal antidystrophin (Abcam; #ab15277; 
1:200 dilution), mouse monoclonal anti-Cx43 (Millipore; #MAB3067; 1:100 dilution), goat 
polyclonal anti-SERCA2a (Santa Cruz; #SC 8094; 1:200 dilution), and goat polyclonal anti-GATA4 
(Santa Cruz; #SC 1237; 1:200 dilution). Secondary antibodies used were the following: goat anti-
mouse (Invitrogen; #A11005 and #A11001; 1:200 dilution), goat anti-rabbit (Invitrogen; #A11012 
and A1108; 1:200 dilution), and donkey antigoat (Jackson ImmunoLab; #705-165-003; 1:300 
dilution). All antibodies were diluted in 3% bovine serum albumin (Sigma-Aldrich). 
 
Calcium measurements 
 
Confocal calcium measurements were performed as previously reported in Martewicz et al.38 
Briefly, CMs were loaded in serum-free 25 mmol/l HEPES Dulbecco's modified Eagle medium (Life 
Technologies) supplemented with 2,5 mmol/l of fluorescent calcium dye Fluo-4 AM (Life 
Technologies) for 20 minutes at 37 °C in the presence of 2 mmol/l of Pluronic F-127 (Life 
Technologies) and 20 mmol/l of sulfinpyrazone (Sigma-Aldrich), then incubated for additional 10 
minutes at 37 °C without Fluo-4 AM, and added with 0.2 mmol/l of di-8-ANEPPS (Life 
Technologies). Cell dynamics were obtained in recording solution: NaCl, 125 mmol/l; KCl, 5 
mmol/l; Na3PO4, 1 mmol/l; MgSO4, 1 mmol/l; HEPES, 20 mmol/l; CaCl2, 2 mmol/l; and glucose, 
5.5 mmol/l, to pH 7.4 with NaOH. Line scans were acquired with a Leica TCS SP5 fluorescence 
confocal microscope using a 63× oil immersion objective, with 488-nm Ar laser line as an 
excitation source and 400-Hz acquisition frequency. Line scans were then analyzed using ImageJ 
software (version number 1.46) to obtain calcium transient profile. For evaluating the calcium 
reuptake rate after contraction, the half-life of the calcium decay was considered. Half-life of the 
calcium decay was calculated by fitting a first-order exponential decay to the calcium reuptake 
phase of the calcium transient profile. For the calcium release phase, the time to peak value was 
calculated considering the time from baseline to a minimum of the second derivative of the 
calcium transient. All numerical data were manipulated with Origin 8.1 software. 
 
Reverse transcription–polymerase chain reaction. 
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Total RNA from hiPS cell colonies and differentiated EBs was purified with RNeasy Mini Kit 
(Qiagen), in accordance with the manufacturer’s instructions, or with TRIzol reagent (Invitrogen) 
and treated using a Turbo DNA-free kit (Applied Biosystems) to remove genomic DNA 
contamination. For the cardiac marker analyses, first strand complementary DNA (cDNA) 
synthesis was performed using an oligo- (dT)20 primer and the cDNA Reverse Transcription Kit 
(Applied Biosystems). PCR was performed with cDNA using AmpliTaq Gold (Applied Biosystems). 
Amplifications were performed with an annealing temperature of 55 or 58 °C for 30–35 cycles. 
For the dystrophin isoform analyses, cDNA retrotranscription was carried out with High Capacity 
cDNA Reverse Transcription Kit (Invitrogen), followed by RT-PCR using Platinum Taq Polymerase 
(Invitrogen) with annealing temperature of 60 °C for 35 cycles. All the amplicons were resolved 
by electrophoresis on a 2% agarose gel, followed by staining with SYBR Safe Gel. Primer 
sequences are given in Table 2. 
 
Real-time PCR 
 
Real-time PCR on cDNA retrotranscribed with High Capacity cDNA Reverse Transcription Kit was 
carried out with Power SYBR Green PCR Master Mix (Applied Biosystems) in a 7000 System 
thermal cycler platform (Applied Biosystems). Annealing temperature for all primer sets was 60 
°C (sequences reported in Table 2). Relative amount of transcripts was calculated with Pfaffl 
method relative to healthy hiPS cell–derived EB expression levels. Amplification efficiency for all 
primer sets was >1.9. 
 
Western blot analyses 
 
Detection of dystrophin (antibody 1:500; o/n + 4 °C; Abcam; #ab15277), cTnT (antibody 1:500; 60 
minutes at room temperature; Thermoscientific #MS-295-P), and GAPDH (antibody 1:2,000; 60 
minutes at room temperature; Abcam; #ab8245) was carried out after protein lysates were 
resolved in a NuPAGE 3–8% Tris-acetate polyacrylamide gel (Invitrogen) and transferred for 6 
hours at 4°C on a polyvinylidene difluoride membrane (Invitrogen) with a BioRad cassette. 
Detection was performed with Novex ECL Kit (Invitrogen). Anti-rabbit (Invitrogen) and anti-mouse 
(BioRad) secondary horseradish peroxidase–conjugated antibodies were used. 
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Introduction 
 
Nuclear shape and structure in eukaryotic cells are recognized to be deeply related with cell 
function during developmental, physiological and pathological modifications (Lombardi et al. 
2010, De Vos et al. 2010, Dahl et al. 2010, ). The nucleus, while regulating cell division and 
transcription processes, is exposed to mechanical stimuli from inside and outside the cell. 
Mechanical stimuli are transmitted by the cytoskeleton to the highly specialized nuclear 
membrane. The nuclear envelope connects to and interacts with the inner nucleus through the 
nuclear lamina, a dense protein network also connected to chromatin structure and gene 
regulatory complexes, which is crucial for structural support of the nucleus. Mechanics of the 
interphase cell nucleus is of paramount importance for the biological function of healthy cells 
and it is related to several pathologies (Lee et al. 2007, Hale et al. 2008, Lammerding et al. 2004,). 
A growing number of studies try to analyze nuclear mechanics behavior, and there is an 
emergent topic in scientific research, which investigates the possible relationship between 
nuclear properties and cancer, pluripotency and mechanotransduction responses (Zink et al. 
2004, Davidson et al. 2009 and 2010, Chalut et al. 2012). 
Nuclear stiffness has been evaluated and compared in healthy and pathological cells, and a 
connection between disease and nuclear stiffness was reported (Lombardi et al. 2010, De Vos et 
al. 2010). Nuclear stiffness seems to increase from human embryonic stem cells to differentiated 
cells and chromatin is shown to be less condensed in the pluripotent stage (Pajerowski et al. 
2007). Few studies consider nuclear mechanics as a property of the nucleus in the cell in 
connection with the cytoskeleton. Studies on cancer cells show a strong deformation of the cell, 
and in particular of the nucleus, which adapts to the surrounding micro-topography. Despite such 
large nuclear deformation, cancer cells are still capable to divide, proliferate and differentiate. It 
has been demonstrated that this capability to self-deform depends on substrate topography, cell 
phenotype and cytoskeleton organization (Badique et al. 2013). Interestingly, cancer and stem 
cells seem to have a comparable nuclear behavior. However, nuclear plasticity and self-nuclear 
arrangement due to geometric constraints on human pluripotent stem cells during differentiation 
has never been reported and the comparison between pluripotent cells and cancer cells has not 
yet been performed. 
In this part of the project, the aim was to study human pluripotent stem cell nuclear capacity to 
self-deform under defined geometrical constraints, meant as the spontaneous nuclear response 
to the morpho-topological environment. Here is reported how nuclei of human pluripotent stem 
cells have a high capability to deform and adapt their shape to the geometry of the substrate. 
Give this, the interest focused on understanding if this strong nuclear deformability could affect 
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pluripotency and it was shown that pluripotency is not affected by a highly deformed nucleus. 
Furthermore, we investigate if an highly deformed nucleus can have an influence in the process 
of early germ layer differentiation. Our results show that the strong nuclear deformation of the 
nuclei when seeded in microstructured substrates affects the process of differentiation. Studies 
on stem cells can represent an effective model to evaluate transitions in nuclear plasticity from 
the pluripotent to the differentiated stage and to elucidate the underlying mechanisms. 
 
Results 
 
Pluripotency maintenance in micropillar cell cultures 
 
To evaluate how nuclear deformability changes in different cell lines, osteosarcoma cells (SaOs-
2), hESCs, hiPSCs, cord blood mesenchymal stem cells (CBMSCs) and human epithelial renal cells 
(hERC) were seeded on matrigel-coated microstructured polymeric substrates characterized by 
square micropillars with a width of 7 micrometers, an inter-axial distance of 14 micrometers and 
a height of 7 micrometers. The substrates were fabricated both in polydimethylsiloxane (PDMS) 
and poly-l-lactic acid (PLLA).  PDMS substrates were fabricated through replica molding technique 
and PLLA substrates through hot embossing technique. Substrate morphology was then 
characterized by SEM measurements (Fig. 1B). The geometrical structure of the substrates has 
been designed in order to impose a geometrical constrain to cell body and nucleus: the available 
space among micropillars is smaller than the average diameter both of cells and cell nuclei. 
HOECHST stained cell nuclei of all cell lines were observed through fluorescent  microscopy after 
two days of culture (Fig. 1A). A qualitative analysis of nuclear morphology show how SaOs-2, 
hESC and hiPSC nuclei strongly deform and assume very unusual shapes, to adapt to the 
morphology of the environment. HERCs keep a rounder shape, while CBMSCs are characterized 
by an intermediate behavior, with some nuclei showing concave shape. For each cell line the 
distribution of the number of concavities (Nc) was also evaluated (Figure 1D): cells that have a lot 
of concave nuclei that present only one concavity have to be considered less deformable than 
cells where high number of nuclei show three or four concavities. Lightly deformable cells as 
CBMSC and hERCs are characterized by nuclei that never present three or four concavities. To 
quantify this deformability we calculated two parameters, which are related respectively to 
nuclear penetration below pillar height and to nuclear shape: nuclear deformability (ND) and 
nuclear concavity (NC).  ND has been calculated as the percentage of the nuclear volume that lies 
below pillar height (Fig. 1C). NC is the percentage of nuclei that present at least one concavity. A 
concavity is defined as a concave curvature in cell nucleus: concave shapes appear only in 
deformable nuclei to adapt to pillar interspaces. The calculation of ND show a higher degree of 
deformability of SaOs-2, hESCs and hiPSCs compared to CBMSCs. HERCs show low deformability 
(Fig. 1D). These data are consistent with results obtained through the calculation of NC (Fig. 1E). 
Again, SaOs-2, hESCs and hiPSCs are the cells whose nuclei adapt the most to the morphological 
environment. 
All together these results show that hPSCs have highly deformable nuclei, and this behavior can 
be compared to results found for cancer cell line SaOs-2. Nuclear deformability is much lower in 
mesenchymal cells and very strongly reduced in adult somatic cells. 
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Figure 1. Evaluation of nuclear deformability for different cell lines. A: HOECHST stained nuclei of 
SaOs-2, hiPSCs, hESCs, and CBMSCs acquired through fluorescent microscopy at day 2. Images 
show very deformed nuclei that assume unusual concave and sometimes branched shapes in 
hESCs, hiPSCs and SaOs-2. hERCs keep a round shape and CBMSCs show an intermediate 
behavior. B: SEM image of the PDMS microstructured substrates were cells are seeded. C: 
Confocal image of a fluorescent labeled deformed nucleus: Vb (volume below) is the part of the 
nucleus which penetrates among pillar interspaces; Va (volume above) is the part of the nucleus 
which stays above pillar height. Nuclear deformability (ND) is defined as ND=(Vb/(Va+Vb))*100. D: 
Examples of nuclei with 0 concavities (Number of concavities=Nc=0), 1 concavity (Nc=1), 2 
concavities (Nc=2), 3 concavities (Nc=3) and 4 concavities (Nc=4). The presence of such concavities 
in the nucleus is related to nuclear capability to deform. E: Plot of the nuclear deformability values 
calculated respectively for SaOs-2, hESCs, hiPSCs, CBMSCs and hERCs after fixing the cells at day 
2. hESCs , hiPSCs and SaOs-2 present a nuclear deformability above 50%. F: Plot of nuclear 
concavity, meant as the percentage of cells having Nc>= 1. The histograms show the distribution 
of the number of nuclear concavities (1 concavity Nc=1, 2 concavities Nc=2, 3 or more concavities 
Nc=3, Nc=4) calculated among all the concave nuclei for each cell line. This graph show that hESCs, 
hiPSCs and SaOs-2  present the more deformable nuclei, in particular hESCs and SaOs-2 cell lines. 
 
After assessing how hESCs have a highly deformable nucleus, we investigated if morphologically 
deformed nuclei can affect pluripotent cell behavior. First, we evaluated the possible effects on 
maintenance of pluripotency. HESCs were seeded both in flat (Ctrl) and microstructured (µP) 
matrigel-coated PDMS substrates, and cultured in expansion medium. After 6 days cells were 
fixed and immunofluorescence analysis of pluripotency markers Oct-4, Nanog and SSEA4 was 
performed (Fig. 2A). The analysis shows a comparable expression of the markers between cells 
expanded in Ctrl and µP substrates. To confirm these data, quantitative real time PCR of 
pluripotency markers Nanog and Oct-4 was also performed (Fig. 2B). The results from qRT-PCR 
demonstrate that there is not a significant difference of marker expression between cells 
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expanded on Ctrl and on µP. Pluripotency is maintained by hPSCs also when the expansion is 
performed in µP substrates, where cell nuclei present very deformed shapes. Consequently, self-
deformation does not affect maintenance of pluripotency. The same experiments were 
performed on PLLA flat (Ctrl-PLLA) and microstructured (µP-PLLA) substrates and the same 
results were obtained (data not shown). 
 
 
Figure 2. HESC pluripotency maintenance on microstructured substrates. A: Immunofluorescence 
panel of cells cultured on flat PDMS substrates (Ctrl), showing pluripotency marker expression  of 
Oct-4, Nanog and SSEA4. Cells cultured on PDMS microstructured substrates (µP). Marker 
expression between Ctrl and µP is similar. These panels show how nuclear deformation have no 
effect on pluripotency maintenance. B: qRT-PCR of Oct-4 and Nanog expression in hESCs cultured 
on flat PDMS (Ctrl) and pillar PDMS substrates (µP), which show comparable expression of 
pluripotency transcripts between the two conditions. Relative fold expression normalized on 
GAPDH (n=3). 
 
Effects of self-deformation during early differentiation 
 
Next, we analyzed if the reorganization of the nuclei morphology can influence the process of 
differentiation into the three germ layers. Again, we seeded hESCs both in flat (Ctrl) and 
microstructured (µP) matrigel-coated PDMS substrates. The scheme in Figure 3A shows all the 
steps that lead to the commitment of the cells into early germ layers. Cells were first expanded 
for two days in expansion medium to achieve 70-80% cell confluence. Early germ layer 
specification was induced for 5 days, after which fluorescent labeled nuclei were observed 
through fluorescent microscopy. Interestingly, nuclei from ectoderm germ layer tend to escape 
from pillar interspaces and assume a round shape, whereas nuclei from mesoderm and 
endoderm germ layers still lies among the microstructures keeping deformed shapes. To 
understand if early germ layer specification took place, we immunolabeled a specific marker for 
each germ layer: β-III tubulin for ectoderm, brachyury T for mesoderm and α-fetoprotein for 
endoderm (Fig. 3B). Immunofluorescence early differentiation markers seems normally 
expressed in µP cells, compared to flat controls, and both in deformed nuclei (meso, endo) and 
de-deformed nuclei (ecto). To quantitatively assess changes in gene expression due to nuclear 
deformation, we performed q-PCR to quantify the expression of β-III Tub, Bra-T and AFP for each 
germ layer, both for ctrl and µP substrates (Fig. 3C). Our analysis shows that the expression of β-
III Tub and AFP is comparable between ctrl and µP substrates, whereas there is a significant 
difference between Bra-T expression in ctrl and µP substrates. Bra-T is very lowly expressed both 
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in ectoderm and endoderm early germ layers when the protocol of early germ layers 
specifications are applied on cells cultured on flat substrates (ctrl) whereas there is an usual and 
significant expression of Bra-T on endoderm germ layer obtained from cells cultured and 
differentiated on microstructured substrates (µP). 
 
 
Figure 3. HESC differentiation on microstructured substrates. A: Schematic showing experimental 
procedure of early germ layer commitment in hESCs with self-deformed nuclei. Cell are passaged 
on microstuctured PDMS substrates and expanded for 2 days. Different replicates are then 
induced with specific media into 3 germ layers for 5 days. B: Immunofluorescence panel showing 
differentiated hESCs on flat PDMS substrates (Ctrl) and on PDMS substrates (µP). Cells are marked 
with beta III tubulin for ectoderm, brachyury for mesoderm and alpha-fetoprotein for endoderm. 
Notably, ectoderm cell nuclei tend to homogeneously emerge from the pillars and gain round 
shape. Mesoderm and endoderm cells tend to differentiate while maintaining highly deformed 
nuclei. C: qRT-PCR of early germ layer markers, β-III tub, bry and AFP in the 3 differentiation 
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protocols in both flat (Ctrl) and microstructured substrates (µP) . β-III tub is significantly higher 
expressed in ectoderm flat and pillar differentiation. Bry is significantly higher expressed in 
mesoderm flat and pillar differentiation, and notably, in endoderm pillar differentiated cells. AFP 
is significantly high in endoderm flat and pillar differentiation. Relative fold expression normalized 
on GAPDH (n=3). Student t test p-values P ≤ 0.01 (**). 
 
The nuclear deformation induced by microstructured substrates does not affect mesoderm 
specification, despite cell nuclei keep a high level of deformation during the all process of 
differentiation. Ectoderm specification can also take place when cells are seeded on 
microstructured substrates, but is associated to a strong loss of nuclear deformability by the cells. 
Endoderm germ layer specification is characterized by strongly deformed nuclei that do not lost 
their deformability, but this nuclear reorganization hinders the physiological process of 
differentiation. 
Being ectoderm the only germ layer showing major nuclear morphological changes, we decided 
to further investigate nuclear behavior during differentiation. In Figure 4A is shown a time-course 
of live-stained HES2 nuclei from pluripotent state at day 0, with highly deformed shapes, to 
ectodermal commitment ad day 4, with almost entirely round-shaped nuclei. Figure 4B shows 
nuclear concavity quantification following a day by day measure of percentage concavity. 
Notably, major shape changes happen between day 1 and day 2, with almost all cells losing self-
deformation capacity. It will be necessary to further analyze this results, mainly studying what 
happens when cells start changing morphology during ectodermal commitment. This will be done 
through cytoskeletal analyses, with chemical and biological selective inhibitors of specific 
proteins though to be involved in nuclear and cytoskeletal organization. New results will help to 
understand how important is nuclear deformation during differentiation and if these properties 
have specific relevant applications.   
 
Figure 4. HESC ectoderm differentiation on microstructured substrates. A: Nuclear morphology 
evolution from pluripotent state (Day 0) to ectoderm germ layer (Day 4). Nuclei progressively pass 
from deformed shapes to rounder morphology. B: Nuclear concavity time-course of pluripotent 
cells (Day 0) induced to ectoderm commitment (Day 4). Major drop of NC % in between day 1 and 
day 2 of differentiation. 
 
These first results on pluripotent nuclei self-deformation capacity are important to understand 
the mechanisms of nuclear properties and plasticity. Further and detailed work has to be done in 
order to understand how this intrinsic property is important for pluripotency, early germ layer 
commitment and functional maturation, and to understand if there is a strict connection 
between pluripotent cells and cancer cells properties. 
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Material and methods 
 
Substrate fabrication 
 
Polydimethylsiloxane (PDMS, Sylgard 184, Dow-Corning. Midland, MI) microstructurated 
substrates were fabricated through a replica-molding process. As first step, the negative pattern 
was prepared through standard photolithography technique: Si-wafers were spin coated with AZ-
1518 negative photoresist (MicroChemicals, Germany) for 30 seconds at 2000 rpm and  for 5 
minutes at 80°C. The photoresist was illuminated with UV light (λ=365 nm) through a chrome-
etched mask that consisted of a square lattice (7 μm width) with a lattice constant of 7 μm. 
Uncross-linked resist was removed rinsing the wafer in an AZ-1518 developer (MicroChemicals, 
Germany) for 20 s. The obtained microstructurated Si-wafers were subsequently silanized by 
exposure to the vapor of (tridecafluoro-1,1,2,2-tetrahysrooctyl)-1-trichlorosilane in vacuum for 
30 minutes, to facilitate PDMS removal during the replica-molding step. PDMS elastomer was 
thoroughly mixed with the silicone elastomer curing agent in a 10:1 ratio, poured over the 
microstructured Si-master and kept under vacuum for 1 h to allow the complete filling of the 
pattern and air bubbles removal. The sample was then cured at 80°C for 3 hours and 
subsequently peeled off the Si-wafers. The final micropillar topography was characterized by 
confocal microscopy and scanning electron microscopy (SEM) (fig. 1). The height of the 
microstructures was fixed at around 6 µm. 
 
Image analysis 
 
Nuclear deformability 
 
Nuclear deformability is defined here as the capability of the nuclei to penetrate among pillar 
inter-spaces and it was quantitatively evaluated as the percentage of the nuclear volume which 
lies below pillar height. The quantification was performed through the use of a MATLAB 
algorithm that analyzes a set of z-stack confocal images fluorescent labeled(HOECHST) nuclei. The 
algorithm counts the number of blue pixels in each image and sum all of the pixel from z-stack 
images above pillar height: this sum represents an approximation of the nuclear volume above 
pillar height (Va). Subsequently the algorithms evaluate through the same method the volume 
below pillar height (Vb). As final step, nuclear deformability (ND) is evaluated as: 
ND=(Vb /(Va + Vb ) ) *100 
ND was evaluated for at least 50 nuclei for each cell line. The final value is given by the mean and 
the error bars are the standard deviation among all the analyzed nuclei. 
                                                  
Nuclear concavity 
 
Nuclear concavity (NC) is defined as the capability of cell nucleus to assume unusual concave 
shapes when it penetrates among pillar interspaces in order to adapt to the available area, and it 
was quantitatively evaluated as the percentage of nuclei having at least one concavity. A set of 
confocal images of DAPI stained nuclei (5 to 8 images for each cell line) which were acquired at a 
height of 3.5 micrometers have been analyzed by a suite of MATLAB algorithms. Nuclear images 
are first of all turned into black and white, then the contour of the nuclei is found. In the 
following step a function that calculates the smallest convex area surrounding the nucleus is 
applied (“convex hull”). Afterwards, the area defined by the nuclear contour is subtracted to the 
area defined by the convex hull. In presence of nuclear concavities the result of this subtraction is 
not zero because the convex hull includes also one or more zones that don’t belong to the 
nucleus. In order to avoid to consider as concavity some very small curvatures in the nucleus or 
some artifacts due to image acquisition, we considered as concavities only the areas with a size 
equal or bigger than the 10% of the nuclear area. The algorithm also displays were these concave 
areas are located and it was possible to make a statistics of how many nuclei have just one 
concavity, two concavities or three or more concavities for each cell line. NC was evaluated for at 
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least 120 nuclei for each cell line. The final value is given by the mean and the errors bar are the 
standard deviation among all the analyzed nuclei. 
  
Human pluripotent stem cell expansion and culture on substrates 
 
HESCs (line HES2; National Stem Cell Bank, Madison, WI) and hiPSCs (line ADHF#1; Center for iPS 
Cell Research and Application, Kyoto University) were cultured in gelatin-coated multiwells with 
mitomycin C-treated mouse embryonic fibroblasts (MEF; Chemicon) co-culture. Cells were 
expanded in expansion medium DMEM F-12 (Invitrogen), 20% KO serum (Invitrogen), 10% MEF 
conditioned medium (not used for hiPSCs), 20 ng/mL basic fibroblast growth factor for hESCs, 10 
ng/mL for hiPSCs (b-FGF; Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), 1% non-essential 
amino acid (Invitrogen) and 1% Pen/Strep (Invitrogen). HPSCs were passaged to new feeder using 
trypsin 0.25% for hESCs (Invitrogen) and CTK solution (trypsin 0.25% - collagenase IV - Ca
2+
) for 
hiPSCs. For MEFs depletion, cell expansion and differentiation, cells were passaged on matrigel-
coated PLLA and PDMS substrates, both flat and micropillar structured. The hPSC suspension was 
seeded on each well containing functionalized substrate, and the plates were incubated at 37°C 
and 5% CO
2
 atmosphere, to allow cell adhesion to substrate. For pluripotency maintenance and 
analysis, we used proper cell seeding concentration to achieve 80-90% confluence cell culture 
after 4-5 days. HPSCs were cultured with expansion medium changed every day. 
 
HPSCs early germ layer microfluidic differentiation 
 
For early germ layer induction and analysis, we used proper cell seeding concentration to achieve 
70-80% cell confluence after 2 days. Ectoderm differentiation was induced with DMEM F-12 and 
Neurobasal medium (both from Invitrogen), 1:1 ratio, supplemented with B27 1% (Invitrogen), 
N2 1% (Invitrogen) and β-met 0.1 mM
1,2
. Medium was changed every 2 days. Mesoderm 
differentiation was induced with StemPro-34 (Invitrogen) supplemented with 2 mM L-glutamine 
(Invitrogen), transferrin 200 ng/mL, 0.5 mM ascorbic acid (Sigma), activin A 0.3 ng/mL (R&D), 
BMP-4 3 ng/mL (R&D)
3
. Medium was changed every 2 days. Endoderm differentiation was 
induced with RPMI1640 containing 1X B27 (both from Invitrogen), 1mM sodium butyrate (Sigma), 
100 ng/ml activin A (Peprotech) and 50 ng/mL Wnt3a (R&D)
4
 for the first 2 days. The second 
endoderm medium was KO DMEM with KO serum 20%, L-glutamine 1 mM, NEAA 1%, DMSO 1%, 
β-met 0.1 mM, P/S 1% for other 3 days. HPSCs specification was induced for 5 days in all three 
germ layers. A minimum of 6 independent microstructured substrates were used for each 
experimental conditions. 
 
Immunofluorescence and Real Time PCR 
 
Immunofluorescence analyses were performed on paraformaldehyde 4% fixed cells for 15 min. 
Blocking and permeabilization was performed with heat inactivated serum 5%, TritonX-100 
(Sigma) 0.1% for 1h. Cells were stained using primary antibodies in blocking buffer 1 h room T for 
pluripotency markers, or overnight 4°C for differentiation markers, depending on the antibody. 
Immunostaining was done with secondary antibodies Alexa Fluor 488, 594 (Invitrogen) and 
Hoechst nuclear staining incubation for 1 h at 37°C. Bright fields, immunofluorescence images 
and merges were taken on Leica DMI 6000 B. The qRT-PCR was performed with TaqMan gene 
expression assay probes (Invitrogen) according to manufactures instructions, using GAPDH 
(glyceraldehyde 3-phosphate dehydrogenase), POU5F1 (oct4), NANOG (Nanog), TUBB3 (beta-III 
tubulin), AFP (alpha-fetoprotein), T (brachyury) probe sets (all from TaqMan Invitrogen). Reaction 
was done on ABI Prism 7000 machine and results were analyzed with ABI Prism 7000 SDS 
software. GAPDH expression was used to normalize values of gene expression, and data are 
shown as relative fold change, with a minimum replicates of n=3 for each experimental condition. 
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